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Abstract 
The design of smart biodegradable scaffolds plays a crucial role in the regeneration of tissues and 
restoration of their functionality. Advances in material science and manufacturing and in the 
understanding on the effects of bio-chemical and bio-physical signals on cell behavior, are leading to a 
new generation of 3D scaffolds. Recent developments in additive manufacturing, also known as 3D-
printing, open new exciting challenges in tissue/organ regeneration by means of the fabrication of 
complex and geometrically precise 3D structures. This thesis aimed the development and characterization 
of 3D scaffolds for tissue regeneration. For this, a nozzle-based rapid prototyping system was used to 
combine polylactic acid and a bioactive CaP glass (coded G5) to fabricate 3-D biodegradable scaffolds. 
Firstly, optimization of the printing conditions represents a key challenge for achieving high quality 3D-
printed structures. Thus, we stress the importance of studying the outcome of the plasticizing effect of 
PEG on PLA-based blends used for the fabrication of 3D-printed scaffolds. Results indicated that the 
presence of PEG not only improves PLA processing but also leads to relevant surface, geometrical and 
structural changes including modulation of the degradation rate of PLA-based 3D printed scaffolds. 
Secondly, the obtained scaffolds were fully characterized from the physic-chemical point of view. 
Morphological and structural examinations showed that 3D scaffolds had completely interconnected 
porosity, uniform distribution of the glass particles, and a controlled and repetitive architecture. In 
addition, incorporation of G5 particles increased both roughness and hydrophilicity of the scaffolds. 
Compressive modulus was dependent on the scaffold geometry and the presence of glass. Cell study 
revealed that G5 glass improved mesenchymal stem cell adhesion after 4 h. Additional biological 
characterization in terms of the inflammatory response were also carried out. Novel studies have pointed 
towards a decisive role of inflammation in triggering tissue repair and regeneration, while at the same 
time it is accepted that an exacerbated inflammatory response may lead to rejection of an implant. Thus, 
understanding and having the capacity to regulate the inflammatory response elicited by 3D scaffolds 
aimed for tissue regeneration is crucial. In this context, cytokine secretion and cell morphology of human 
monocytes/macrophages in contact with biodegradable 3D-printed scaffolds (PLA, PLA/G5 and chitosan 
ones) with different surface properties, architecture and controlled pore geometry was reported. Results 
revealed that even though the material itself induced the biggest differences, scaffold geometry also 
affected on the secretion of cytokines. These findings strengthen the appropriateness of these 3D 
platforms to study modulation of macrophage responses by specific parameters (chemistry, topography, 
scaffold architecture). Finally, novel scaffolds composed by two phases (PLA and PLA/G5), for use in 
guided bone regeneration (GBR) were evaluated. Structural, morphological changes were observed 
during the in vitro degradation of both PLA and PLA/G5 structures. Although mechanical properties 
decreased, PLA/G5 scaffolds still showed higher compressive modulus than PLA ones, confirming the 
reinforcing effect of glass particles after immersion time. In vivo implantation was carried out 
subcutaneously in mice up to 30 days. Results showed that PLA scaffolds induced mononuclear cell 
without activating any relevant angiogenic process, while PLA/G5 induced higher presence of 
  iv 
multinucleated giant cells and consequently stimulated the vascularization process and further tissue 
regeneration. The technique/materials combination used in this PhD thesis led to the fabrication of 
promising fully degradable, mechanically stable, bioactive and biocompatible composite scaffolds with 
well-defined architectures valuable for TE applications.  
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Kublai Khan: "Why do you speak to me of the 
stones? It is only the arch that matters to me." 
Marco Polo: "Without stones there is no arch." 
Italo Calvino, Invisible Cities 
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Aims and outline of the thesis 
In previous years, different biodegradable materials based on PLA and calcium phosphate glass for bone 
tissue engineering applications have been developed within the biomaterials research group (Navarro 
2005 and Charles-Harris 2007). In particular 3D porous composite scaffolds have been elaborated. Two 
scaffold processing methods, Solvent Casting and Thermally Induced Phase Separation were optimized 
and characterized. The surface degradation properties, and cellular behavior of the produced scaffolds 
were studied. 
However, the fabrication of scaffolds using these methods lacks consistency and reproducibility. For 
these reasons it is interesting to study 3D-printing, a new technique able to design scaffold architecture 
that may not only improve mechanical performance but also cell growth. Scaffolds produced by 3D-
printing technique have a high degree of interconnectivity and the porosity can be controlled to a great 
extent by optimizing the processing parameters and geometry. 3D- printing offers a unique opportunity to 
study the influence of the micro-architecture of the scaffold upon cell proliferation and ECM generation.  
Furthermore, although PLA has been widely used for scaffolds fabrication, only few studies of nozzle-
printed PLA have been reported. Up to now, setting the right materials composition and process 
parameters has represented a challenging task. Therefore, in this thesis we propose the use of a low 
temperature 3D-printing process that guarantees scaffolds development without any thermal 
degradation of the PLA. In addition, this work aims at dissecting the right conditions such as 
plasticizer concentrations, together with the suitable polymer/solvent concentration and the 
appropriate set of printing parameters in order to fabricate PLA-based 3D direct-printing scaffolds 
with superior geometrical definition and mechanical properties. Thus, the general aim of this thesis 
is the development of three-dimensional PLA-based composite biodegradable scaffolds through an 
additive manufacturing technique and their physico-chemical and biological characterization.  
The main specific objectives are: 
 
• Study of the effect of the incorporation of PEG in the PLA/CaP glass composite system and 
optimization of the protocols and parameters of the CAD/CAM system to produce well defined 3D 
structures. 
• The design, fabrication and characterization of the 3D porous scaffolds fabricated by 3D-printing 
using a PLA/PEG blend and CaP glass particles.  
• Evaluation of the in vitro behavior of human monocytes/macrophages on the developed scaffolds. 
• Evaluation of the in vitro degradation of the developed scaffolds. 
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In order to reach these objectives the thesis has been divided in the following chapters: 
In Chapter 1, a review of the state of the art relevant to this thesis is presented. 
In Chapter 2, the plasticizing effect of PEG on PLA-based blends used for the fabrication of 3D-direct-
printed scaffolds for tissue engineering applications is studied. A comprehensive characterization 
(comprising structural, surface, mechanical and in vitro degradation studies) of the polymer blends and 
composite is done. The selection of a suitable PLA/PEG blend is assessed. 
In Chapter 3, PLA-based composite scaffolds are developed via 3D-printing and characterized in terms 
of their structural, thermal, mechanical properties. Moreover an initial biological evaluation (adhesion, 
proliferation) of the developed scaffolds is presented. 
In Chapter 4, the impact of four different 3-D printed PLA- and chitosan-based platforms (tuning on 
demand specific parameters: chemistry, topography, scaffold architecture) on human 
monocyte/macrophage responses and cytokine profiles is studied. A new protocol for the elaboration of 
3D chitosan scaffolds is developed.  
Chapter 5 presents an in vivo study of biphasic 3D-printed scaffolds for guided bone regeneration. In 
addition, the in vitro degradation behavior of the studied 3D structures has been investigated and related 
to the in vivo findings. 
Chapter 6 presents the conclusions obtained out of this thesis.  
In addition, three appendixes are included: 
In Appendix A, technical specification of the additive manufacturing technique used in this thesis is 
described. 
In Appendix B, the optimization of the parameters for the printing process via calibration curves is 
studied.  
Appendix C is a commentary that stresses on the importance of tuning scaffolds parameters (materials, 





Chapter 1 - State of the Art 
 
1.1. Introduction 
The goal of this PhD thesis is the development and characterization of three-dimensional scaffolds for 
their application in tissue engineering. The thesis has been structured in various chapters devoted to: 1) 
optimization of the materials, 2) development and fabrication of three-dimensional scaffolds, 3) in vitro 
evaluation of the inflammatory response to the developed scaffolds, 4) in vitro degradation study of the 
developed scaffolds, and 5) in vivo tissue regeneration of biphasic scaffolds. This first introductory 
chapter has been divided in different sections to guide the reader through the main aspects and the state of 
the art in which the present work is involved. The first part describes the main tissue engineering 
strategies in the current scenario. In the following part, a comprehensive picture of the materials used in 
Tissue Engineering with focus on poly-lactic acid polymer and a calcium phosphate soluble glass has 
been done. In the same way a state of the art of scaffolds fabrication techniques have been shown, going 
from the traditional processes till additive manufacturing with particular focus on 3D-printing. The 
following section introduces the main biological concepts with special attention to scaffold-based tissue 
engineering, going in more detail in the understanding of bone tissue engineering. Moreover, a brief 
presentation of the inflammatory response and foreign body reaction to biomaterials has been included.  
 
1.2. Biomaterials, tissue engineering and regenerative medicine 
Nowadays, there is a large demand of new available tissues and organs to replace the damaged ones after 
traumatic injuries or diseases. Lack of organs and tissues for transplantation and the necessity of 
immunosuppressive therapies represent onerous problems in human health care. In addition, the scientific 
community has shown a great interest for the concept of “healthy ageing” to enhance quality of life to the 
growing aged population in the world. Different surgical approaches have been adopted to address these 
problems and most of them are based on replacing the damaged tissue with xenografts, allografts or 
autografts. 
Xenografts are organs or tissues of an organism of one species implanted in another individual of a 
different specie or family. A typical example is the transplantation of pig heart valve in human bodies [1]. 
Such strategy has shown quite high availability, but also strong risks of infections and immunological 
responses that could lead to the rejection of the graft from human body.  
Allografts are grafts coming from human donors, usually after death, transplanted in other individuals 
having different genotype. The lack of human donors and the risk of immune response, as mentioned for 
the previous case, are strong limitations for this kind of transplants [2].  
Autografts consist in tissues transplantation from one part to another of the same individuals, mostly used 
for tissue reconstruction e.g. skin or cartilage. On the one hand, these grafts show a faster healing without 
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triggering any immune response on the patients. Autografts can avoid the use of drugs to suppress the 
rejection and “foreign body reaction”. On the other hand, this approach requires a double surgical 
treatment: firstly the tissue should be explanted and harvested with autologous cells and secondly such 
graft will be implanted in the damaged site. In addition, a large period after the surgery is necessary for 
the healing of the explanted zone.  
In order to cover the large demand of new tissues and solve the problems and limitations related to the 
previous strategies, the fundamental concept of Tissue Engineering is to develop new engineered tissue 
with suitable biochemical and physicochemical cues in order to replace normal biological functionality 
into patients. In the last decades, Tissue Engineering has emerged as a multidisciplinary area involving 
fields such as engineering, biology and medical sciences and is expected to achieve a breakthrough in 
regenerative medicine. 
In 1993 Langer and Vacanti gave the first definition of Tissue engineering: “an interdisciplinary field that 
applies the principles of engineering and life sciences towards the development of biological substitutes 
that restore, maintain, or improve tissue or organ functions” [3]. Since then, many other similar 
definitions have been given to define this emerging field. However, several approaches can be identified 
and summarized in three principal strategies: cell therapy, cell instructive materials, and cell within 
matrix.  
 
• Cell therapy. This approach consists in treating damaged tissues by injecting cells previously isolated 
from the same patient or a compatible donor (Fig. 1.1a). Many processes via cells’ transplantation 
e.g. stem cells, have been adopted and approved for human use in different operations. However, the 
main limitation of this method is the lack of fixation of cells in the injured area, indeed they move 
into the body and have been found also in many organs such as the liver, spleen and lungs [4]. 
 
• Cell within matrix. Also known as cell-scaffold engineered constructs, represent a method in which 
3D matrices are associated with biochemical factors and cells previously explanted and expanded in 
vitro from the patient (Fig. 1.1b). It drives to the generation of an in vitro engineered tissue enabling 
continuity and faster cell fixation and attachment, once the implantation is done. The combination of 
cells with matrix currently represents one of the most used approaches in tissue engineering [5]. 
However, in spite of the great efforts made by researchers, currently there are only few cell-based 
products available in the market, mostly for the replacement of skin and cartilage. One explanation is 
the difficulty to overcome the gap between bench-scale research and clinical-scale, providing at the 
same time good manufacturing practice (GMP) qualifications.  Moreover, the culturing process is 
quite complicated making the use of cell-constructs as a regular surgical procedure and obtaining a 
clinical license an enormous challenge.  
• Cell-instructive materials. The development of the new generation of smart biomaterials, also called 
“Cell-Instructive Materials” containing chemical and physical cues able to restore and enhance the 
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function of healthy tissues is strongly required (Fig. 1.1c). This method represents a new option to the 
regeneration of tissues and organs. However, the development of a cells’ free scaffold is one of the 
main challenges in the field. Once implanted in the injured site of the patient, such scaffolds should 
be able to direct and guide cell recruitment, homing, proliferation, differentiation of cells into the 
inner part of the structure [6]. A considerable challenge in the area of regenerative medicine is 
angiogenesis, the formation of new blood vessels that reach the inner part of new engineered complex 
constructs allowing blood delivering nutrients and oxygen to the cells [7,8]. In this context, tuning 
biochemical and physical cues of smart 3D scaffolds may trigger the angiogenic response. In 
addition, it is expected that such “smart devices” could be introduced easier in the market since they 
present fewer limitations than the cell-based constructs previously described. 
 
 
Figure 1. 1 Schematic representation of the three mainstrategies in tissue engineering. a) cell therapy, b) cell with matrix, c) 
cell instructive materials 
 
Finally, the possibility to create three dimensional engineered structures able to simulate the in vivo 
scenario, with respect to the traditional 2D-approaches (tissue culture plate- based), open new 
possibilities in the application of Tissue engineering concepts. Indeed, during the last decade, scaffold-
based investigation is starting to be used not only to regenerate damaged tissues but also for the in vitro 
examination of inflammatory reaction, drug screening, and development of disease models among others. 
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Synergistically coupling the state of the art in scaffolds fabrication techniques [9] with the advances in the 
field of developmental biology [10] lead to new strategies in tissue engineering such as the attainment of 
faster and cheaper high-throughput analysis systems and even the reduction of animal testing [10]. 
 
 
Figure 1. 2.Different Tissue engineering approaches. Adapted from [9]. 
 
As shown in Figure 1.2, mostly there are three components that opportunely combined can guide the 
process of regeneration of a damaged tissue: scaffolds, stem cells, biochemical signals. Undoubtedly, 
scaffolds development represents one of the main challenges in regenerative medicine. Such structures 
should exhibit adequate physicochemical properties, pore size, interconnectivity, and mechanical 
properties in order to trigger a cascade of cellular events leading to the regeneration of damaged tissue. 
Stem cells are the most encouraging source in the regeneration of aged and damaged tissues for their 
capacity to differentiate in specialized cell types [11]. In order to improve the effectiveness of cells, the 
scaffold should mimic as much as possible the natural environment of the extracellular matrix (ECM).  
In this direction, a number of strategies have been used to modify surface properties from a physical and 
chemical point of view. Recapitulation of the biological complexity could be obtained by improving the 
bioactivity of the 3D scaffolds. Many studies have been done by introducing biomolecules, such as grow 
factors, hormones, and small molecules in the scaffold [6,10]. Other approach, mostly adopted for bone 
tissue engineering, consists in the inclusion of inorganic components (e.g. calcium phosphate glass 
particles among others) [12] able to improve bioactivity and to stimulate specific responses at molecular 
level [7].  
Chapter 1  
  7 
Definition of biomaterial 
During the last five decades, the definition of biomaterials has radically changed as much as the evolution 
of the field has been continuously evolving. Indeed, the rising of the biomaterials world and the related 
entry in the market has improved the quality of life for a growing number of people. Nowadays, 
biomaterials have been used in a wide range of applications such as hip prosthesis, contact lenses, heart 
valve, arterial prosthesis, dental implant, and skin. Along time, the development of fabrication 
technologies and knowledge in molecular biology is giving new concepts and adding more complexity to 
bypass undesirable effects of biomaterials implantation. Basically, the biomaterials have been defined and 
summarized in three generations: 
 
• The first one consisting in bioinert materials that minimize the interaction with the biological 
environment in which they are implanted. This strategy leads to a lack of recognition of the material 
by the body and leads the formation of a surrounding fibrous capsule all around the prosthesis. 
 
•  The second one considering biodegradable and bioactive materials. A fundamental property of 
these materials is the capacity to progressively degrade in situ while the new tissue regenerates. 
Bioactivity consists in stimulating the interaction between the biological environment and the 
material itself in order to modify or activate specific responses from surrounding tissue. An example 
of bioactive materials in bone tissue engineering are bioactive glasses, ceramics and composite 
materials, ensuring the formation of hydroxyapatite nano-crystals on the surface and leading to higher 
fixation and replacement of the damaged bone. 
 
• The third-generation of biomaterials was described by Hench and Polak:  “biomaterials are meant to 
be new materials that are able to stimulate specific cellular responses at the molecular level” 
[13,14]. 
 
Certainly the previous classification is not strictly connected with a chronological evolution of the 
biomaterials world being each generation contained in the next one. Furthermore, the strong effort done 
in the last 10 years from a molecular and biological point of view push to refine the definition of third 
generation:  
‘‘A biomaterial is a substance that has been engineered to take a form which, alone or as part of a 
complex system, is used to direct, by control of interactions with components of living systems, the 
course of any therapeutic or diagnostic procedure, in human or veterinary medicine’’ [15]. 
In other words, the new challenge in the development of biomaterials is to achieve the degree of 
complexity of the natural environment by mimicking the extracellular matrix (ECM). Designing scaffold 
with spatial and temporal distribution of mechanical and biochemical signals by using new micro and 
nanofabrication systems will allow the generation of dynamic environments able to tune cells response till 
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the remodeling of the new tissue [6]. 
Lastly, the scientific community is paying great attention to find new strategies for the translation of 
smart biomaterials concepts from the “bench to the bedside”. It seems that the time is coming to transfer 
to the clinic the innovation and the reached maturity achieved in the biomedical labs [16,17]. 
 
1.3. Bone and Bone Tissue Engineering 
Bone tissue is one of the most important connective tissues in the human body. Bone is basically formed 
by an organic phase and inorganic mineral phase. The organic material mainly constitutes the matrix of 
the tissue and it is mostly composed by collagen fibers and other noncollagenous proteins. Bone matrix 
occupies almost the totality of the bone tissue (90%) and collagen is the most abundant protein in the 
human body. The collagen molecule, also called “tropocollagen”, is part of larger molecules called fibrils. 
Tropocollagen is approximately 300 nm long and 1.5 nm in diameter. It is formed by two left-handed and 
one right-handed helices arrangement of polypeptides chains in a way that stabilize the high number of 
hydrogen bonds. Polypeptides chains are composed by arrangement of specific amino acids, such as 
Glycine, Proline, Hydroxyproline and Arginine. The noncollagenous proteins indicated in Table 1.1, 
consist mostly in: osteonectin, osteopontin, osteocalcin, hyaluronan, thrombospondin, proteoglycans, 



































influence deposition of hydroxyapatite and cell-cycle antiadhesive protein; 
binds to growth factors 
 
regulate activity of osteoclasts and precursors; tuning bone formation and 
resorption, balance mineral maturation 
 
cells binding, inhibition of mineralisation and nitric oxide synthase; 
regulation of cells proliferation, tissue repair, and mineralization 
 
a phosphotransferase; potential Ca2+ carrier; hydrolyses inhibitors of 
mineral deposition such as pyrophosphates 
 




cell attachment, binds to heparin, platelets, type I and C collagen, thrombin, 
fibrogen, laminin, plasminogen, and plasminogen activator inhibitor 
 
 
binds to cells, fibrin, heparin, gelatine, collagen. Organises the intracellular 
cytoskeleton by means of receptors. Helps create a cross-linked network in 
the ECM by binding to other ECM components. 
 
 
cell attachment protein due to binding sites for integrins, binds to collagen 
and heparin, plasminogin, and plasminogen activator inhibitor 
 
binds to cells, binds Ca2+; may initiate mineralization 
 
Table 1. 1. Noncollageneous proteins found in bone and their functions. Adapted from [18]. 
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The other major component of bone is the mineral phase corresponding to the inorganic hydroxyapatite. It 
is a calcium orthophosphate containing water with the following chemical composition: Ca10(PO4)6(OH)2. 
The inclusion of hydroxyapatite crystals into the collagenous matrix gives the hardness and rigidity that is 
fundamentally important for bone function. However, bone function is not only restricted to support the 
body and organs that would collapse onto each other but also other important relevancies. Above all, bone 
is a dynamic and highly vascularized tissue acting in a continuous remodeling during the life of every 
individual [19]. 
Indeed, bones also act for: a) protection of the organs (ribs protect heart and lungs, skull protects the 
brain and vertebrae for spinal cord); b) movement (muscles, tendons and ligaments are connected to 
bones allowing allow for bending and movements in different directions); c) mineral reserve of ions (in 
particular Ca and P) which are crucial electrolytes in the blood and take part to every chemical reaction of 
the cells; d) hematopoiesis, that is the process of blood cells (erythrocytes, leukocytes, thrombocytes) 
production starting from  hematopoietic stem cells (HSCs) contained in the marrow of long bones. 
 
 
Figure 1. 3. Hierarchical bone structure [19]. 
 
As every biological tissue, bone (illustrated in Figure 1.3), has a complex hierarchical structure ranging 
from macro to nanoscale. As previously explained, at a nanoscopic level the collagen fibrils are 
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intimately connected with hydroxyapatite crystal forming such bright arrangement from a chemical and 
mechanical point of view. Bone extracellular matrix gives topographical and chemical signals to the cells 
in an intricate ultra porous geometry.  
From a macroscopically point of view, bone tissue is arranged in mainly two conformations: cortical bone 
and spongious or trabecular bone [20]. Cortical bone represents the 80% of the bone mass in the body; it 
is very dense and contains only few microscopic channels. The remaining 20% of the mass is formed by 
trabecular bone consisting in an ultra-porous and interconnected structure with honeycombed or spongy 
appearance into the inner part of bone.  The orientation and density of the trabeculae are strongly 
influenced toward stress directions.  
 
1.3.1. Mechanical properties of bone 
The mechanical properties of trabecular bone are strongly dependent on age [21]. Moreover, mechanical 
tests could be conducted on entire anatomic bone shape or by isolation of particular components of the 
structure. A number of techniques have been used to measure different mechanical properties such as 
uniaxial compressive and tensile assays, three and four-point bending, ultrasound atomic force 
microscopy (AFM) and nanoindentation techniques. In addition, different age, species, dry/wet conditions 
have been analyzed. Nevertheless, as shown in Table 1.2, a wide range of values is obtained when testing 
the mechanical properties. The elevated complexity of the bone microstructure and variation of data do 
not allow setting accurate mathematical models for the understanding of the properties. 
 
 
Property Cortical bone Trabecular bone 
Compressive strength (MPa) 
Flexural, tensile strength (MPa) 
Strain to failure (%) 
Fracture toughness (MPam1/2) 











Table 1. 2. Mechanical properties of bone. Adapted from [22]. 
 
1.3.2. Bone cells 
From a biological point of view, bone has a high regenerative capacity and it is able to heal without the 
help of relevant external intervention. This self-repairing and remodeling behavior is due to the presence 
of three different kinds of cells: osteoblasts, osteocytes and osteoclasts (Figure 1.4). 
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Osteoblasts are the cells responsible of the formation of bone tissue. They are mononuclear cells able to 
produce new bone matrix by secretion of collagen type I, osteocalcin sialoprotein, osteonectin, 
osteopontin, fibronectin, vitronectin, and other proteins of the bone extracellular matrix. Osteoblasts are 
polarized cells, with the nucleus at a boundary, and are deposited along the interface adjacent to bone 
formation such as the periosteum (external surface) and bone marrow (internal surface). They present a 
structurally complex apparatus of organelles (ample endoplasmic reticulum, a great number of ribosomes, 
important Golgi apparatus and mitochondria), characteristic of cells activity involved in protein synthesis. 
Moreover, they are able to influence the mineralization of the tissue by secretion of alkaline phosphatase 
enzyme. High values of alkaline phosphatase are expressed during the differentiation of osteoblasts. 
 
Osteocytes 
Osteocytes are modified osteoblasts that once surrounded by osteoid or demineralized bone matrix, reach 
their maturity. Osteocites represent the primary cells of mature bone and the most common among bone 
cells. They are entrapped in little pores into the bone matrix and show a stellate shape with a reduced 
endoplasmic reticulum and mitochondria and a single nucleum. Such morphology is particularly apt to 
fulfill the function of checking and maintaining mineral concentration in the matrix through thin channels 
within the bone matrix. 
 
Osteoclasts 
Osteoclasts are large multinucleated cells, mostly derived from monocytes/macrophage differentiation. 
They are specialized in bone resorption. They are located at the surface of bone and at sites of old, 
injured, or unneeded bone. In healthy bones the right equilibrium between the actions of osteoclasts (bone 
resorption) and osteoblasts (bone deposition) should exist. This constant process is responsible of bone 
growth and remodeling. 
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1.3.3. Bone tissue engineering 
Bone tissue engineering represents one of the most important branches of regenerative medicine. It is 
particularly involved in the increasing demand of new therapies for significant clinical challenges such as 
osteoarthritis, cranial maxillofacial, dental, osteoporosis and bone cancer. Materials for bone regeneration 
have shown a great potential in clinical applications even with the launch of new strategies of patient-
specific solution to the treatment of damaged tissue.  
First and foremost, the materials suitable for bone tissue engineering should exhibit three essential 
conditions:  
• osteoinduction: capacity of recruitment progenitor cells and the stimulation to differentiate in 
osteoblastic lineage;  
• osteoconduction: aptitude to encourage bone growth and endorse the ingrowth of surrounding tissue 
• osseointegration: potential to integrate both structurally and functionally the implanted material into 
the surrounding bone. 
 
1.4. Materials for biomedical applications 
A great number of materials have been used in the field of tissue engineering in order to fabricate three-
dimensional scaffolds. As previously mentioned, it is well known that bone tissue is a composite material 
principally formed by an organic phase, consisting of a biological polymer (collagen), and an inorganic 
phase composed by a biological ceramic (natural apatite). Taking that into account, it is easy to explain 
why polymers, ceramic and their composites have been widely used to fabricate scaffolds for bone 
tissue engineering [2-4].  
 
1.4.1. Biodegradable polymers 
There are two kinds of biodegradable polymers:  
• Naturally derived polymers include polysaccharides (chitosan, chondroitin sulfate, starch, alginate, 
hyaluronic acid, cellulose) or proteins (collagen, soy, fibrin gels, silk) [24-28].  
• Synthetic polymers are the largest family of biodegradable polymers. They show commonly 
predictable and reproducible physical and mechanical properties (i.e. elastic modulus and degradation 
rate) as result of controlled conditions during the synthesis. An important advantage offered by this 
class of polymers is a high control of impurities with respect to the natural polymers. Thus, it 
decreases any possible risks of toxicity or immunogenicity.  
A brief summary of biodegradable polymers is shown in Figure 1.5, while a list of the main advantages of 
different biodegradable polymer families is indicated in Table 1.3. 
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Figure 1. 5. Biodegradable polymers 
 
 
Polyesters are the most common synthetic polymers for Tissue Engineering applications. They are 
basically divided in unsaturated and saturated depending on the final chemical structure.  
 
Unsaturated polyesters 
Among the unsaturated polyesters, polypropylenefumarate (PPF) and polyhydroxyalkanoates (PHA) are 
the most famous. The main advantage in using these polymers is the biocompatibility of their degradation 
products. The body can easily remove fumaric acid and propylene glycol upon hydrolysis. The limitation 
in using PPF consists in high viscosity at room temperature that makes it difficult to handle. PHA is 
produced by microorganisms under a particular reaction and is also degradable by hydrolysis [29]. PHA 
exhibits degradation by surface erosion mostly at the interface between polymer and water. This class of 
surface-eroding polymers has been intensively investigated for the development of drug-delivery carriers. 
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Saturated aliphatic polyesters 
This class of polyesters is very well known for regenerative medicine applications and has been mostly 
used for the development of 3D scaffolds. In this group of saturated poly-α-hydroxy esters are included 
polycaprolactone (PCL), polylactic acid (PLA) and polyglycolic acid (PGA), as well as many copolymers 
such as polylactic-coglycolide (PLGA) [30-33]. These polymers are among the few synthetic polymers 
approved by the US Food and Drug Administration (FDA) for several medical devices for human clinical 
applications. However, these polymers withstand a bulk erosion process by absorption of water followed 
by ester bonds hydrolysis. In some case, a fast acidification of the surrounding environment can 
exacerbate the inflammatory response [34,35]. The choice of composite materials, mainly Calcium 
Phosphate based (CaP), has been largely used to solve this problem. In general, the degradation rate 
decrease with this order: PGA > PDLLA > PLLA > PCL [30]. Combining different polymers by a co-
polymerization synthesis can also be tuned molecular weight (Mw), glass transition temperature (Tg), 
crystallinity, and degradation rate. In order to improve PLA degradation properties, PLA-based 
copolymers have been synthesized [36]. 
 
 
Table 1. 3. Summary of different polymeric families’ applications: advantages and disadvantages. Adapted from [37]. 
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Polylactic acid (PLA) 
Polylactic acid is one of the most widely used synthetic polymers in biomedical products for drug 
delivery, barrier membranes, guided tissue regeneration (in dental applications), orthopedic, stents, 
sutures, and scaffolds for Tissue Engineering. PLA is a chiral molecule that gives rise to four polymers 
with different morphologies: P-DD-LA, P-LL-LA (also called PLLA), P-DL-LA (also called PDLA) and 
a P-meso-LA. By adjusting the ratio of such polymers, Mw, and fraction of crystallinity it is possible to 
modulate mechanical properties, degradation rate, Tg and many other factors in a desirable way for a 
specific application. The synthesis method of PLA is the ring-opening polymerization of the dimeric 
cyclic ester of lactic acid (or lactide). The polymerization requires heat and a metallic or an 




Figure 1. 6. Production route of polylactic acid. 
 
Pure L-lactic acid or D-lactic acid, or mixtures of both components are needed for the synthesis of PLA. 
L-lactic acid and D-lactic acid, the two isomers of lactic acid, are shown in Figure 1.7. 
 
 
Figure 1. 7. Stereoisomers of lactide acid. 
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In particular, PLLA is the most used polylactic polymer because its degradation follows a hydrolytic 
process typical of the stereoisomer of lactic acid [38,39]. PLLA is semicrystalline and has a Tg in a range 
of 50-65ºC and a melting temperature (Tm) around 170-190ºC. On the other side, PDLA is an amorphous 
polymer with a Tg in a range of 50 - 60°C.  
The polymer used in this thesis is a high molecular weight poly-95LL/5DL-lactic acid (PLA) from 
PURAC Biochem (Gorichem, The Netherlands). It is a copolymer of the LL and DL polylactic acids with 
95% and 5% of each, respectively.  




Table 1. 4. Properties of the P-LL/DL-LA used in this thesis. 
 
 
The degradation of PLA consists in a non-enzymatic break of the ester bonds in it contained. The 
autocatalytic reaction finishes with the elimination of CO2 and H2O [38]. One of the main inconveniences 
of PLA degradation is the release of lactic acid (due to the cleavage of ester bonds) that causes the 
acidification of the surrounding environment [34,35].  
 
Polyethylene glycol (PEG) 
Poly(ethylene glycol) (PEG), also known as poly(ethylene oxide) (PEO), polyoxyethylene (POE) and 
under the trade name Carbowax is the most commercially important type of polyether (Figure 1.8). PEG, 
PEO or POE refers to an oligomer or polymer of ethylene oxide.  
 
 
Figure 1. 8. Polyethylene glycol 
 
Chapter 1  
  17 
PEGs are synthetized by polymerization of ethylene oxide and are commercially available over a wide 
range of molecular weights from 300 g/mol to 10,000,000 g/mol. PEGs are water-soluble liquids or waxy 
solids used in cosmetic and pharmaceutical preparations and in the manufacture of emulsifying or wetting 
agents and lubricants (FDA approved because of its low toxicity). Also, PEGs are good plasticizers due to 
their low glass transition temperature (Tg = -75 to -65°C).  
 
1.4.2. Bioactive ceramics 
Calcium phosphate ceramics and glasses are inorganic compounds that represent another relevant type of 
biomaterials [40]. They have been successfully used as biomaterials to replace hard connective tissues 
specifically for orthopedic and dental applications. This family of materials presents high bioactivity both 
in vitro and in vivo. In vivo, surface modification happens once implanted in host tissues, a thin layer of 
hydroxycarbonate apatite (HCAp) cauliflower-like shape is formed on the surface enhancing the 
integration of the implant with the surrounding tissues [30]. In vitro, this phenomenon has been observed 
when immersing the materials in simulated body fluid (SBF). SBF, developed by Kokubo and his 
colleagues [41], is an acellular solution that has inorganic ion concentrations comparable to those of 
human blood plasma. During immersion in SBF, a HCAp layer is also formed. The HCAp layer is 
chemically and structurally similar to the apatite found in bone tissue. It allows a good integration 
between the implanted material and the external body (surrounding tissue). Moreover, such HCAp phase 
improves the mechanical sustaining of the implant with stronger chemical bonds.  
The most widely used bioceramics are Hydroxyapatite (HAp) and its related crystalline tricalcium 
phosphate α-TCP and β-TCP. They show excellent biological performance but their application in bone 
tissue engineering is limited due to low mechanical strength and slow degradation rate, typical of the 
crystalline materials.  
Within the family of bioactive ceramics, bioactive glasses as well as glass ceramics and other calcium 
phosphate compounds are also included.  
Bioactive glasses are one of the most studied bioceramics in the field of bone tissue engineering. They 
are mainly divided in two families: silica-based and phosphate-based glasses.  
Silica-based glasses, such as Bioglass [42], are composed by SiO2, Na2O, CaO and P2O5, with SiO2 less 
than 60% mol, high concentrations of Na2O, CaO and ratio Ca/P higher than 1 in order to decrease 
acidification and solubility of the material [37]. A number of in vitro and in vivo assessments have proved 
cell attachment, proliferation and differentiation by using different cell sources such as osteoblasts and 
mesenchymal stem cells [43,44]. Nevertheless, due to the high content of silica, this type of glasses is 
stable to hydrolysis and only partially degradable.  
 
Chapter 1  
  18 
Calcium phosphate glasses 
Phosphate-based glasses are completely soluble in water and their degradation rate can be tuned 
depending on the application. Therefore, phosphate-based glasses offer an alternative to the silica-based 
glasses. This type of bioactive glasses is suitable for the development of temporary bioresorbable 
implants. With the aim of modifying the mechanical properties and solubility of these compounds, 
different oxides, such as magnesium, titania, sodium and fluorine among others have been used. 
The biodegradable glass used in this thesis is a titania-stabilised, completely degradable, calcium 
phosphate glass named G5. This glass has the following molar composition (Table 1.5): 
 





Table 1. 5. Molar composition of the titania-stabilised calcium phosphate glass G5. 
 
The addition of G5 [45,46], in particles shape to reinforce and improve bioactivity of PLA scaffolds has 
been explored [47]. It is known that G5 glass is highly hydrophilic (contact angle = 29.8°) [12]. Thus, 
addition of G5 particles contributes to decrease PLA contact angle. Previous studies have demonstrated a 
preferential attachment and spreading of cells on G5 glass particles than in the polymer matrix [12,31]. 
This soluble glass degrades along time while releasing different ions to the surrounding media [45]. It has 
been demonstrated that the presence of G5 glass particles not only increases cell attachment and 
spreading but also triggers angiogenesis and bone formation owing the Ca2+ release and stiffness of the 
glass [7,48].  Indeed, several studies have demonstrated the relevant role of ions on tissue regeneration 
[49,50]. 
The G5 glass was elaborated following a three-step procedure. All compounds were provided by Panreac 
Química S.A. First, CaCO3 is calcinated at 900°C (Figure 1.9) in order to obtain CaO by reaction {1}: 
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Figure 1. 9. Temperature cycle for the calcination of CaCO3. 
 
Next, the CaO is mixed with the other ingredients shown in Table 1.5, placed in a platinum crucible, and 
melted at 1350°C. The mixture remains at 1350°C for eight hours in order to ensure complete 
homogeneity of the molten matter. After eight hours, the molten glass is quenched on a stainless steel 
plate heated at 480°C, and is annealed at 533°C (the glass transition temperature of the G5 glass) for 30 
minutes. The glass cools to form transparent slabs, which are then milled and sieved within a certain 
range. The properties of the G5 glass manufactured with this procedure can be seen in Table 1.6. 
 
 
Density 2.903 gm-3 
Glass Transition Temperature 532.9 ⁰C 
Rate of dissolution 3.2x10-7 g cm-2h-1 
Vickers Hardness 431.1 kg mm-2 
Table 1. 6. Properties of the G5 glass used in this study.  Adapted from [51]. 
 
Undoubtedly, mechanical properties of calcium phosphates strongly decrease by increasing microporosity 
or particle size. Moreover, in bone tissue a high tensile strength and fracture toughness are due to the 
presence of collagen fibres. Thus, the use of a calcium phosphate particles mixed with a biodegradable 
polymer is an available approach to enhance the mechanical behaviour of the material. The use of glass 
particles instead of a bulk system increases the degradation rate of the calcium phosphate phase. In 
addition, they act as filler opportunely introduced in the composite system in order to improve stiffness 
and compressive strength. In Table 1.7, the main properties of the PLA, calcium phosphate (CaP) glass 
and the composite PLA/CaP glass are briefly synthesized.  
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 Bioactivity Degradation Mechanical properties 
PLA Low 
acidification of the surrounding 
environment, could be toxic, induce 
strong inflammatory response 
high tensile strenght and fracture 
toughness, low stiffness: 300 kPa 
(solvent casting); 4.72 MPa (TIPS) 
scaffolds [31] 
CaP glass High high mechanical stability, low degradation rate 
low tensile strenght and fracture 
toughness, high stiffness: 66.6 - 





CaP act as buffer for PLA decreasing 
acidification; the use of CaP particles 
instead bulk glass increase the 
degradation rate 
stiffness: 190 kPa (solvent casting); 
7.10 MPa (TIPS) scaffolds [31] 
Table 1. 7. Bioactivity, degradation and mechanical properties of PLA, CaP glass and the relative ccomposite. 
 
1.5. Scaffolds for Bone Tissue Engineering 
As previously mentioned, the fundamental tesserae of the Tissue Engineering mosaic are scaffolds, cells, 
and signals. Every tissue presented in nature is composed by a matrix and one or more cells types. The in 
vivo matrix represents the ideal environment for cells providing a specific architecture with a precise 
spatial disposition of molecular signals. The design and development of a 3D construct is mainly a great 
challenge in every field of engineering and is the main objective of this thesis.  
In case of Tissue Engineering, the production of temporary structures that provide the cells with the 
appropriate chemical and mechanical signals is crucial for the satisfactory growth of new tissue. To 
achieve this goal, scaffolds should also present bioactive signals and act as reservoir of water, nutrients, 
cytokines, and eventually growth factors. The optimal scaffold candidate for Tissue Engineering 
applications should accomplish a series of specifications [52]: 
 
• The material used should be biocompatible. Once implanted in the body should perform its functions 
without inducing adverse immune response [52,53]. 
 
• The scaffold morphology should possess a highly porous configuration with a fully interconnected 
pore network to allow cells invasion and growth into the inner part of the structure. Porosity and 
interconnectivity are also important to consent flow transport of nutrients, oxygen and metabolic 
waste. Considering that the in situ distance between blood vessels and mesenchymal cells is not 
larger than 100 μm [53,54], the presence of meso and microporosity is also crucial for the 
neovascularization from the surrounding tissue. Thus, an interconnected porous scaffold with pore 
size in a range of 200-600 μm enhances the diffusion rates of nutrient, allowing the bone formation 
[55]. For the in vitro bone regeneration, some authors [56-59] proposed pore sizes ranging from 200 
to 400 μm. Pore sizes between 20 and 125 μm have been used for regenerating adult mammalian skin 
[60] and 45–150 μm for liver regeneration [61]. Pores particularly small could cause pore occlusion 
[62] by cells, stopping the penetration and elaboration of new ECM inside the scaffolds. 
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• Two other factors having strong influence on the oxygen profile and permeability are pores 
tortuosity and shape. A suitable fabrication technique could modulate them, depending on the target 
tissue. Indeed, degree of porosity affects other properties of the scaffold such as its mechanical 
behaviour. Thus, a compromise should be found to achieve suitable features for the tissue that is 
going to be replaced. 
 
• Scaffolds should be bioresorbable, and its degradation rate must be in tune with the growth of new 
tissue.  
 
• Scaffolds’ mechanical properties are one of the main aspects to take into account for the 
development of 3D matrices. They must be similar to those of the tissues at the site of implantation. 
In in vitro conditions, mechanical strength should be sufficient to compete with the hydrostatic 
pressure and the new ECM formation. In vivo the scaffold should resist to load-bearing site pledging 
the tissue regeneration by limiting pore occlusion. In other words, the structure should maintain its 
structural integrity during the first stages of the new bone formation [2]. 
 
• It is important that the designed structure has a high surface/volume ratio in order to enhance cell 
attachment. 
 
• Scaffolds should possess suitable surface properties by tuning both topographical and chemical 
features in order to stimulate cell attachment, proliferation, and differentiation [63-65]. 
 
 Scaffolds fabrication 
From the material science point of view, native bone is a composite material that combines collagen, a 
natural polymer, with a biological hydroxyapatite. Thus, materials used for mimicking bone tissue should 
be mostly composed by a biopolymer matrix and an inorganic phase. Such materials should be organized 
into three-dimensional highly porous structures in which a particle-system of bioactive ceramic/glass is 
entrapped into a polymer matrix. The development of composite scaffold that synergistically combine the 
workability (shapeability) of polymers and fractions of a bioactive ceramic phase in order to reinforce 
mechanically the developed structure can be achieved.  
To this end, a number of scaffold fabrication technologies have been successfully adopted, among others: 
solvent casting with and without particle leaching, thermally induced phase separation (TIPS) combined 
with freeze-drying, microsphere sintering, supercritical gas-foaming, and electrospinning have been 
applied successfully to the fabrication of polymer-ceramic composite scaffolds. In addition to this group 
of conventional techniques, recently, a new family of additive manufacturing techniques has emerged. 
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1.5.1. Conventional techniques for scaffolds fabrication 
Solvent casting particulate-leaching 
Solvent casting is one of the most largely used conventional techniques to produce scaffolds. It involves 
the dissolution of the polymer in an organic solvent and casting into a predesigned Teflon mould. In the 
same way, composite scaffolds have been produced by mixing the polymeric solution with bioactive CaP 
ceramic or glass granules (Figure 1.10). This approach is mostly associated with particulate-leaching in 
order to get highly porous three-dimensional structures. A porogen agent (such as salt or sugar) is added 
to the polymer solution. Then, after the evaporation of the solvent, the salt is dissolved in water leaving 
the pores behind.  
 
 
Figure 1. 10. Schematic description of a particle-leaching method. Adapted from [48]. 
 
The advantages of using this technique are its simplicity and low cost that allows scaffolds fabrication 
without the need of specialised equipment. The primary disadvantages of solvent casting are a) the 
possible retention of toxic solvent within the polymer and b) the limitation in the shapes (basically flat 
sheets and tubes). Furthermore, the use of organic solvent could lead to denaturation of the proteins and 
other biochemical signals incorporated into the polymer. Porosity can be controlled by varying salt 
particles size and the polymer/salt ratio. Nevertheless, control of pores shape and interconnectivity 
between adjacent pores is very low (Figure 1.11). 
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Thermally induced phase separation (TIPS) 
Porous scaffolds have been largely developed by thermally induced phase separation (TIPS) (Figure 
1.12). Polymer and solvent are homogeneously mixed at low temperature. In the case of composites, 
inorganic particles are also included. Once the solvent solidifies, polymer and particles are forced into the 
interstitial spaces. The frozen mixture is then lyophilised using a freeze-dryer in which the iced solvent 
(and water) sublimates allowing the formation of homogeneous and highly porous scaffolds with 
anisotropic tubular morphology. TIPS process has been used to produce PLA/CaP glass scaffolds and its 
in vitro and in vivo response has been intensively studied [51]. Moreover, the attachment and spreading of 
osteoblast cells has been also confirmed [31]. 
 
 
Figure 1. 12. Scanning electron micrograph of a PLLA scaffold fabricated using TIPS [66]. 
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Microsphere sintering 
This process consists in sintering polymer microspheres, previously produced by an emulsion/solvent 
evaporation technique. The sintering process can be thermally or chemically activated depending on the 
system used to attach and fuse the microspheres one to each other: heat or solvent vapour [67]. In the case 
of composites, inorganic particles have been encapsulated into the microspheres. Three-dimensional 
biodegradable and bioactive scaffolds have shown lower porosity of solvent casting or TIPS, but 
mechanical properties closer to cancellous bone.  
 
Gas Foaming 
This technique allows the production of macro-porous scaffolds from biodegradable polymers by using a 
process with high-pressure carbon dioxide at room temperature. After a melt-extrusion step, the 
ceramic/polymer mixture is exposed to high pressure of CO2 gas in order to saturate the system. By 
reducing the CO2 pressure to atmospheric levels, the solubility of the gas rapidly decreases causing 
thermodynamic instability in the network and the formation of pores. Open-pore foams using polyesters 
polymers have been fabricated [68]. 
 
Electrospinning 
In the last years, electrospinning has attracted enormous attention in the scaffold fabrication community, 
particularly for reconstructive surgery application. It is a versatile and simple process to fabricate fibrous 
mats of biodegradable polymers. The dimension of the fibers, at the micro- nanoscale, gets particular 
interest in order to synthetically reproduce the extracellular matrix of living tissues. In the process, a 
polymer solution is forced in a capillary and forms a jet of solution at the tip. As shown in Figure 1.13, a 
high voltage is applied between the tip and the collector where the mat of thin fiber is deposited after the 
evaporation of a volatile solvent.  
 
 
Figure 1. 13 .Schematic representation of electrospinning system. Adapted from [69]. 
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Additionally, the easy incorporation of biochemical signals such as drugs, growth factors or enzymes, 
makes this approach attractive for tissue engineering applications. Nevertheless, significant drawbacks of 
this technique: are a) only few synthetic (PLA, PCL, PLGA) and natural (collagen, fibrinogen) polymers 
have been used to produce random fibers scaffolds; b) only thin layers have been produced, making 
difficult to fabricate geometrically complex three dimensional scaffold with controlled pores. Lastly, fiber 
diameter sometimes undergo in the micrometer range, which is not properly in the size of the natural 
extracellular matrix. 
To conclude, Table 1.8 briefly shows a summary of the main advantages and limitations in using the 
conventional fabrication techniques. 
 
Fabrication technique Advantages Disadvantages 
Solvent casting / particulate-
leaching High porosity, quick and easy Organic solvents are used 
Thermally induced phase 
separation (TIPS) 
High porosity, easily combined with other fabrication 
techniques 
Shrinkage issues, organic solvents are 
used, anisotropic pores 
Microsphere sintering Gradient of pore size and complex shape are possible Interconnectivity is an issue 
Gas Foaming Organic solvent and high temperature are not required Low pore and geometry control 
Electrospinning Structural features similar to extracellular matrix, high aspect ratio and surface area 
Organic solvent are used, low pore and 
geometry control 
Table 1. 8. Main advantages and disadvantages in using conventional fabrication techniques. 
 
 
1.5.2. Additive manufacturing techniques 
Critical size bone defects, especially in the craniofacial region, are significant challenges in surgery and 
are strictly connected with patient’s quality of life and high socio-economical costs. Therefore, new 
technologies should be adopted to achieve successful regenerative strategies. Additive manufacturing 
(AM) is changing radically implantology and regenerative therapies by adding new possibilities to 
reconstruct and regenerate tissues in a patient-specific way [9]. It also provides a tremendous tool to 
fabricate scaffolds on demand for the generation of in vitro platforms for preclinical drug development. 
Compared to the conventional fabrication technique, this new approach brings many advantages. First of 
all, a precise control and reproducibility of geometrically complex microstructures is achievable.  
A fine control of pores size and shape allows tuning mechanical properties and permeability of the 3D 
structures. Honeycomb-like structures can be produced with morphological features similar to the natural 
structure of cancellous bone.  
Overcoming low mechanical properties has always been a great challenge in the development of scaffolds 
for bone tissue engineering.  By setting the design, pore volume, and eventually post processing 
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condition, the new scaffolds produced via AM technologies show higher mechanical properties in 
comparison with the ones produced by other conventional techniques. Moreover, precise selection of 
structural cues, eventually coupled with computational approaches like finite element analysis could give 
estimation of the scaffold behavior once implanted and during the tissue regrowth.  
Such porous structures also provide higher pores interconnectivity and the interconnection area between 
pore volume results bigger and more suitable for cell migration. In the same way, permeability is also 
increased due to a decrease of tortuosity within the structure. Thus, oxygen and nutrients diffuse better 
into the inner part of the scaffold affecting positively the cell response and blood vessel infiltration [70]. 
From a technological point of view, this approach consists in a controlled robotic system connected to a 
CAD/CAM tool that allows the fabrication of 3D structures with well-defined geometries. A fundamental 
aspect to be highlighted is the capacity to produce patient-specific bone grafts. A new protocol based on 
medical imaging (such as computed tomography, CT) can be used. Once the CT data of the patient defect 
is treated in order to generate a 3D model, it can be imported into the software of the AM system. After a 
“slicing process” the three dimensional object is converted in a sum of thin horizontal layers having the 
specific informatics code requested (2D instructions). Afterwards, the code is used to instruct the robotic 
system in order to shape layer by layer the scaffold (Figure 1.14) [71].  
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Figure 1. 14. Tissue Engineering of patient-specific bone grafts [71]. 
 
AM offers a new bottom-up philosophy, contrarily to most of the conventional fabrication approaches in 
which pores formation is due to the volume left by solvents or other agents randomly immersed in the 
bulk material (subtractive approach). As previously explained AM consists in building 3D structures by 
sequentially layering one material on top of another in a desired pattern in a precise and repeatable way. 
This aspect allows choice and spatial positioning of biophysical and biochemical signals (such as calcium 
phosphate glass particles or growth factors) all over the volume of the scaffolds, aiming to trigger specific 
biological responses. 
Before entering a detailed exposition of the main AM used in the tissue engineering field, it is important 
to remark that such technology is still in its infancy [9]. Nowadays, the scientific community is doing a 
great effort in order to develop suitable biomaterials to be used for this aim. Indeed, biomaterials should 
have: a) adequate mechanical properties, b) fitted degradation rate while maintaining structural integrity, 
and c) appropriate rheological quality to be processed. Synergistically coupling suitable biomaterials with 
the extraordinary potential of the AM techniques will make possible the evolution of a new class of 
smarter scaffolds.   
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Moreover, due to the great number of recent publications, the nomenclature used to classify this emergent 
technology is quite confused. Additive manufacturing is also known as rapid prototyping (RP), solid free 
form fabrication (SFF), 3D-printing among many others. Trying to clarify between a great variety of 
categorization, the AM systems have been divided in three fundamental families: laser based, powder 
based, and nozzle based techniques. 
 
Laser based systems 
Stereolithography (SLA) is one of the most famous additive manufacturing techniques and one of the first 
to be commercialized. This laser based process basically consists in a photo-polymerization, in which a 
UV laser is used to build structures layer by layer (Figure 1.15a). A liquid photo-curable monomer resin 
that polymerize when exposed to UV light is used. The laser scans the top of a bath and polymerizes the 
resin creating a solid layer. The process is repeated on the sequent layers by moving down the table until 
the 3D structure is achieved. A post-process treatment could eventually be done by curing in a UV oven 
the obtained scaffold. Large porosity could be obtained with this method, with pore size in the range of 
20-1000 μm. An accurate control over pore size and interconnectivity can be achieved. The layer-wise 
fashioned process allowed fabrication of complex and anatomically shaped structures. However, the 
machinery required are very expensive and only few polymers compatible with UV curing can be used. 
Figure 1.15b shows an example of SLA scaffold. A resin based on PDLLA monomers functionalized 
with methacrylate end-groups was photo-polymerized in the presence of ethyl lactate as a non-reactive 




Figure 1. 15.  (a) Schematic description of stereolitography method; (b) SEM micrographs of PLA scaffolds. Scale bars 




Chapter 1  
  29 
Powder based systems 
The first powder based system, named “3DP” or 3D-printer, was developed in the early 1990s at MIT 
(Cambridge, MA) by Sachs et al. [73]. Nowadays, the word 3D-printer has became one of the most 
common ways to state an additive manufacturing process. 
This class of technology aims to the fabrication of layer by layer three-dimensional structures in which 
every 2D slide supplied by a computer model is printed on a new layer of powder by releasing a thin 
coating of binder [58]. A suitable binder (glue or solvent) should act as a plaster between adjacent powder 
microparticles. Crucial parameters such as powder packing density, wettability, flowability, layer 
thickness, binder drop volume, binder saturation should be optimized to improve the quality of the final 
architecture [59]. 
As shown in Figure 1.16a, successive 2D profiles are printed on a freshly prepared layer of powder until 
the whole model is completed. Once reached the final height of the designed structure, the next step 
consists in the removal of the entrapped unreacted powder. Finally, a suitable post-process is needed. In 
the case of ceramics powder deposition, a typical post-processing method involves high temperature 
sintering in order to promote binder removal and powder coalescence.  A suitable alternative way to 
develop powder-based scaffold has been also the adoption of Selective Laser Sintering (SLS), in which 
the binder jet is replaced by a laser beam that melts selected patterns of powdered material [74]. Figure 
1.16b shows the typical structural morphology of a calcium phosphate scaffold produced via 3D-printing 
technique. Layer thickness and powder particles size are the main factors influencing the final surface 
resolution of the scaffolds. Interconnected porous channels of about 800 μm and micro-porosities of 45–





Figure 1. 16. (a) Schematic description of powder-based method; (b) calcium phosphate scaffold produced by a powder-
based system. Adapted from [23, 58]. 
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Nozzle based systems 
The nozzle based system machines constitute the third family of additive manufacturing techniques.  
Fused deposition modeling (FDM) is one of the most popular rapid prototyping technologies. It was used 
to fabricate scaffolds with honeycomb-like pattern, fully interconnected porous network, and controllable 
porosity and channel size [32].  
FDM is based on an extruder nozzle covered with a heating jacket that push out a thermoplastic polymer 
filament and dispense the melted polymer onto a table along a layer by layer process. The filament is 
forced by two rollers into the extruder and drives the flow out of the polymer. Once the layer is finished, 
the platform moves down and a new pattern is deposited (Figure 1.17a). 
Also for this class of AM techniques, a preliminary optimization of the process parameters is strongly 
required. Fabrication condition such as speed of deposition, diameter of the nozzle, and the design of the 
2D path are depending by the material properties and by the application aimed by the researcher. 
Poly(e-caprolactone) (PCL) is the main used polymer used for this application, due to its low glass 
transition temperature of -60°C. PCL exists in a rubbery state at room temperature, and also has a low 
melting temperature of 60 °C, easily achievable by this kind of machines. Moreover, due to the high 
thermal stability, PCL can be strongly heated without degrading or losing its initial properties. Figure 
1.17b shows the SEM micrograph of scaffold produced by FDM. PCL scaffolds with pore size in a range 




Figure 1. 17. (a) Schematic description of Fused Deposition Modeling method; (b) SEM micrograph of a PCL scaffold. 
Adapted from [23, 39]. 
 
 
Contrarily to the traditional 3D printer systems, in which powder based aliphatic polyesters required the 
use of organic solvents as binder [74], FDM is a solvent free method to produce scaffolds. Nevertheless, 
many are the limitations in using this technique to produce tissue engineering scaffolds. Among them, the 
resolution of the deposited struts is limited and strongly dependent on the diameter of both filament and 
needle tip.  
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Other important restriction to utilize a FDM system is the necessity to prepare polymeric filaments before 
starting the process. It makes the procedure longer and expensive. Moreover, the range of materials 
choice decreases and the eventual development of composite filaments containing CaP microparticles 
makes the printing process even harder to achieve.  With the aim of eliminating the need of filaments and 
to enlarge the range of suitable materials, a number of novel technologies have been developed. Most of 
them are capable to melt and extrude raw polymer in pellets by connecting a heating jacket with a 
cylinder and plunging the materials by screw, coaxial metallic piston or compressed air systems. 
Lastly, high temperatures required during the process do not match with the thermal stability of many 
biodegradable polymers. Biodegradable polymer such as collagen or chitosan, need to be printed at low 
temperatures to avoid denaturation that could lead to fast degradation both in vitro and in vivo.  
This is also the case of polylactic acid, showing a lack in thermal stability at high processing temperature. 
Different mechanisms of degradation can affect the polymer, such as hydrolysis, thermolysis, and 
monomer reformation. It explains also why a number of studies employing nozzle based techniques 
presented in literature shows the use of PCL instead of PLA. Being PLA the polymer used in this 
thesis, it represents a great issue to be taken into account during the implementation. 
Only few studies using PLA have been reported, and most of them were carried out with a laser based 
system approach as stereolithography [72].  An indirect approach to build 3D PLA scaffolds was used by 
Taboas and colleagues [76]. As can be observed in Figure 1.18a, PLA/porogen slurry was casted in a 3D 
printed wax mold containing global pore templates. After the evaporation of the solvent, the PLA 
structure solidified and the mold could be removed leaving a network of interconnected pores. Starting 
from a PLA/solvent solution, Xiong and colleagues developed PLA scaffolds (shown in Figure 1.18b) by 
combining nozzle-printing technology with a freeze-drying system [77]. However, published studies have 
shown a low resolution in term of design, pore size and shape and a great effort should be done to 
improve the complexity and repeatability of PLA microporous structures.  
Thus, this thesis proposes a novel low temperature nozzle-based system in order to avoid the thermal 
degradation of PLA. Moreover, addition of PEG to a PLA/solvent solution will allow the fabrication of 
precise and reproducible 3D structures with higher resolution than the ones obtained by currently (nozzle-
based) methods. 
To conclude, Table 1.9 briefly shows a summary of the advantages and limitations in using additive 
manufacturing systems to develop Tissue Engineering scaffolds. 
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Figure 1. 18. 3D printed PLA scaffolds by (a) indirect approach and (b) low temperature deposition.                                   
Adapted from [60,61]. 
 
 
AM family Advantage Disadvantage 
Laser based system 
Hydrogel, high-resolution and accuracy  
liquid build material can be easily 
removed from within complex 
scaffolding 
Limited choice of materials, may require 
furnace post processing (e.g. bioceramics), 
high material cost, complex and expensive 
equipment 
Powder based system 
Wide range of material choice, low 
cost, quick process, multimaterial 
capabilities through multiprint-heads 
Hard to remove trapped materials, low to 
medium resolution, powder particles may not 
bind well, binders are always necessary to 
bind powders 
Nozzle based system No trapped materials, minimal material waste, low cost 
Materials may thermally degrade during the 
process, lower range of material choice, 
medium resolution 
Table 1. 9. Brief summary of advantages and disadvantages of using AM technologies.   
Finally, to have an idea of the ambitious growth of the additive manufacturing scenario, it should be 
mentioned that a new society and journal (Biofabrication) focused on this topic, have been recently 
established. Moreover, a first generation of FDM PCL-based scaffold has been FDA approved and 
commercialized (http://www.osteoporeinternational.com) after clinical trials. Furthermore, new 
bioprinting strategies are being developed due to the possibility to print living cells solutions. Among 
others, Mironov and collegues, by means of an automated modular approach for cell printing opens new 
possibilities to regrowth tissues and to build engineered tissue construct for better in vitro simulation of 
the in vivo milieu [78].  
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1.6. Inflammatory response to biomaterials   
The inflammatory reaction triggered at the time of implantation by the invasive intervention and as part of 
the host response to the foreign body being implanted influences the behavior of different cell populations 
involved in the regenerative process, and therefore the success of the implanted materials [79]. 
In the materials section of this introduction it was mentioned that one of the main drawbacks of PLA 
degradation is the generation of acidic products that decrease the pH of the surrounded environment. It 
provokes autocatalytic degradation that causes an intense inflammatory response [34,35]. The addition of 
CaP glass particles to PLA, activating a pH buffering mechanism, hinders the acidic degradation and is 
expected to modify the related inflammation [30,81].  
Moreover, though it is commonly known that an acute inflammatory response could lead to the rejection 
of an implant, it is also recognized that inflammation may also be essencial in tissue regeneration. Thus, a 
deeper understanding of the biological response to the implanted biomedical devices is a paramount issue 
in the tissue engineering field. Moreover, Anderson and colleagues in 2008 said, “the chemical, physical, 
and morphological characteristics of the synthetic surface are considered to play a role in modulating 
cellular events” [79]. Thus, it is currently accepted that a comprehensive understanding of cell/material 
interactions may lead to a better control of the inflammatory response in the direction of tissue 
regeneration. 
Nowadays, the scientific community is doing a strong effort in order to understand the complex 
interaction between cells and materials with the aim of developing a new type of biomaterials and 
medical devices. Modulating the biochemical and biophysical cues of biomaterial surfaces will impact 
inflammatory reaction by tuning macrophages behavior such as adhesion, apoptosis, fusion, and cytokine 
secretion. 
Up to now, most of the traditional studies stress on the need to diminish inflammatory response to 
implanted biomaterials. In spite of this, recently, researchers are considering the positive aspects and 
potentialities of this phenomenon. Indeed, inflammation and the mechanism behind the foreign body 
response are relevant factors to enhance tissue repair and remodeling, in particular bone [80]. 
 
Foreign body reaction 
The foreign body reaction is basically an inflammatory response that persists as long as there is a foreign 
body present to respond to. It comprises a sequence of interconnected events concluded with the fibrous 
encapsulation of the implant [79]. Such isolation from the surrounding tissue provokes the loss of 
functionality and then the failure of the device.  
An inflammatory response involves the migration of neutrophils and monocytes/macrophages to the 
injury site by chemotaxis of different cytokines in order to phagocytose all the material labelled as foreign 
and cellular debris. Neutrophils disappear after finishing their task, leaving place to macrophages. A 
sustained macrophage response is typical of a chronic inflammatory reaction and is common in most 
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implants. The numerous presences of macrophages lead the formation of multinucleated giant cells or 
foreign body giant cells (FBGC), also called multinucleated giant cells (MGCs), as a response to the 
effort to overcome the frustrated phagocytosis process experienced by single cells [79]. 
In other words, macrophages are not able to phagocyte the surrounding materials thus they fuse one in 
each other forming multinucleated giant cells.  
At this stage, macrophages and also fibroblasts release chemotactic factors for the recruitment of more 
fibroblasts. Macrophages inactivate their attack mechanisms and fibroblasts become the main cell line. At 
this time, fibroblasts start secreting a collagen I and III-based extracellular matrix that will encapsulate 
the material. The thickness of the collagenous capsule varies depending on the movement of the 
implanted device [22], and will isolate the material from the host tissue. 
The foreign body reaction is a serious limitation; it can lead to chronic pain and eventual device rejection 
and failure. The result of all the previous considerations is that the implant or medical device surface 
plays the leading role in its interaction with the biological environment. Consequently, the study and 
characterization, modification and functionalization of the biomaterials surfaces are probably the main 
strategies for success of implants and the tissue regeneration. 
To summarize, Figure 1.19 shows the different steps of the monocytes route from blood to tissue and in 




Figure 1. 19. Schematic of the in vivo transition from blood derived monocyte to biomaterial adherent 
monocyte/macrophage to multinuclear giant cell at the tissue/biomaterial interface. Adapted from [79]. 
 
 
In order to understand better the complex mechanisms involved in inflammation and foreign body 
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Monocytes/macrophages cells 
Monocytes derived from the bone marrow, migrate through the peripheral blood stream and reach the 
tissue surrounding the biomaterial where the inflammation phenomenon takes place. Once adhered on the 
biomaterial surface and releasing/exchanging cytokines signals, they differentiate into macrophages. 
Macrophages are a fundamental element in the immune system giving a crucial contribution to 
inflammation and host protection [82]. Furthermore, they are able to secret both angiogenic and growth 
factors that are particularly important for new blood vessel formation and tissue remodeling [68]. Such 
cells are strictly interacting with lymphocytes, another kind of white blood cell, involved in specific 
immune response. Lymphocytes are mainly classified in large granular ones (natural killer cells, NK) and 
small ones (T cells and B cells) that play an important role in cell-mediated immunity.  
 
Cytokines 
The response of the body to foreign agents or pathogens is managed by a great number of complex 
interactions between different kinds of cells involved in the immune system. Such cells interact with one 
another by delivering and replying to chemical signals called cytokines.  
Cytokines (from the greek cyto- cell; and –kinos, movement) are a wide group of small proteins (but also 
exist in peptide and glycoprotein form) released by immune cells. They are very specific chemical 
messengers capable to interact with other cells via specific receptors of the target cell membrane in order 
to coordinate the immune response. Hence, together with mitogens, chemoattractants and growth factors, 
they provide the generation of natural drug delivery systems acting on the sustained release of 
biochemical signals to control wound healing [79].  
The large family of cytokines includes a diverse collection of interleukins (IL), interferons (IFN) and 
growth factors. However, they are also classified in lymphokines, monokines, chemokines, and 
interleukins, depending from the supposed function or cell of secretion: 
 
• Lymphokines - produced by lymphocytes; 
• Monokines - produced by monocytes; 
• Chemokines - chemotactic activities; 
• Interleukins - manufactured by one leukocyte to act on other leukocytes. 
Cytokines are mainly involved in the following actions: 
• regulation of the expression of membrane proteins (including cytokine receptors); 
• release of effector molecules: histamine release; antibody secretion - IgA, IgG1, and IgE synthesis; 
IL-1 synthesis; cytokine production; MHC Class II; and CAM expression; 
• cell proliferation and differentiation; 
• chemotaxis of neutrophils, monocytes, and T cells; 
• inflammation; 
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• phagocytosis; 
• death of tumor cells; 
• elimination of pathogens. 
 
Some of them, acting as chemical switches, are capable to turn specific immune cell types on and off. 
Chemokines are an interesting group of cytokines, which possess chemoattractant properties for specific 
cell types. Released by cells, they are capable to recruit other immune cells to the injury site for repairing 
the damaged zone. For this reason, they are recently studied for the formulation of new drugs to regulate 
the immune response. In particular, chemokines comprise four major families: CC, CXC, C, and CX3C 
[66]. In addition they are also involved in other processes such as hematopoiesis, angiogenesis, tumor 
metastasis, homing and differentiation of lymphocyte [80,82]. 
Some points regarding cytokines should be mentioned before continuing. Firstly, cytokines activity is 
redundant and different cytokines can trigger similar functions. They are produced in cascades; indeed 
cytokines are targets for other cells that will secrete other cytokines. Moreover, there could be synergistic 
and antagonistic effects between two or more cytokines acting contemporarily. Finally, many cell types 
can produce the same cytokines or each cytokine could stimulate many different cell types behavior.  
 
Macrophages polarization 
Among the myelomonocytic cells, macrophages show a relevant diversity and plasticity. Due to a high 
capacity to identify and interchange signals with lymphocytes, they are able to switch their phenotype 
functions going through a response modification [83-85]. Thus, depending on various stimuli, 
macrophages can undergo M1 or an alternative M2 activation [84,85]. Such phenotype shift, particularly 
relevant in macrophages, is called polarization. Briefly:  
• M1 stimulated by toll-like receptors (TLR) and IFN-γ; 
• M2 stimulated by IL-4/IL-13; 
• They show a similar behavior with T cells that polarize in Th1 and Th2; 
• M1 and M2 phenotypes show a quite different chemokine profiles. 
The phenotype of M1 macrophages could be identified by a strong release of proinflammatory cytokines, 
a high microbicidal and tumoricidal activity, and a stimulation of Th1 cells response. 
On the other hand, M2 phenotypes are characterized by immunoregulatory functions. They are 
particularly active on parasites control and encapsulation thanks to high phagocytic skills. M2 are mainly 
involved in tissue remodeling and repair, tumor progression, angiogenesis promotion [84,85]. The 
different properties of M2 are emphasized by three different versions of this phenotype: M2a, M2b, M2c. 
M2a is stimulated by interleukins IL-4 and IL-13 and promote Th2 response. Among M2 macrophages, 
M2a are the main involved in killing and encapsulation of parasites. M2b is stimulated by exposure to 
immune complexes and TLR or IL-1R. Together with M2c is the main phenotype involved in 
immunoregulation process. Finally M2c phenotype, stimulated by IL-10 interleukin, is essentially 
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associated to matrix deposition and tissue remodeling activities [85]. A schematic representation of the 
macrophages polarization is described in Figure 1.20.  
M1-M2 polarization is reversible both in vitro and in vivo [86]. Furthermore, M1-M2 polarization switch 
often happens in pathologies where M1 activation leads to a continuous inflammation (proinflammatory 
properties) while M2 drives to soften an acute inflammation (anti-inflammatory properties).  
Therefore, the scientific community is paying great attention to understand mechanisms and molecules 
associated with macrophage plasticity and polarization in order to develop new macrophage-focused 
therapeutic strategies [84]. In particular, from a Tissue Engineering point of view, it is enormously 
important to find suitable strategy to boost the M2 anti-inflammatory polarization with the aim of 
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Chapter 2 - Relevance of PEG in PLA-based blends for Tissue 




Understanding the impact of materials on the fabrication of 3D structures, and dissecting the right 
fabrication technique and conditions is of paramount importance to optimize both 3D scaffolds’ 
production and performance. Rapid prototyping (RP) techniques, in particular, low temperature nozzle-
based dispensing systems are an interesting option that allows scaffolds production under non-aggressive 
processing conditions. Nozzle-based dispensing systems enable the fabrication of scaffolds with well 
defined and reproducible architectures, and ultimately, the production of customized scaffolds adapted to 
patient-specific needs [1-3]. These direct printing systems build 3D structures following a layer-by-layer 
approach, dispensing the material solution or slurry accordingly to a previously designed geometry and 
internal architecture [1-7]. 
Curiously, although direct printing techniques have been widely used to fabricate 3D porous polymer 
structures [4-7], printing of polylactic acid (PLA), a well-known and currently used biodegradable 
polymer for the development of 3D scaffolds [8,9], has been barely reported [10,11]. In the case of PLA, 
keeping the right solution viscosity at low temperature during the entire printing process is of paramount 
importance and most of the times it represents a challenging task. 
In order to maintain the right viscosity of the PLA-printing ink, two methods are mainly acknowledged: 
a) increasing the processing temperature or b) using a plasticizer. Using the right plasticizer is most 
advantageous since it enables working at low temperatures without causing any thermal degradation to 
the polymer. Different biodegradable as well as non-biodegradable plasticizers have been used to lower 
the glass transition temperature, increase ductility, and improve processing of PLA [12]. Among them, 
polyethylene glycols (PEG), especially low molecular weight PEG, has been reported as one of the most 
efficient plasticizers for PLA. Furthermore, PEG is a hydrophilic, biocompatible polymer that has been 
used for many applications from industrial manufacturing to biotechnology [13,14]. Similarly to PLA, 
PEGs are also soluble in chloroform. Thus, it is possible to obtain homogeneous PLA/PEG blends for the 
fabrication of 3D porous scaffolds, in particular by low temperature nozzle based 3D printing. 
Incorporation of PEG in the PLA solution not only facilitates scaffolds printing process by means of its 
plasticizing effect but also introduces structural and physico-chemical changes to the resultant scaffolds. 
Various studies on the structural/thermal and mechanical properties of PLA/PEG blends and block 
copolymer systems of PLA with PEG have been reported [15-17]. However, the effect of PEG on the 
final structural, surface and mechanical properties of 3D scaffolds processed by RP has not been fully 
explored. This work aims to study the effect of PEG concentration on PLA/PEG blends and its relevance 
on the development of porous scaffolds by 3D printing, especially on their final structural and surface 
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features. Furthermore, owing to PLA’s lack of bioactivity, it was also combined with a calcium phosphate 
based biodegradable and bioactive glass [18-20] in order to develop PLA/PEG/glass bioactive composite 
scaffolds. The effect of PEG on the distribution of the glass particles in the PLA matrix, and the 
polymer/particle interface was also studied in this work. 
 
2.2. Materials and Methods 
2.2.1. Materials 
Poly(95L/5DL)lactic acid (Purasorb, PURAC) and PEG (Mw=400 Da; Sigma Aldrich) were dissolved in 
chloroform (5%w/v) with various PEG concentrations (0, 5, 10, 20% w/w) on an orbital mixer during 48h 
and combined to obtain a homogeneous polymer blend solution. A completely degradable, calcium 
phosphate glass with the following molar composition: 44.5P2O5-44.5CaO-6Na2O-5TiO2, coded G5 was 
used in the form of particles (< 40 μm) to elaborate the PLA/PEG/G5 composite materials [9,18] G5 is a 
bioactive glass that has shown outstanding in vitro and in vivo results and has successfully improved PLA 
biological response [19, 20]. 
 
2.2.2. Scaffolds fabrication 
A nozzle-deposition system also known as a direct-print tool (Tissue Engineering 3Dn-300, 
Sciperio/nScrypt Inc. Orlando, Florida; available in the Rapid Prototyping service of the Biomedical 
Networking Center, CIBER-BBN and IBEC www.ibecbarcelona.eu/biomaterials) was used to fabricate 
the 3D scaffolds. It utilizes a computer-aided design/computer-aided-manufacturing (CAD/CAM) 
approach to build layer-by-layer three-dimensional structures. Orthogonal displaced doubled layer 
scaffolds with distance between struts D=375 ± 25 μm were fabricated. Polymer blends containing 5, 10 
and 20% (w/w) of PEG and a PLA/PEG/G5 composite as described in Table 2.1 were used. A printing 
pressure in a range between 40-80 psi, a motor speed of 7-10 mm/sec, and a G27 (200 μm) nozzle were 
used to print the polymer solutions. Both pressure and motor speed were tuned accordingly to the 
viscosity of each blend solution. The syringe temperature was set at 40±5ºC by using a heating jacket, and 
room temperature was kept at 25±2ºC. 
 
Material Polymer matrix (w/w%) G5 particles (w/w%) 
PLA PEG 
PLA/PEG 95/5 95 5 --- 
PLA/PEG90/10 90 10 --- 
PLA/PEG80/20 80 20 --- 
PLA/G5 a 100 --- 50 
PLA/PEG/G5 a 95 5 50 
Table 2. 1. Composition of the studied materials. aThe percentages shown for the polymer matrix of PLA/G5 and 
PLA/PEG/G5 corresponds to 50% of the total weight of the scaffold. 
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2.2.3. Scaffolds characterization 
Materials characterization was conducted on both three dimensional RP structures and films in order to 
better analyze the surface properties. Films were made by solvent casting in an attempt to recreate the 
procedure followed to print the struts of 3D scaffolds by nozzle-based rapid prototyping. Materials were 
combined according to the compositions shown in Table 2.1. 
 
2.2.3.1. Morphological SEM study 
Scaffolds and films morphological observation was carried out by scanning electron microscopy (SEM, 
JEOL JSM 6400, Tokyo, Japan). In both cases, surface morphology of the polymer matrix as well as 
glass distribution was observed. In the case of scaffolds, SEM observation permitted a qualitative 
evaluation of the effect of PEG on the geometrical parameters of the final structures. Image J software 
was used to measure struts and pores size. In the case of the polymer films, SEM observation after t= 0, 2, 
4, 6 and 8 weeks was carried out to visualize possible surface changes during degradation. 
 
2.2.3.2. Porosity 
The theoretical volume porosity percentage (%Voltheoretical) was calculated for each scaffold using the 
initially designed geometries based on a unit cube, whereby the strut diameter and spacing between layers 
were equal (i.e., no overlapping due to the fusion between struts from one layer to the adjacent one was 
assumed).  
 
%Voltheoretical = (Va – Vt) / Va  ×100%       (1) 
 
where Vt is the true volume (mm3) (=VcNcNl = (Ø2/4) π LNcNl); Vc is the cylinder volume (mm3); and Va 
is the apparent volume (mm3) = Lwh; L = ØNc + D(Nc - 1); D is the distance between struts; h = ØNl. 
Therefore, 
 
%Voltheoretical = (1 - (Ø2/4) πNcNl /(wh)) ×100%      (2) 
 
where Ø, L, w and h refer to the strut diameter, strut length, scaffold width and scaffold height in 
millimeters, respectively. Furthermore, Nc represents the number of cylinders (struts) per layer, while Nl 
represents the number of layers per scaffold. 
 
2.2.3.3. Mechanical properties of the 3D-scaffolds 
A universal testing machine (Zwick-Roell, Zwicki-Line Z0.5TN) with a 200N load cell was used to 
evaluate the compressive mechanical properties of the developed scaffolds. Cylindrical scaffolds (4 mm 
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diameter x 2 mm height) were cored from larger 3D printed blocks. The real dimensions of the specimens 
were measured before test. For each material composition, three samples were tested. A speed of 1 mm 
min-1 was used and a preloading of 0.5N was applied. Stress-strain data were computed from load 
displacement measurements. The compressive strength at 40% deformation (σ40%) was reported. 
 
2.2.3.4. Surface Topography 
Surface topography as well as glass distribution at the surface of the composite material were observed by 
optical interferometry (WYCO NT1100, Veeco), a non-destructive technique that allows measuring 
surface topography in 3D. The studied parameters were: surface roughness (Sa), and skewness (Ssk), or 
the asymmetry of the surface about the mean plane. The study was carried out in films as previously 
mentioned. Three samples of each material (PLA/PEG 95/5, 90/10, 80/20, PLA/G5 and PLA/PEG/G5 
films) with the following dimensions (2 x 2 x 0.1 cm3) were used for the study. Three different zones 
(124 × 96 μm2) were analyzed for each material. 
 
2.2.3.5. Mechanical properties by atomic force microscopy (AFM) 
Evaluation of the surface mechanical properties at the nanoscale was carried out by atomic force 
microscopy (AFM) using a force mapping method. The surface morphology and mapping of the Young’s 
modulus (E) of the PLA/PEG blends and composites at the nanoscale were explored using an innovative 
AFM technique, Peak Force QNM (Quantitative Mechanical Property Mapping at the Nanoscale) [21]. 
Samples with the following dimensions (10 x 10 x 1 mm3) were sticked onto Teflon discs with epoxy 
glue and images were captured under ambient condition. For the polymeric materials a silicon oxide tip 
(VistaProbes T300R-W with 40nN/nm nominal spring constant) mounted on a stainless steel cantilever 
(Bruker Corporation, CA, USA) was used, while a diamond one was used to analyze the composite 
material. Tip radius of 2 nm and 18 nm for the polymeric and the composite materials respectively were 
used. Probe calibration was carried out by thermal noise method and 40x40 μm2 modulus images were 
achieved. All AFM data analysis and image processing were carried out with NanoScope software 
version 8.10 (Veeco Instruments Inc.). 
 
2.2.3.6. Wettability 
Contact angle measurements were performed to evaluate the materials wettability. The sessile drop 
method was used to measure the contact angle by depositing ultrapure water (3μl; Milli-Q; Millipore, 
USA) on the surfaces of the polymer films using a contact angle measurement system (OCA 20; 
Dataphysics, GmbH, Germany). As in the case of interferometry and AFM, polymer films were used to 
perform the measurements. Three samples of each material (PLA/PEG 95/5, 90/10, 80/20, PLA/G5 and 
PLA/PEG/G5) with the following dimensions (3 x 1 x 0.1 cm3) were used for the study. Three 
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measurements were performed in each specimen, and independent experiments were conducted on three 
different samples. 
 
2.2.4. In vitro degradation study 
In vitro degradation studies were performed by immersing the films in simulated body fluid (SBF), an 
acellular solution whose chemical composition is similar to that of blood plasma [22]. Samples were 
immersed in SBF at 37ºC keeping a volume/mass ratio of 250/1 for 8 weeks. The degradation of the 
materials was evaluated by means of weight loss measurements, DSC and SEM analysis. 
 
2.2.4.1. Weight loss 
Materials' weight loss during degradation was calculated from the changes in the specimens’ dry weight 
before and after the incubation time periods. After 2, 4, 6 and 8 weeks of immersion in SBF, the samples 
were removed from the fluid, rinsed with distilled water and dried in a furnace at 37°C for 12h or until 
complete weight stabilization. The percentage of weight loss was computed according to the following 
equation:  
 
%W = 100 × (Wo −Wt)/Wo, 
 
where Wo is the initial dry weight and Wt is the dry weight of the specimen at different degradation 
times. Values are expressed as the average of three replicates. 
 
2.2.4.2. Differential Scanning Calorimetry 
A differential scanning calorimeter (DSC-2910, TA Instruments) was used to determine the thermal 
properties of the materials after 0, 4 and 8 weeks of degradation. Samples (5-10 mg) from PLA/PEG and 
PLA/PEG/G5 films, were firstly heated from 10ºC to 200ºC then cooled to -25ºC and heated up to 200ºC, 
at a heating rate of 10ºC/min in aluminum pans with nitrogen as a purge gas. The resulting DSC curves 
were analyzed to determine the glass transition (Tg) temperature, and the crystallinity (Xc) of the 
polymer. Tg values were taken from the thermograms corresponding to the second heating cycle whereas 
for the Xc calculation enthalpy values were taken from the first cycle. The crystallinity percentage was 
calculated using the reference heat of enthalpy (93.1 J/g) for theoretically 100% crystalline PLA [23]. In 
the case of the composite materials, the heat of fusion (ΔHm) and the heat of crystallization (ΔHc) of the 
samples were recalculated according to the amount of inorganic phase present at each time. The new 
heats of fusion and crystallization (ΔH'f and ΔH'c) were calculated as:  
 
ΔH' = ΔH/Xp,  
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where Xp is the fraction of polymer matrix present at each time. This fraction was determined by means 
of a standard ash method (data not shown). The specimens were heated in an electric furnace at 600 ºC 
for 3 h to burn out the organic matrix and then reweighed in order to calculate the inorganic fraction. 
 
2.2.5. Statistical analysis 
All the results are described as means ± standard deviation (SD). The statistical significance was 




2.3.1. Morphological evaluation 
Figure 1 shows the morphology and geometrical accuracy of the different 3D structures. It reveals clear 
differences between pore size and strut thickness of the three scaffolds depending on PEG concentration. 
Indeed, by increasing PEG concentration the originally designed squared pores (Figure 2.1a) turned into 
slightly rounded ones (Figure 2.1c). Figure 1e summarizes differences found on struts and pores size 
according to the amount of PEG added in the blend. Strut size increased from 52.09 ± 6.39 μm to 80.32 ± 
23.13 μm while pore area decreased from 161.16±5.19 mm2 to 121.8 ±3.25 mm2 for the 5 and 20% 
blends respectively. A noteworthy increase of the SD in the strut thickness of 20% blends due to their 
non-uniformity was observed. In the case of the PLA/PEG/G5 material (Fig. 1d), the plasticizing effect of 
PEG allowed a good distribution and embedment of the glass particles in the polymer matrix. Also, it was 
observed that the theoretical design was reproduced properly showing well-defined orthogonal pores.  
Figures 2a and c show SEM images of PLA and PLA/PEG 80/20 films before the degradation process. 
Remarkable differences in terms of their surface morphology were observed. PLA showed a smooth and 
flat surface whereas the blend with 20% of PEG showed a rather bumpy and rough surface with irregular 
coarse protuberances. After 8 weeks of immersion in SBF, PLA surface (Fig. 2.2b) did not show any 
degradation sign and remained similar to the one observed before immersion in the fluid; conversely, the 
PLA/PEG 80/20 showed clear signs of intense degradation such as numerous cracks at the surface 
(indicated with white arrows in Fig. 2.2d). After 8 weeks PLA/PEG 80/20 samples were significantly 
damaged and broken into pieces. 
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Figure 2. 1. SEM images of 3D-printed scaffolds. Axial view of a) PLA/PEG 95/5, b) PLA/PEG 90/10, c) PLA/PEG 80/20, d) 
PLA/PEG/G5 structures. Higher concentrations of PEG led to thicker struts and smaller rounded pores. Scale bar indicates 
500μm. e) Variation of struts and pore size of 3D scaffolds printed with the studied PLA/PEG blends (5, 10 and 20% PEG) and 
PLA/PEG/G5; f) Compressive strength at 40% deformation (σ40%) for PLA/PEG (5, 10, 20% of PEG and PLA/PEG/G5); g) 
theoretical volume porosity percentage of the 3D-printed scaffolds with the different PLA/PEG blends and PLA/PEG/G5. The 
values marked with an asterisk (*) showed statistical significant differences (p ≤ 0.05).  
 
Figure 2. 2. SEM images of PLA films a) before and b) after 8 weeks of degradation. PLA/PEG 80/20 films c) before and d) 
after 8 weeks of degradation. Black arrows indicate the presence of PLA spherulites while white arrows show the cracks formed 
between spherulites peaks due to material degradation. Scale bar indicates 50 μm. 
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2.3.2. Porosity evaluation 
Figure 1g shows the theoretical volume porosity percentages of the 3D-printed structures fabricated with 
the different PLA/PEG blends. As observed scaffolds porosity decreased from 91.4% to 86.75% as PEG 
concentration increased from 5 to 20% (w/w), while the composite scaffold PLA/PEG/G5 shows a value 
of 85.91%. 
 
2.3.3. Scaffolds’ Mechanical Properties 
Figure 2.1f shows the data corresponding to the compressive strength at 40% deformation (σ40%) for the 
polymeric scaffolds with 5, 10 and 20%w/w of PEG and for the composite one (PLA/PEG/G5). 
Compressive strength values decreased from 9.11 ± 1.19 MPa to 3.63 ± 0.82 MPa for the scaffolds with 5 
and 20% PEG respectively. The composite scaffold PLA/PEG/G5 showed the highest compressive 
strength. 
 
2.3.4. Surface Topography 
As seen in Figure 2.3, interferometry provided a qualitative morphological evaluation of the surface of 
the studied materials. PLA showed the smoothest topography (Fig. 2.3a). Figure 2.3 a-d shows the 
influence of the different PEG concentrations on PLA surface topography. Addition of PEG induced the 
formation of spherulites as indicated by the arrows. Moreover, by increasing the concentration of PEG, 
the number of peaks increased while the distance between them and their height decreased. Figures 2.3a 
and d, showing the surface of PLA and PLA/PEG 80/20, are in good agreement with the SEM images 
shown in Figure 2.2.  
 
 
Figure 2. 3. Interferometry images of the surface of a) PLA, b) PLA/PEG 95/5, c) PLA/PEG 90/10, d) PLA/PEG 80/20, e) 
PLA/G5, f) PLA/PEG/G5 films. Arrows indicate spherulites domains in b) PLA/PEG 95/5, c) PLA/PEG 90/10 d) PLA/PEG 
80/20. Asterisks indicate the presence of glass particles in e) PLA/G5, f) PLA/PEG/G5. 
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Composite materials (PLA/G5 and PLA/PEG/G5) displayed in Figures 3e and f, exhibited a significantly 
rougher topography. PLA/G5 seemed to be more wrinkled than its PLA/PEG/G5 counterpart. Asterisks in 
Figures 2.3e, f show the presence of G5 particles distributed and embedded in the polymer matrix. 
PLA/G5 showed the highest peaks. 
Table 2.2 displays the values obtained for the topography study. Interferometry measurements showed 
that the average roughness of PLA (117.72 ± 60.50 nm) increased significantly with the addition of G5 
glass particles and PEG (PLA/G5=1401.81±570.59 nm and PLA/PEG/G5=1003.89±228.45 nm). The 
polymeric blends showed an increase of their surface roughness (Sa) values with PEG concentration. 
Nevertheless, PLA/PEG 80/20, the material with highest PEG concentration showed the lowest Sa value. 
Ssk values indicated a higher surface asymmetry when 5% PEG was added to PLA, while both composite 
materials (PLA/G5 and PLA/PEG/G5) revealed negative Ssk values. 
 
 
Material Sa (nm) Ssk 
Young modulus 
by AFM (GPa)  
Distilled and 
Deionized Water (°) 
PLA 117.72±60.50 0.79±0.66 0.87 83.77±0.77* 
PLA/PEG 95/5 147.12±29.11 1.08±0.55 2.5§  and 6.2  76.56±1.61* 
PLA/PEG 90/10 377.96±121.22 0.37±0.71 5.6§  and 6.9  79.±8.2 
PLA/PEG 80/20 296.22±34.58 0.34±0.42 18.3 68.±13.4 
PLA/G5 1401.81±570.59 -0.5±0.17 16.2 77.57±7.58 
PLA/PEG/G5 1003.89±228.45 -0.03±0.52 20 60.33±8.57* 
Table 2. 2. Surface properties for the studied materials. Sa = average roughness, Ssk = skewness. The values marked with 
the § correspond to the Young modulus calculated in the dark zones as indicated in Figure 4. The values marked with the 
asterisk (*) showed statistical significant differences between them (p ≤ 0.05). 
 
2.3.5. Mechanical evaluation by AFM 
Surface Young’s modulus values for the studied blends are shown in Table 2.2. It can be appreciated that 
the Young’s modulus increased by increasing the concentration of PEG. In particular the Young’s 
modulus value for pure PLA samples was 0.87 GPa while for PLA/PEG 80/20 a modulus of 18.3 GPa 
was obtained. The presence of 50% of G5 particles into the polymer matrix increased the Young’s 
modulus to 16.2 GPa. 
Moreover, the addition of both PEG and G5 led to a synergistic effect as observed in the case of the 
PLA/PEG/G5 composite (E = 20 GPa). According to AFM results, the blends containing 5 and 10% of 
PEG showed a “bimodal distribution” of the Young’s modulus. A Peak Force QNM-modulus image 
(scanning area 40 μm × 40 μm) of PLA/PEG 90/10 blend is shown in Figure 2.4. In this case, the 
presence of two different E values was observed, a high modulus corresponding to bright (light-colored) 
and a low modulus for the dark (dark-colored) regions which are intercalated and are indicated by white 
arrows. 
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Figure 2. 4. Mechanical evaluation by AFM. Image showing a bimodal distribution of the Young modulus (on the left); white 
arrows indicate the regions with lower E (darker regions). Histogram for the PLA/PEG 90/10 sample (on the right).   E value 
histogram shows two very well defined peaks corresponding to the two “phases” that appear in the image. In this case, the mean 
values for the dark and the bright coloured regions were 5.6 GPa and 6.9 GPa respectively.  
2.3.6. Contact angle evaluation 
Contact angle values for the studied materials are shown in Table 2.2. Overall, the presence of PEG 
decreased the contact angle values of the polymer blends in comparison to pure PLA. As observed, the 
presence of G5 increased the wettability of the PLA surface. Furthermore, the combination of PEG and 
G5 glass into the PLA matrix also led to a clear decrease of the contact angle. 
 
2.3.7. Weight loss 
Weight loss percentages of the studied samples along in vitro degradation are recorded in Figure 2.5a. 
Overall, the weight loss curves showed the effect of both PEG and G5 particles on the degradation of 
PLA/PEGs and PLA/PEG/G5 materials. In the case of the materials with PEG, a visible weight loss was 
observed after the first two weeks of immersion in SBF. The concentration of PEG in the polymer blends 
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Figure 2. 5. (a) Evolution of the percentage of weight loss underwent by the studied PLA/PEG and PLA/PEG/G5 films along 
degradation in SBF at 37ºC. PLA and PLA/G5 films were used as control (n=3); (b) Initial thermal properties (Tg, %Xc) of the 
studied materials. Evolution of (c) glass transition temperature (Tg) and (d) Crystalline fraction (%Xc) along the 
degradation time in SBF at 37ºC. Error bars not shown if smaller than symbols. 
 
In particular, the PLA/PEG 80/20 blend underwent a prompt weight loss after only two weeks of 
degradation. This abrupt degradation hampered further weight measurements due to difficulties to 
manipulate the sample pieces. Though the incorporation of the glass particles into the polymer matrix 
(PLA/G5) increased the weight loss in comparison to PLA, PLA/PEG/G5 showed a higher weight loss 
starting from the second week of degradation as in the case of the other PLA/PEG blends. Indeed, 
PLA/PEG/G5 showed a similar tendency to that of PLA/PEG 95/5. 
 
2.3.8. Thermal characterization 
Figure 2.5b, c and d shows a summary of the thermal properties obtained by DSC for the set of studied 
materials throughout the degradation period. A decrease in the glass transition temperature (Tg) values 
was observed before degradation (t = 0) when increasing the concentration of PEG in the polymer blend. 
In particular Tg values decreased from a value of 59.15 ºC to 15.34 ºC by increasing PEG concentration 
from 0% to 20% (w/w) respectively. Incorporation of G5 particles did not influence Tg values. In fact, 
PLA/G5 and PLA/PEG/G5 showed quite similar values to PLA and PLA/PEG 95/5 respectively. 
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The percentage of crystallinity (Xc) significantly increased from 2.41% to 30.57% when different 
amounts of PEG were added to the blend. It appeared to achieve its highest value with 5% of PEG 
(30.57%) and then decrease and undergo further stabilization at Xc around 23% at higher PEG 
concentrations (10 and 20% (w/w)). 
In general, the behaviour of the materials during degradation was strongly influenced by the presence of 
PEG. A progressive increase of Tg values along the degradation time was revealed, especially for the 
materials with higher concentration of PEG. With respect to the evolution of the crystallinity percentage 
during the degradation period, a general increase was observed for the materials with and without PEG. In 
the case of PLA, Xc underwent a gradual increase whereas in the case of PLA/G5 a steeper increase was 
displayed, especially after the first 4 weeks of degradation. Crystallinity was also increased in the 
PLA/PEG blends. However, the blend with 5% of PEG showed a different behaviour. In this particular 
case, Xc values decreased along the degradation time. Blends with 10 and 20% (w/w) of PEG showed a 
significant increase being it more obvious in the PLA/PEG 80/20 material. Regarding the composite 
materials, PLA/G5 showed an increase of the crystallinity fraction, as expected from previous studies 
[24], while in PLA/PEG/G5 95/5 the percentage of crystallinity was rather constant. 
 
2.4. Discussion 
Polyethylene glycol, in particular low molecular weight one has been widely acknowledged as an 
efficient plasticizer for PLA [12,16,17]. Thus, it is expected that the use of PLA/PEG blends may 
facilitate the fabrication process of 3D structures for tissue engineering. In particular, in rapid prototyping 
structures where the nozzle-based printing process is highly dependent on the polymer solution viscosity 
and flow, the plasticizing effect of PEG is of great help to ease and optimize the fabrication process at 
low temperature [25]. Besides affecting PLA processing, it is anticipated that PLA/PEG combination lead 
to various changes in scaffolds properties including its structural, surface, and mechanical properties as 
well as its in vitro degradation. Therefore, knowing the effect of PEG’s concentration on the blends 
properties and their degradation behavior, it is of main importance to find the right interplay between 
PEG concentration, material performance and fabrication process. 
In this work, the effect of PEG concentration on the structural and surface properties of PLA/PEG based 
3D scaffolds as well as in their in vitro degradation was studied. A set of materials with different PEG 
concentration was investigated by means of various characterization techniques. 
Overall, the results obtained in this study showed a clear effect of PEG on both, the morphology and 
mechanical properties of the 3D structures as well as in their surface properties and the degradation 
behavior of the polymer blends with the different concentrations of PEG. 
With respect to the 3D structures, both SEM examination and mechanical compression tests indicated 
structural changes due to PEG incorporation into the polymer matrix. In fact, it was observed that though 
all the blends followed the predetermined geometry, there were clear variations on struts’ diameter and an 
increase in pores roundness owed to PEG addition. The effect of PEG was particularly obvious in the case 
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of the 20% PEG blend. These changes in struts and pores size and geometry are attributed to the 
important decrease of viscosity experienced by the polymer blends due to the addition of PEG. Lower 
viscosities led to a faster and easier polymer flow out of the tip during printing and therefore to less 
defined and less uniform struts. 
Furthermore, a clear decrease of compressive strength was observed by increasing PEG concentration 
(Figure 2.1f). Despite the structural changes induced by the addition of PEG in the blend, variations in 
mechanical properties were mainly attributed to its plasticizing effect. In the case of the PLA/PEG/G5 
composite scaffolds, G5 glass reinforcing effect was more evident than the plasticizing effect of PEG. 
With respect to the surface properties, morphological differences were observed at the surface of the 
different blends. Both SEM and interferometry images displayed evident differences in the samples with 
PEG and glass particles in comparison to pure PLA (Figures 2.2 and 2.3). Incorporation of PEG into the 
PLA matrix led to different chain arrangements during the solvent evaporation process of the films. It is 
known that the plasticizing effect of PEG increases chain mobility and also acts as nucleating agent 
accelerating the creation of crystalline domains and therefore, increasing their density on the surface 
[26,27]. This in turn, affects the crystallinity, topography (due to the formation of spherulites), and other 
surface properties of the material. In fact, thermal analysis of the different blends showed a progressive 
decrease of the Tg and an increase of the crystallinity values with higher concentrations of PEG (Figure 
2.5b). Lower Tg values suggested higher chain mobility allowing chain arrangement and the nucleation 
process described above. 
In this study, a significant increase of surface roughness values (Sa) was observed when adding PEG into 
the system. The formation of spherulites with different morphologies, size and distribution in the 
PLA/PEG blends (Figure 2.3) led to higher Sa values than in PLA, especially in the films with 10 and 
20% of PEG. Though, no statistically significant differences were observed between the Sa values of both 
surfaces, interferometry images showed clear differences in the peaks’ shape and distribution on the 
surfaces. The blend with 10% PEG showed an elevated standard deviation owing to the presence of a 
combination of high and low mounds with large diameter and well separated from each other; whereas 
the blend with 20% PEG displayed a higher amount of mounds with lower diameter and height but more 
homogeneous and almost no separation between them. In the case of PLA/G5 composite materials, a 
substantial increase of Sa was observed in both PLA/G5 and PLA/PEG/G5 (SaPLA/G5 =1401.81 nm and 
SaPLA/PEG/G5 =1003.89 nm respectively). Again, the plasticizing effect of PEG was present as revealed by 
the Ssk values. Negatively skewed surfaces were obtained for the composite materials (PLA/G5 and 
PLA/PEG/G5) indicating the predominance of valleys due to the glass/polymer interface. Nonetheless, 
the Ssk value obtained for PLA/PEG/G5 (Ssk = -0.03 ± 0.52) was significantly lower than the one obtained 
for PLA/G5 (Ssk=-0.5 ± 0.17) indicating that the plasticizing effect of PEG smoothed the material surface. 
Surface wettability was also affected by the addition of PEG. Though contact angle values decreased in 
comparison to pure PLA, no statistically significant differences were observed between the studied 
blends. As anticipated, composites including G5 revealed lower contact angle values [25,28]. 
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Hydrophilicity of both G5 and PEG contributed to improve samples wettability, in particular, in the case 
of the PLA/PEG/G5. 
The effect of PEG distribution on the films obtained from the different polymer blends was also translated 
in differences in the surface Young’s modulus of the studied blends. AFM analysis allowed determining 
surface Young’s modulus of the blends at the nanoscale. It is known that mechanical behaviour of 
materials at the nanoscale is different from that at macroscopic scale, and this phenomenon is mainly 
attributed to the increasing surface/volume ratio. In general, an improvement of the Young’s modulus 
with PEG incorporation was observed. Of particular interest were the blends containing 5 and 10% of 
PEG (shown in Figure 2.4). In these cases, AFM analysis permitted the identification of a bimodal 
distribution of the Young’s modulus corresponding to areas with higher and lower crystallinity. The blend 
with 20% PEG presented only one E value, remarkably higher in comparison to the other blends. The 
high density of spherulites on the PLA/PEG 80/20 blend provided certain uniformity to the material 
surface leading to only one E value. The mechanism responsible for such an elevated Young’s modulus is 
not well known; however, it is most likely that these differences respond to the roughness differences 
between surfaces. In fact, it has been reported that surface Young’s modulus is highly dependent on 
surface roughness [29]. 
A key issue when choosing a material for temporary tissue engineering templates is its degradation rate. 
Therefore, a preliminary in vitro degradation study was carried out as an additional parameter for the 
evaluation of the role of PEG in PLA-based structures.  
The presence of PEG in the polymer blend also affected the material behaviour in simulated physiological 
conditions. Weight loss results indicated that presence of PEG strongly influenced the degradation rate of 
the blends (Figure 2.5a). This phenomenon became more relevant at higher concentrations of plasticizer; 
indeed a striking degradation was observed in the case of the blend with 20% PEG after two weeks of 
immersion in SBF (Figure 2.5a). The hydrophilic PEG domains in the films surface led to a faster 
degradation when in contact with the fluid. Addition of G5 also accelerated the degradation of the 
material in agreement with previous studies [24]. However, presence of PEG elicited a more determinant 
effect. In fact, the mass loss underwent by PLA/PEG/G5 was considerably higher than the one 
experienced by PLA/G5 after the first 2 weeks of degradation (Figure 2.5a). 
Important differences were also observed along the degradation time in terms of the thermal properties of 
the studied polymer blends with the different percentages of PEG (Figure 2.5c,d). Overall, both glass 
transition temperature and crystallinity percentage values obtained for the PLA/PEG blends increased 
during the degradation period. Again, the increase of Tg and %Xc values was more evident in the case of 
blends with higher PEG concentration. In fact, TgPLA/PEG80/20 increased from 15.34ºC to 54.5ºC while 
TgPLA/PEG95/5 increased from 41.67 ºC to 46.72 ºC. This important increase of Tg suggested a significant 
loss of PEG from the polymer blends due to hydrolytic degradation. In fact, after 8 weeks of immersion in 
SBF, PLA/PEG blends with 10 and 20% of PEG displayed Tg values similar to the one obtained for PLA. 
It is worth mentioning that this substantial increase of Tg took place after the first 4 weeks of degradation 
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for all the PEG-containing blends. According to the weight loss curves, an analogous behavior was 
observed after the first two weeks of immersion in SBF, when PEG-containing samples also exhibited an 
important mass loss. 
With respect to Xc, an important boost of crystallinity was revealed for the polymeric matrix of both 
PLA/G5 and PLA/PEG/G5 composites after the first 4 weeks of in vitro degradation. As previously 
described by Navarro et al. [24], a hydrolysis process initiated at the interface between the polymer and 
G5 particles drove to a faster molecular packing and degradation of the polymer matrix, in particular of 
the PEG and amorphous domains leading to a higher fraction of crystallinity. 
 
2.5. Conclusion 
Finding the right processing conditions is crucial in the fabrication of 3D structures by rapid prototyping. 
Addition of PEG has shown to be advantageous to produce high-resolution PLA-based scaffolds at low 
temperature. Thus, knowing the effect of PEG in the final scaffolds properties is of great importance not 
only from the fabrication point of view but also from the structural and physico-chemical one as it is 
known that scaffolds success is ruled by their surface, structural and degradation properties. This chapter 
provides a full-scale study on the effect of PEG in PLA-based blends used to fabricate 3D-printed 
scaffolds. Results obtained from this work make evident that the incorporation of different percentages of 
PEG leads to significant changes in PLA/PEG structures and also accelerates their degradation rate. In 
fact, it was shown that addition of PEG increased surface roughness and wettability, led to non-uniform 
struts, and decreased mechanical properties of the 3D structures. Thus, in addition to improving scaffolds 
processing, incorporation of PEG is an effective method for tailoring both surface and structural 
properties, and modulating scaffold degradation. The outcomes of this work suggest that addition of 5% 
(w/w) of PEG in the PLA matrix allows the fabrication of 3D structures with a fair balance between their 
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Chapter 2 stressed the importance of developing suitable biomaterials and blends for scaffolds fabrication 
via computer-aided design and manufacturing (CAD/CAM) techniques, specifically nozzle-based 
systems. Indeed, ideal materials should fit a number of requirements such as having good rheological 
properties to ease the fabrication processes while preserving structural integrity, providing adequate 
mechanical properties to the final structures, and tuning degradation throughout tissue development. 
Thus, in the previous chapter, a first step was taken in order to determine the most suitable PLA/PEG 
blend for scaffolds fabrication. To this end, a comprehensive study on the effect of PEG in PLA-based 
blends was done. The objective of the present chapter is the fabrication and characterization of 3D-printed 




Rapid prototyping (RP), also known as additive manufacturing (AM), has emerged in the biomaterials 
field as a new tool for the fabrication of scaffolds with well-defined and reproducible architectures. RP 
techniques open the possibility of building custom-made scaffolds based on patient-specific tissue 
defects. These techniques combine computer design together with automated printing technology. In 
addition, temporary, tailor-made scaffolds fabricated by RP provide an excellent in vitro platform for the 
study of the effect of geometry/architecture on cell response, and for computer modeling of the scaffold’s 
behavior. It also allows three-dimensional (3-D) structures with improved mechanical performance to be 
obtained. In fact, RP structures show mechanical properties significantly higher than those of structures 
fabricated by other well-known techniques such as solvent-casting and particle leaching, thermal-induced 
phase separation and gas foaming, among others [1–4]. 
Several RP techniques have been developed in recent decades. The elaboration of different polymer and 
ceramic scaffolds with different geometries has been reported [1–8]. Of remarkable interest are the 
nozzle-deposition-based techniques, particularly the approach consisting in a dispensing system 
integrated with pumping technology and a CAD/CAM tool. This is a versatile technique that allows the 
building of 3-D structures and complex geometry models with precise control and reproducibility, using a 
large variety of materials [5]. Reviewing the literature on RP fabricated scaffolds reveals that numerous 
degradable polymers such as polycaprolactone, polylactic acid (PLA), polyglycolic acid, chitosan and 
their copolymers have been used to fabricate 3-D scaffolds [2,6,8–11]. In particular, PLA is a currently 
used biodegradable polymer that has been approved by the FDA for various biomedical applications. 
Though this polymer has been extensively studied, its use in the fabrication of RP scaffolds and 
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specifically those elaborated through nozzle-based systems has been limited and scarcely reported. At 
present, most of the reported PLA-based scaffolds fabricated by RP require the molecular modification of 
the PLA matrix, the use of temperature during printing or further processing of the structure by freeze-
drying [12,13]. The RP tool used in the present study allows the fabrication of PLA 3-D structures 
without modifying the polymer structure with specific chemical groups, without melting the polymer and 
without using any subsequent process to remove the solvent from the final structure. 
One of the strategies to improve the bioactivity and mechanical integrity of polymer scaffolds is the 
incorporation of an inorganic phase such as calcium phosphate (CaP) particles [14]. Indeed, several 
studies combining biodegradable polymers with different CaP ceramics have been reported [15–17]. In 
this area, CaP-based glasses are an interesting option, given their controlled biodegradability and 
bioactive potential [18]. In particular, CaP glasses in the system P2O5–CaO–Na2O–TiO2 have shown 
excellent biocompatibility both in vitro and in vivo [19,20]. This work describes the fabrication of PLA-
based 3-D scaffolds by RP. Both polyethylene glycol (PEG) and G5 glass particles were combined with 
the PLA matrix to obtain 3-D fully biodegradable porous composite structures with superior mechanical 
and bioactive properties. The structures obtained were characterized in terms of their processing effect, 
final architecture, mechanical behavior, surface properties and biological response. 
 
 
3.2. Materials and methods 
3.2.1. Material 
The materials used have been described in the previous chapter (2.2.1). From now on, a PLA-
blend containing 5% (w/w) of PEG is used. Materials were combined according to the 
compositions shown in Table 3.1. 
 
Material Polymer matrix (w/w %) G5 particles (w/w%) 
 PLA PEG  
PLA/PEG 95 5 - 
PLA/PEG/G5 95 5 50 
Table 3. 1. Composition of the studied materials 
 
3.2.2. Scaffolds design and fabrication 
Scaffold fabrication has been conducted following the protocol described in 2.2.2. In order to study the 
influence of pore size and pore distribution in the axial and transversal direction, two different 
architectures were designed and fabricated (see Fig. 3.1): (a) an orthogonal layer configuration (ORTH) 
with distance between struts axes (d1) of 500 μm and diameter of the struts (Ø) ∼200 μm, and (b) a 
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displaced double-layer design (DISPL) [22] with distance between struts d2 = d1/2 dispensing a double 
layer in each direction.  
Three-dimensional structures were built accordingly to the created designs by means of the layer-by-layer 
deposition of the material using the pumping equipment. A printing pressure in a range between 40 and 
80 psi and a motor speed of 3 mm s-1 were used to enable the material flow through a G27 (200 μm) 
nozzle. The syringe temperature was set at 40 ± 5 °C using a heating jacket, and room temperature was 





Figure 3. 1. Axial and cross-section view of the theoretical 3D structures of (a) ORTH and (b) DISPL scaffolds: d1 = 500 μm; 
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3.2.3. Scaffold characterization 
3.2.3.1. Differential scanning calorimetry 
Differential scanning calorimetry (DSC; DSC-2910, TA Instruments) was used to determine the effect of 
PEG in the thermal properties of the polymer blend, and the thermal properties of the material pre- and 
post-processing. Samples of the PLA/PEG 3-D-deposited scaffolds were analyzed following the protocol 
exposed in chapter 2 (2.2.4.2.). 
 
3.2.3.2. Morphological scanning electron microscopy study 
Morphological analysis of the 3-D structures was carried out by scanning electron microscopy to 
visualize and evaluate the architecture of the 3-D scaffolds, surface morphology and structural stability of 
the deposited struts and layers. SEM observation allowed qualitative evaluation of the differences 
between the theoretically defined pore geometry and size and those obtained after processing. The 
protocol used is detailed in chapter 2 (2.2.3.1). It also allowed verification of the distribution of glass 
particles within the polymer matrix and the final 3-D scaffold. 
 
3.2.3.3. Porosity 
The theoretical volume porosity percentage (%Voltheoretical) was calculated for each scaffold using the 
initially designed geometries based on a unit cube (Fig. 3.1) and following the protocol described in 
chapter 2 (2.2.3.2). It was also considered that, when changing the design from the ORTH to the DISPL 
configuration, the value of volume porosity was not changed. 
 
%Voltheoretical = (1 - (Ø2/4) πNcNl /(wh)) ×100%.        
 
3.2.3.4. Microstructure analysis and 3-D reconstruction by microcomputer tomography 
Three scaffolds (for each material composition) were scanned using a micro-computer tomography (μCT) 
X-Tek HMX225 (Digisens) instrument with a voxel resolution of 8 × 8 × 8 μm3. Computer 3-D 
reconstruction of the scaffolds was made using Mimics 14.0 software (Materialise, Leuven, Belgium) to 
determine the porosity as well as the percentage and distribution of the glass particles within the 3-D 
composite structures. 
 
3.2.3.5. Mechanical properties of scaffolds 
A Universal Testing Machine (MTS-Bionix 858, MTS Systems Corporation, Eden Prairie, USA) with a 
2.5 KN load cell was used to evaluate the mechanical properties of the scaffolds. The samples were tested 
at a speed of 1 mm min-1 without preloading. Stress–strain data were computed from load–displacement 
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measurements. The compressive modulus was determined based on the slope of the stress–strain curve in 
the elastic region. For each material composition, three cubic scaffolds (5 × 5 × 5mm3) were tested. Cubic 
samples were cored from larger 3-D printed blocks initially designed in the CAD software. The real 
accurate dimensions of the specimens were measured before the test.  
An ANOVA test was performed to determine the statistical significance (p ≤ 0.05) of the differences in 
the values of compressive modulus. 
 
3.2.3.6. Topography 
Surface topography as well as glass distribution at the surface of the composite material were observed by 
optical interferometry following the protocol described in chapter 2 (2.2.3.4). The studied parameters 
were: surface roughness (Sa), skewness, or the asymmetry of the surface about the mean plane (Ssk) and 
kurtosis, or peakedness of the surface about the mean plane (Sku).  
 
3.2.3.7. Wettability 
Contact angle measurements were performed to evaluate the material’s wettability. The protocol used is 
detailed in chapter 2 (2.2.3.6).  
 
3.2.3.8. Cell cultures 
Rat mesenchymal stem cells (rMSC) isolated from bone marrow were employed for cell culture studies. 
Cells were plated in culture flasks with Advanced Dulbecco’s modified Eagle medium (DMEM, 
Invitrogen) supplemented with 15% fetal bovine serum, 1% penicillin/ streptomycin, 1% L-glutamine, 
and 1% pyruvate (all supplements from Invitrogen) at 37 °C in a humidified atmosphere of 5% CO2 in 
air. The culture medium was changed every 2 days. At the fifth passage, cells were rinsed with phosphate 
buffered saline (PBS) and trypsinized with trypsin–EDTA (0.25%) in an incubator for 5 min at 37 °C. 
The cells were replated according to the conditions for the WST test. 
 
3.2.3.9. Adhesion test 
Cell adhesion was investigated by WST assay (Roche, Germany), which quantified the formazan released 
from cells into the supernatant by viable cells. The WST assay measures the reduction of the tetrazolium 
salt to formazan by mitochondrial succinate dehydrogenase. The increase in the supernatant formazan 
was directly correlated to the amount of viable cells. The 3-D PLA/PEG and PLA/PEG/G5 structures (10 
mm diameter, 3 mm high) previously sterilized by ethanol were located in a 48-well polystyrene standard 
culture plate. A concentration of 1 × 105 cells was seeded in the scaffolds with 300 μl of medium per 
well. Polystyrene microplate wells were used as control. Cell adhesion was studied at 4 and 24 h. After 
each adhesion time point, scaffolds were replaced in new culture plates with 300 μl of fresh medium. For 
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the assay, 30 μl of WST reagent were added to each sample including the polystyrene controls. The plate 
was incubated at room temperature for 1 h, and absorbance values were read in the spectroscopic 
microplate reader at 450 nm using a Power-Wave X, Bio-Tek spectrophotometer. The results are 
expressed as the averaged absorbance levels of three replicates.  
An ANOVA between groups test was performed to determine the statistical significance (p ≤ 0.05) of the 
differences in the absorbance values. 
 
3.2.3.9.1. Immunofluorescence study 
In order to observe the morphology of the cells attached to the studied surfaces, an immunofluorescence 
study was performed. After 4 h of culturing, the cells were fixed by immersion in 3% paraformaldehyde 
in 10 mM PBS at room temperature for 15 min. The cells were rinsed with a mixture of 10 mM PBS and 
20 mM glycine. Subsequently, the cells were permeabilized with a solution of 0.05% saponine in 10 mM 
PBS/20 mM glycine. After 10 min, the cells were blocked with a 1% bovine serum albumin solution in 
10 mM PBS/20 mM glycine for 20 min and then incubated with various specific antibodies and dyes 
(phalloidin-TRITC, 1:2000; and DAPI, 1:500) for 1 h at 37 °C. The phalloidin-TRICT was used to stain 
actin filaments of the cytoskeleton, and DAPI was used to dye the cells’ nuclei. The samples were rinsed 




3.3.1. Thermal characterization 
The thermal characteristics of PLA and PLA/PEG samples both before and after processing are shown in 
Table 3.2. DSC analysis showed that the addition of 5%w/w of PEG into the PLA matrix decreased Tg to 
40 °C. It also confirmed that the crystalline fraction of PLA/PEG did not changed significantly when the 
polymer was processed. Indeed, it varied between 27.48% and 26.51% for the material before and after 
processing, respectively. Moreover, there were no significant differences between the glass transition 
temperature values before and after the process. 
 
 
Material  Tg (ºC) %Xc 
PLA  59.15±0.16 40.68±0.42 
PLA/PEG 
Non-processed 40±0.6 27.48±0.72 
Processed 44.61±0.32 26.51±0.19 
Table 3. 2. Thermal characteristics of PLA/PEG 
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3.3.2. Morphological evaluation by SEM and porosity 
Fig. 3.2 shows the final ORTH structures for both PLA/PEG and PLA/PEG/G5. Both polymeric and 
composite scaffolds showed well-defined structures with pore size ≈ 375 ± 25 μm in the axial view and 
strut width ≈75 ± 5 μm. The total spacing between the struts axes was therefore ≈ 500 μm, according to 
the nominal design. In the case of the material with G5 glass, a fairly homogeneous distribution of the 
particles within the matrix was observed. The glass was well incorporated and embedded by the polymer 
(Fig. 3.2b, d) adding an interesting topography to the scaffold surface.  
 
 
Figure 3. 2. SEM micrographs of 3-D printed scaffolds with ORTH pattern: (a, c) PLA/PEG ; (b, d) PLA/PEG/G5; (a,b) top 
view; (c,d) cross-section view. 
 
 
Fig. 3.3 shows the final DISPL structures obtained for PLA/PEG and PLA/PEG/G5. SEM images showed 
well-defined structures with pores ≈165 ± 5 μm and struts ≈ 75 ± 5 μm. In this case, the pores size in the 
transversal direction (Fig. 3.3c, d) was improved (double) with respect to the one of the ORTH design. 
Furthermore, in both cases, these 3-D structures showed a combination of porosities ranging from the 
macroscale due to the initial designed pore size to the micro and nanoscale due to the presence of glass 
particles and to the pores left by solvent evaporation (Fig. 3.4c, d). 
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Figure 3. 3. SEM micrographs of 3-D printed scaffolds with DISPL pattern: (a, c) PLA/PEG; (b, d) PLA/PEG/G5; (a,b) top 
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Figure 3. 4. SEM micrographs of (a) PLA/PEG and (b) PLA/PEG/G5 scaffolds surface. Higher magnification of (c) PLA/PEG 
and (d) PLA/PEG/G5 struts surface showing microporosity due to the evaporation of solvent and presence of glass particles. 
 
 
3.3.3. Porosity and microstructure characterization by μCT 
Theoretical volume porosity percentage ranged between 85.7% and 87.2% (for both materials, ORTH 
geometry) considering a distance between struts (D) of 400 μm and 350 μm, respectively. 
μCT enabled 3-D characterization of RP-fabricated scaffolds. The 3-D reconstructed model for 
PLA/PEG/G5 scaffold, displayed in Fig. 5a, shows disposition of struts and pores size similar to the SEM 
image (Fig. 3.5b) of the same structure. Moreover, analogous topography, due to the presence of glass 
particles embedded by the polymer struts, can be observed in both images. 
The evaluation of porosity from the μCT 3-D reconstruction revealed values of 75 ± 0.86% for the 
PLA/PEG blend scaffold and 70 ± 1.2% for the PLA/PEG/G5 one. A homogeneous distribution of the 
glass particles throughout the scaffold structure, and full pore interconnectivity were confirmed from the 
analysis of 3-D reconstruction (Fig. 3.5). 
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Figure 3. 5.  (a) 3-D reconstructed and (b) SEM images of a PLA/PEG/G5 scaffold. Three-dimensional reconstructions of 




3.3.4. Mechanical evaluation 
Fig. 3.6 shows the data corresponding to the compressive modulus for the polymer both with and without 
glass particles and for both geometries, ORTH and DISPL. The compressive modulus of PLA/PEG 
scaffolds was found to be 92.32 ± 2.18 MPa for the ORTH design and 28.38 ± 3.99 MPa for the DISPL 
one, whereas for PLA/PEG/G5 the value increased to 99.81 ± 3.55 MPa for the ORTH and to 44.19 ± 
2.67 MPa for the DISPL design. 
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Figure 3. 6. Compressive modulus of PLA/PEG and PLA/PEG/G5 scaffolds with both ORTH and DISPL geometries. The 
values marked with the asterisk (*) showed statistical significant differences (p ≤ 0.05).   
 
3.3.5. Topography 
Table 3.3 displays the results obtained for the topography study. Interferometry measurements showed 
that the average roughness of PLA (117.72 ± 60.50 nm) increased significantly with the addition of G5 
glass particles and PEG (SaPLA/G5 = 1401.81 ± 570.59 nm and SaPLA/PEG/G5 = 1003.89 ± 228.45 nm). 
Additionally, Ssk values suggested a higher surface asymmetry when 5% PEG was added to PLA. No 
statistically significant differences (p ≤ 0.05) were found for Sku values for the studied materials.  
 
Material PLA PLA/PEG PLA/G5 PLA/PEG/G5 
Sa (nm) 117.72±60.50 147.12±29.11 1401.81±570.59 1003.89±228.45 
Ssk 0.79±0.66 1.08±0.55 -0.5±0.17 -0.03±0.52 
Sku 7.56±5.62* 4.71±0.39* 3.8±1.10* 2.82±0.26* 
Table 3. 3. Roughness parameters for the studied materialsa (value ± SD). aSa = average roughness, 
Ssk = skewness, Sku = kurtosis. The values marked with the asterisk (*) didn’t show statistical 
significant differences (p ≤ 0.05). 
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3.3.6. Contact angle measurement 
The contact angle values for the studied materials are showed in Table 3.4. As observed, the presence of 
G5 increased the wettability of the surface. Moreover, the addition of 5% PEG into the PLA and PLA/G5 
materials also led to a decrease in the contact angle. 
 
Material PLA PLA/PEG PLA/G5 PLA/PEG/G5 
Distilled and Deionized 
Water (°) 83.77±0.77* 76.56±1.61** 77.57±7.58*
,** 60.33±8.57 
Table 3. 4. Contact Angle Values for the studied materials (value ± SD). The values marked with the asterisk (*,**) 
didn’t show statistical significant differences (p ≤ 0.05).  
3.3.7. Cell adhesion 
Cell adhesion was assessed from two different points of view. The viability of the cells was evaluated 
using the WST assay, and the cell morphology was monitored using immunofluorescence staining. Fig. 
7a displays the absorbance values after both 4 and 24 h adhesion as measured by the WST assay, and the 
fluorescence images of the attached cells. 
After 4 h of contact with the studied scaffolds, the polystyrene control plate showed the highest 
absorbance values, and no significant differences (p ≤ 0.05) were observed between the PLA/PEG and 
PLA/PEG/G5 samples. After 24 h of culture, no significant differences were observed between the 
studied samples and, once again, the polystyrene plate showed the highest absorbance values. 
Despite the fact that, after 4 h, the WST assay did not display any important difference (p ≤ 0.05) for both 
scaffolds (PLA/PEG and PLA/PEG/G5) the immunofluorescence study demonstrated very clear 
variations in the morphology of the cells. Fig. 3.7b and c shows images of the rMSC adhering to the two 
different scaffolds after 4 h of contact. 
The cells adhering to the surface of the PLA/PEG scaffold showed mostly rounded shapes, and were 
sparsely spread on the surface. In the case where the glass particles were added, the cells showed a very 




Figure 3. 7. (a) WST assay and fluorescence images of attached cells on (b) PLA/PEG and (c) PLA/PEG/G5 scaffolds. 
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3.4. Discussion 
In this study, the RP method was used to fabricate 3-D polymeric (PLA/PEG) and composite 
(PLA/PEG/G5) scaffolds for tissue engineering applications. Scaffolds’ fabrication parameters were 
optimized, and the final structures were studied using SEM, μCT, optical interferometry, contact angle, 
compressive mechanical testing, and DSC to characterize their architecture, the surface topography and 
wettability, and their mechanical and thermal properties. 
It is known that an optimal ‘‘printing’’ process involves complex interactions between the hardware, 
software and material properties [7,23]. Thus, each aspect has to be carefully tuned in order to 
successfully obtain the right 3-D structures for each particular application. Choosing the right processing 
conditions guarantees obtaining high quality 3-D structures without harming the material properties; in 
the case of PLA, processing by nozzle deposition is relatively complex, owing to the combination of 
parameters affecting the polymer solution, such as solvent evaporation and processing temperature, 
among others. 
In this work, the most advantageous set of parameters for fabricating 3-D scaffolds without degrading or 
affecting the polymer properties was chosen. In the case of the composite material, a set of parameters 
and an adequate polymer/solvent concentration were chosen to avoid any segregation phenomenon in the 
syringe due to the glass particles. In addition, PEG was used as plasticizer to decrease the Tg of the blend 
and to facilitate the material processing at low temperature. A PEG percentage of 5%w/w was chosen, 
given that it was the minimal amount for considerably lowering the Tg of the blend (PLA Tg = 59.15 °C; 
PLA/5% PEG Tg = 40 °C) and for improving the material processing without affecting the physico-
chemical properties of the polymer. In fact, DSC results confirmed that the processing parameters used to 
elaborate the scaffolds did not induce significant changes in terms of polymer Tg and crystallinity (Table 
3.2). Thus, the material did not undergo degradation because of possible elevated temperatures or shear 
forces during material deposition, which in turn could compromise scaffold in vitro and in vivo 
behaviour. 
The selected set of fabrication parameters allowed well-defined porous structures to be obtained, as 
observed by SEM. According to the morphological analysis, though the struts were thinner than the 
needle diameter, the distance between axes and the overall structure are very close to the theoretical 
geometries designed by CAD software. Two different geometries were used in this work, namely 
orthogonal and displaced geometry. The idea was to decrease the pore size in the axial direction and 
improve it in the transversal one by changing the printing pattern of the scaffold. 
In addition, important information regarding pore and strut dimensions was also retrieved from the SEM 
analysis. It was observed that the average diameter of the struts was ≈ 75 μm, while pore size ranged 
between 165 and 375 μm and between 75 and 150 μm in the axial and transversal directions, respectively, 
depending on the scaffold geometry. These results are in good agreement with those reported in previous 
investigations of bone ingrowth into porous materials [2,3,24,25]. In addition, large pore size could 
improve infiltration of new blood vessels into the scaffold enhancing its vascularization and providing 
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cell survival into the inner part of the scaffold. Moreover, RP scaffolds showed high pore size 
interconnectivity required to improve permeability, facilitating mass transport within the 3-D construct. 
The diameter of the struts of the structures obtained in this study was significantly thinner than the 
diameter of other polymer RP structures reported in the literature and fabricated by similar nozzle-
deposition-based systems [7,26,14]. This ‘‘high-resolution’’ effect was attributed to the interplay between 
the right printing parameters (pressure, temperature, speed, nozzle diameter and distance between the 
needle and the substrate), the viscosity of the polymer solution and the evaporation of the solvent that 
takes place once the material has been deposited. It allowed overall control of the printing process. The 
solvent found in the polymer solution plays a major role, since it evaporates immediately after the 
solution flows out from the syringe, leading to an important increase in viscosity, shrinkage of the struts 
and formation of pores at the scaffold surface. 
Differences observed between the nominal diameter of the struts and the experimental are mainly 
attributed to this solvent evaporation effect. Indeed, in the case of fused deposition systems, where 
polymers are melted and subsequently extruded without using solvent, this shrinkage phenomenon is not 
as significant [7,10,14,26]. 
In general, a reduction in strut diameter confers a higher scaffold resolution though it leads to a reduction 
in pore size in the transversal direction and increases the fabrication time to obtain a desired volume. 
Additionally, lower dimension of struts lead to scaffolds with higher specific surface, improving the 
interaction between the material and the biological environment. In order to double the interconnecting 
pore size in the cross-section view, the approach adopted was to dispense two equal layers one on top of 
the other in each direction. 
Two different methods were used to measure the scaffolds porosity: theoretical and experimental by μCT. 
As expected, the theoretical porosity was higher than that obtained by μCT 3-D reconstruction. During 
the fabrication process, it is possible that some fusion between the struts (of deposited material) and the 
underlying layers takes place; this is the reason why μCT evaluations of porosity were somewhat lower 
than the theoretical ones. Moreover, differences between porosity values can be further explained by the 
fact that the theoretical calculations assume a unit cube as opposed to the actual deposition of struts, 
which generated edge effects [26]. Despite the structure fabrication defects, porosity evaluation by μCT 
gives lower values than the theoretical one (Voltheoretical > VolμCT) as a consequence of considering 
fabricated scaffolds. However, 3-D reconstruction allowed a quantitative measurement and examination 
of morphologies, interconnectivity and the internal architecture of the scaffolds. Composite scaffolds 
showed a porosity value of 70%, whereas the polymer blend scaffolds with the same geometry showed 
75% of porosity. This difference could be attributed to the lower content of polymer per strut in the case 
of composites. Since the polymer is the shrinkable phase during solvent evaporation, a lower content of 
polymer could lead to less shrinkage and, therefore, to smaller pores and lower porosity. 
It is well known that not only the architecture of the scaffolds, but also their surface properties are of 
paramount importance for understanding cell/material interactions and developing successful constructs. 
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Two-dimensional (2-D) solvent-casting films were used to reproduce the surface of the scaffolds’ struts 
and to analyse their topography and wettability. As shown in Fig. 3.5, glass particles were well 
distributed in the polymer matrix. The presence of G5 particles added an interesting topography to the 
scaffold surface, as observed in Fig. 3.4. In addition, the surface of the polymer struts showed micro and 
nanopores left by the evaporation of the solvent. Thus, the final structures presented a combination of 
porosities ranging from the macroscale due to the pores initially designed to the micro and nanoscale due 
to solvent evaporation. According to the interferometry results, the addition of both glass particles and 
PEG significantly increased the average roughness (Sa) of the surface in comparison with PLA. In the 
case of PLA/PEG samples, incorporation of PEG increased Sa values because of its plasticizing effect, 
which accelerated the spherulite growth and formation rate of PLA [27,28]. The fast spherulites formation 
in PLA/PEG led to higher values of skewness (Ssk) showing a higher asymmetry of the surface about the 
mean plane in comparison with PLA. Nonetheless, in the case of PLA/PEG/G5 material, the good 
plasticizing properties of PEG led to a better coating and embedment of the glass particles in the polymer 
matrix, providing a smoother surface and decreasing Sa values. According to the results obtained, both 
PLA/G5 and PLA/PEG/G5 showed negative Ssk values. This fact indicates that, in these cases, the 
asymmetry with respect to the mean plane was mainly due to the presence of valleys rather than peaks. 
These valleys were probably caused by the polymer/glass non-unions. No statistical differences in the 
values of the kurtosis (Sku) were found. Nevertheless, similarly to the Ssk results, Sku values for the 
materials with G5 suggested some differences with respect to PLA and PLA/PEG surfaces. The materials 
without glass particles showed the spikiest surfaces, probably due to the presence of scratches caused 
during their manipulation and to the presence of non-randomly distributed spherulites induced by the 
effect of PEG [28]. Composite materials PLA/G5 and PLA/PEG/G5 showed Sku values ≈ 3 driving to a 
random distribution of peaks within the surfaces. 
With respect to the wettability, the contact angle measurements reported in Table 4 showed important 
differences on addition of PEG and G5 glass to PLA. It is known that G5 glass has a highly hydrophilic 
surface (29.8⁰) [29]. Thus, addition of G5 particles contributed to a decrease in PLA contact angle. PEG 
is also considered to be a hydrophilic polymer [30]. Therefore, the contact angle obtained for the 
PLA/PEG/G5 material showed the synergistic contribution of PEG and G5 particles’ hydrophilicity. 
The mechanical properties of 3-D structures are an important issue to consider in order to fulfil the 
requirements of the final application of the scaffold. According to the compression test results, changing 
the scaffold geometry from ORTH to DISPL decreased the scaffold’s compressive modulus significantly. 
This diminution could be caused mainly by two aspects: (1) the separation between layers in the case of 
the DISPL geometry, and (2) the displaced disposition of the struts. The synergistic effect of both aspects 
leads to a combination of compressive and flexural stresses in the struts that decrease the mechanical 
stability of the structure in comparison to the ORTH scaffold. In the case of the ORTH structures, layers 
are closer and pores are smaller in the transversal direction, leading to a more dense and solid structure in 
the direction where compressive forces are applied during the mechanical test. Conversely, the displaced 
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disposition of the struts in the case of the DISPL structures led to a higher pore size in the transversal 
direction, and the discontinuous arrangement of the vertical struts increased the bending effect of the 
horizontal struts under the compressive forces, resulting in lower compressive modulus values. 
It was also observed that, independently of the geometry, the addition of G5 particles increased the 
compressive modulus of the scaffolds, being more remarkable in the case of the DISPL structures. More 
specifically, the compressive modulus of the DISPL structures increased ≈ 35%, whereas ORTH ones 
showed an increase of 8%. In general, the structures obtained in this study showed compressive modulus 
values considerably higher than those reported in the literature for other RP structures with similar 
geometry and similar porosity percentages [7,14]. 
With respect to the biological evaluation, the WST test results, in combination with the images obtained 
from the immunofluorescence study, showed an interesting picture of the cells’ behavior in contact with 
the studied surfaces after short periods of time. The addition of G5 glass particles into the polymer matrix 
strongly influenced the cell response in terms of morphology at early culture times. According to the 
WST results, though there was a general increase of the number of cells after 24 h of culture, there were 
no statistical significant differences (p ≤ 0.05) between PLA/PEG and PLA/PEG/G5. It is worth 
mentioning that the substantially higher absorbance values obtained in the case of the control polystyrene 
plate were due to some extent to the fact that, after each culture time point, scaffolds were removed from 
the plate and replaced in a new plate to quantify only the amount of viable cells attached to the structure, 
leaving behind the ones attached in the bottom of the polystyrene wells. However, cells cultured on the 2-
D control material were quantified directly in the same wells and the cell density was higher. 
In spite of the WST results obtained after 4 and 24 h, remarkable differences were observed in the cells’ 
morphology on comparing both types of scaffolds. After 4 h of adhesion, immunofluorescence images 
showed clear differences in the morphology of the cells, depending on what substrate was used (see Fig. 
3.7b, c). In the case of PLA/PEG, cells showed a relatively rounded morphology with a clear nucleus, and 
no signs of cytoskeleton spreading as observed by the phalloidin stained actin fibres. In the case of the 
material with glass particles, cells spread very well, with a clear cytoskeleton extending along the 
scaffolds struts. Moreover, a higher intensity of the phalloidin staining was concentrated toward the edges 
of the extended filopodia. Surface characterization indicated remarkable differences between materials 
both with and without glass particles in terms of their wettability and roughness. Thus, the information 
obtained from the surface analysis together with cell results suggest that both topography and chemistry 
changes owing to the presence of the glass particles in the surface of the scaffolds’ struts strongly affect 
cell response at early contact times. 
These results are in full agreement with previous work showing how other cell types preferentially attach 
and spread when in contact with G5 glass [16,29]. Moreover, it has been reported recently that the 
biological effect of G5 glass is attributed mainly to the contribution of the chemotactic effect of the Ca 
ions released by the particles (mediated through the calcium sensing receptor, CaRS) and the material 
stiffness (mediated through NMII cytoskeletal contraction and signaling) [31]. 
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3.5. Conclusion 
RP, in particular the nozzle-based deposition system used in the present work, is suitable for fabricating 
3-D composite scaffolds based on PLA and glass (G5). The addition of 5% PEG to the PLA matrix in 
combination with the chosen processing parameters allowed high-resolution 3-D scaffolds to be obtained 
without affecting the polymer blend properties. The technique also permitted the fabrication of highly 
porous scaffolds with mechanical properties considerably higher than other methods commonly used to 
fabricate 3-D polymer scaffolds, such as solvent-casting and phase separation. 
The addition of the soluble G5 glass particles (and PEG) to the PLA matrix changed both the morphology 
and the physico-chemical properties of the surface of the materials. These surface changes affected cell 
behavior. Both types of scaffolds showed positive biological response; however, only the scaffolds with 
G5 displayed well-spread cells. In general, the technique/materials combination used in this work led to 
the fabrication of promising fully degradable, mechanically stable, bioactive and biocompatible 
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Chapter 4 - Impact of 3-D printed PLA- and chitosan-based scaffolds 
on human monocyte/macrophage responses: Unraveling the effect of 
3-D structures on inflammation 
 
Implants success is highly dependent on the inflammatory response and subsequent foreign body reaction. 
In fact, cell response triggered immediately after material implantation may activate either the 
regenerative pathway or implant rejection. Therefore, understanding the effect of scaffolds properties 
(pore size, chemistry, surface among others) on inflammation is of paramount importance to design a new 
generation of materials and scaffolds able to provide the right signals to the biological environment and 
modulate the inflammatory response towards the regenerative side. 
The previous chapters focused on the development, physico-chemical characterization and optimization 
of RP 3D structures with well defined geometries. This chapter focuses on a more biological approach; it 
studies the impact of the developed structures on human monocytes/macrophages in order to assess their 
in vitro inflammatory response and also to help unraveling the effect of 3D scaffolds´features on 
inflammation. To this end, not only PLA-based scaffolds developed in chapter 2 and 3 were used but also 
new Chitosan structures in order to introduce two new parameters namely chemistry and geometry. 
 
4.1. Introduction 
Implantation of a biomaterial elicits an inflammatory reaction, which influences the behavior of different 
cell populations involved in the regenerative process determining implant success [1]. The emerging view 
is that activation of the inflammatory process can lead to implant rejection, but is also key for efficient 
tissue regeneration and repair [2,3]. Having the capacity to modulate the inflammatory response will lead 
to more effective tissue engineering (TE) strategies. Indeed, it has been recently shown that materials 
modified with inflammatory molecules can impact on human natural killer cell behavior, and lead to 
increased mesenchymal stem/stromal cell (MSC) recruitment [4]. 
Inflammation is an extremely complex, multistage process involving numerous cell types and mediator 
signals. Macrophages are dominant infiltrating cells that respond rapidly to biomaterial implantation and 
play a crucial role in regulating the inflammatory response and tissue remodeling, by secreting large 
amounts of bioactive mediators that can initiate inflammation, cell migration and differentiation, tissue 
remodeling and blood vessel formation [1,2]. The mediators secreted will depend on the material 
properties, and will direct subsequent inflammation and/or tissue repair. If macrophages fail to 
phagocytose a certain material or foreign body, cells may fuse and form multinucleated giant cells 
(MGC), which have thus been related with the foreign body response. It is generally believed that 
macrophages can polarize towards either a proinflammatory or anti-inflammatory phenotype, exhibiting 
regulatory, pro-regenerative and angiogenic functions [5]. 
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Monocyte/macrophage activation and cytokine secretion are affected by surface chemistry and 
topography [6–8]. Additionally, porous structures promote faster healing and form a thinner fibrous 
capsule than dense solid implants [9,10], suggesting that the implant architecture can play a role in 
foreign body reaction. Thus, not only the intrinsic material properties but also the geometry/architecture 
and surface cues of the 3-D scaffolds may be of importance in the design of new surfaces and scaffolds 
that can tailor macrophage activation towards a regenerative pathway. 
Polylactic acid (PLA) and chitosan (Ch) are two well-known biodegradable polymers that are widely used 
in scaffolds for TE purposes. Both materials possess distinct chemical, physical and biological properties 
that may affect the inflammatory response. The inflammatory impact of the US Food and Drug 
Administration (FDA) approved PLA has been mainly reported in terms of the effect of its acidic 
degradation by-products upon implantation [11]. 
Though there is some literature on the PLA inflammatory response in vitro, only a few works have 
tackled the behavior of cells in 3-D structures [12,13]. As for Ch, some contradictory results have been 
reported on the inflammatory response elicited when the polymer was presented in different forms 
[14,15]. Recently, it was shown that 2-D Ch surfaces drive polarization of human macrophages towards 
an anti-inflammatory phenotype and dendritic cells towards a pro-inflammatory profile [16]. However, 
the effect of PLA and Ch 3-D scaffolds on primary human monocyte/macrophage responses has not been 
fully established. 
Rapid prototyping (RP) is an emergent tool in the biomaterials field that enables fabrication of 3-D 
structures with well-defined and reproducible geometries and architectures. By combining polymers 
together with RP, it is possible to build 3-D scaffolds with different characteristics and well-distinguished 
geometric and physico-chemical features, allowing the study of the effect of these factors on 
inflammatory cell responses. 
The hypothesis behind this work was that both the chemical composition and the architecture of 3-D 
scaffolds affect macrophage responses. We hypothesized that the geometry of pores could affect 
macrophage behavior and, in particular, cytokine secretion, as it has already been shown for other cells, 
particularly for MSCs, that differentiation depends on the geometry of the substrate (in two dimensions), 
by affecting the curvature of the cytoskeleton actin fibers [17]. Thus, here we set out to determine which 
impacted on macrophage behavior the most: the chemical composition or the geometry of the scaffold. 
Therefore, this work aims at: (i) the controlled fabrication of novel 3-D platforms of PLA and Ch using 
RP, and (ii) the study of the macrophage morphology and cytokine profile in these matrices. To this end, 
Ch scaffolds with two different geometries (orthogonal and diagonal) and PLA-based orthogonal 
scaffolds made of PLA and a combination of PLA and a biodegradable calcium phosphate glass (G5) 
were fabricated. Fabrication of Ch scaffolds with two defined geometries allowed us to evaluate the effect 
of scaffolds architecture while keeping the surface properties and material chemistry constant. In contrast, 
by adding G5 glass to PLA scaffolds, the effect of the surface topography/chemistry was investigated, 
while enhancing both the biological and mechanical performance of the scaffolds [18,19], due to G5’s 
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bioactive properties [20]. The impact of these 3-D scaffolds on the secretion of the cytokines tumor 
necrosis factor (TNF)-α, interleukin (IL)-6, IL-10, IL-12/23(p40) and tumor growth factor (TGF)-β1 was 
analyzed. TNF-α and IL-6 are pro-inflammatory cytokines commonly analyzed when studying the 
inflammatory response induced by different biomaterials. Timely production of the appropriate amounts 
of TNF-α and IL-6 is critical for the efficient repair of, for example, bone [3], and macrophages usually 
associated with an inflammatory M1 or a regenerative M2b phenotype produce increased amounts of 
these two cytokines [21]. We also quantified the amounts of p40, thus detecting the monomer p40 and the 
heterodimeric cytokines IL-12 or IL-23, which consist of p40 bound to either p35 or p19 chains, 
respectively. These two pro-inflammatory cytokines of the same family can be produced at high levels by 
M1 macrophages and stimulate the differentiation of proinflammatory TH1 and TH17 cells [22]. 
Regarding cytokines with anti-inflammatory properties, we analyzed IL-10 and TGF-β. IL-10 is one of 
the most studied anti-inflammatory cytokines, as it regulates many steps of an immune response, being 
crucial in restraining inflammation [23]. TGF-β has a role in controlling immune homeostasis [23] and is 
also an important player in regulating bone repair [3]. 
 
 
4.2. Materials and methods 
4.2.1. Materials 
The materials used for the fabrication of the PLA-based scaffolds have been described in chapter 3 
(3.2.1). Endotoxin-free Ch powder (Chitosan 123, France-Chitine), with MW = 324 ± 27 × 103 and 11–
12% of N-acetylation [4], was purified as previously described [25]. Ch solution (3%W/V) was prepared by 
hydrating Ch overnight in MilliQ water, dissolving in acetic acid (2%, Sigma) overnight at 4 °C under 
constant stirring and centrifuging for 5 min at 800g. 
 
4.2.2. Scaffolds fabrication 
Scaffold fabrication has been conducted following the methodology described in chapter 2 (2.2.2). Two 
different architectures were designed and fabricated (Fig. 4.1): (i) an orthogonal displaced doubled layer 
(orthogonal) configuration, with distance between struts D = 1 mm and 500 μm for Ch and PLA-based 
scaffolds, respectively; and (ii) an orthogonal–diagonal double layer design (diagonal) with distance D1 = 
1 mm between the struts axes of the orthogonal layers and D2 = 700 μm between the struts axes of the 
diagonal layers. In the case of the PLA-based scaffolds, the orthogonal design was used. In the case of 
Ch, scaffolds were produced in two different geometries: ChO, with orthogonal struts, and ChD, with 
diagonal and orthogonal struts. Three-dimensional structures were built by layer-by-layer deposition. In 
the case of PLA-based scaffolds, a printing pressure between 40 – 80 psi, a motor speed of 3mm s-1 and a 
G27 (200 μm) nozzle were used. The syringe temperature was 40 ± 5 °C, and room temperature was 25 ± 
2 °C. In the case of Ch scaffolds, a printing pressure around 40 psi, a motor speed of 7 mm s-1, and a 
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Teflon tip with diameter of 150 μm were used. Additionally, NaOH (8%W/V) in ethanol (70%) was 
dispensed drop by drop on top of the printed struts to cross-link the polymer structure during the 
fabrication process [26]. Ch scaffolds were kept protected from light overnight at room temperature in 
NaOH (8%W/V) and washed three times for 5 min each with MilliQ water. Ch scaffolds were kept 
hydrated at 4 °C until use. Endotoxin levels were measured in water extracts prepared by incubating 
scaffolds in endotoxin-free water (40 ml g-1 material) for 24 h at 50 °C while shaking (250 rpm), and 
measured using the Limulus Amebocyte Lysate (LAL) QCL-1000 test (Lonza), as described elsewhere 
[27]. All extracts revealed endotoxin levels lower than the recommended FDA limit (0.5 EU ml-1). Table 
4.1 shows the different scaffolds according to their composition and geometry. Henceforth, PLA-based 




Figure 4. 1. 3-D view of the theoretical 3-D structures of (a) orthogonal and (b) diagonal scaffolds. D = 1 mm; D1 =1mm; 
D2 = 700 μm; w = scaffold width, h = scaffold height, L = scaffold length, Ø = 200 μm and 150 μm for PLA and Ch, 
respectively.  
Scaffold code Material Composition (w/w %) Geometry Porosity (%) 
Strut size (μm 
± SD) 
 Polymer matrix Glass particles 
   
 PLA PEG Ch G5 
PLA 95 5   Orthogonal 85.7 75 ± 5 
PLA/G5a 95 5  50 Orthogonal 85.7 75 ± 5 
ChO   100  Orthogonal 75.6 250 ± 30 
ChD   100  Diagonal 79.1 250 ± 30 
Table 4. 1. Composition and geometry of the studied scaffolds. a The percentages shown for the polymer matrix of the 
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4.2.3. Scaffold characterization 
Morphological analysis of the structures was carried out by scanning electron microscopy following the 
procedure described in chapter 2 (2.2.3.1). However, a low vacuum was used to minimize Ch dehydration 
during the assays. Scaffolds porosity was calculated using the approach explained in chapter 2 (2.2.3.2).  
 
4.2.4. Cell isolation and seeding 
Human monocytes were isolated by negative selection from healthy donors buffy coats by using a 
RosetteSep human monocyte enrichment cocktail (StemCell Technologies), as described elsewhere [16]. 
Cells were resuspended in complete medium (RPMI 1640 + Glutamax (Invitrogen) supplemented with 
FBS (10%, Lonza) and penicillin G–streptomycin (1%, Invitrogen)). Prior to cell seeding, scaffolds 4 mm 
in diameter and 2 mm in height were cut and placed in 96-well culture plates. Scaffolds were disinfected 
in 70% ethanol, washed with PBS and then incubated in complete medium (200 μl) for at least 1 h at 37 
°C/5% CO2. Medium was removed and 1.6 × 105 cells in complete medium (5 μl) were added on top of 
each scaffold. As a control, cells were also cultured on tissue culture polystyrene (TCPS). Cells were 
incubated at 37 °C/5% CO2 for 3 h and complete medium (200 μl) was added. Negative controls 
consisting of scaffolds without cells were treated in the same way. Cells were incubated for 3, 7 and 10 
days prior to analysis of their metabolic activity, morphology and cytokine secretion. 
 
4.2.5. Determining metabolic activity 
Metabolic activity after 3, 7 and 10 days of incubation was assessed with a resazurin assay as described 
elsewhere [28]. Values obtained with scaffolds incubated in the absence of cells were subtracted in the 
final analysis. Three replicates for each scaffold were performed. 
 
4.2.6. Actin staining 
In order to observe cellular morphology, cells were stained for actin and nuclei. After 10 days of cell 
differentiation in the scaffolds, cells were washed with PBS and fixed with paraformaldehyde (4%) for 20 
min at room temperature, washed with PBS and incubated with PBS/Triton (0.1%) at room temperature 
for 5 min. Cells were incubated with phalloidin–AlexaFluor 488 (50 μl, Invitrogen) in PBS/Triton (1:40) 
for 1 h and washed with PBS. Nuclei were then counterstained with 4’,6-diamidino-2-phenylindole (100 
μg ml-1) for 10 min followed by washing with PBS. Scaffolds were imaged on a laser scanning confocal 
microscope (Leica TCS SP5 II, model DMI6000B-CS, Bioimaging Center for Biomaterials and 
Regenerative Therapies, b.IMAGE, Porto). To image the whole diameter of scaffolds, Tile Scan 
functionality followed by the Mosaic Merge tool were used. Nine fields of view (×10), through a depth of 
approximately 200 μm, were imaged. More detailed images were obtained with a × 20 water immersion 
objective. Maximum projection images were visualized with software LAS AF version 2.6.0.7266 
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(Leica). Cells with three or more nucleus were classified as MGCs and cells with an aspect ratio (major 
axis/minor axis) higher than 2 were considered to be elongated. A qualitative analysis was performed to 
compare which scaffolds favored the presence of cells with different morphologies (MGCs, with 
filopodia-like structures, elongated). 
 
4.2.7. Cytokine secretion 
For evaluation of cytokine secretion, supernatants were collected after 3, 7 and 10 days, centrifuged and 
kept frozen until analysis. TNF-α, IL-6, IL-10, IL-12/23(p40) and TGF-β1 levels were quantified by 
enzyme-linked immunosorbent assay (ELISA; Legend Max human ELISA kits, BioLegend) according to 
manufacturer’s instructions. Concentrations were determined for three replicates pooled together per 
condition and values were corrected with the amount determined for scaffolds incubated in the absence of 
cells. The regulatory effect of different cytokines may depend on the context they will be acting in, but 
overall, TNF-α, IL-6 and IL-12/23(p40) are considered pro-inflammatory cytokines. IL-12/23 refers to 
the subunit p40, shared by both IL-12 and IL-23. IL-10 is an anti-inflammatory cytokine and TGF-β is 
associated with tissue repair. 
 
4.3. Results 
4.3.1. Scaffold characterization 
Fig. 4.1 shows a schematic representation of the orthogonal and diagonal structures obtained for PLA, 
PLA/G5 and Ch. SEM images (Fig. 4.2) showed well-defined PLA and PLA/G5 structures, with pores of 
around 165 ± 5 μm in the axial direction and struts of approximately 75 ± 5 μm. Ch structures showed 
pores of around 380 ± 60 μm and 600 ± 93 μm for ChD and ChO, respectively, in the axial direction, and 
struts of around 250 ± 30 μm, which varied depending on the degree of dehydration of the hydrogel 
sample. 
Differences between the two materials were also observed in the transverse porosity. Due to Ch swelling, 
pores in the transverse direction were more defined and uniform in the PLA-based scaffolds than in the 
Ch ones. Moreover, in PLA and PLA/G5 scaffolds, a combination of porosities, ranging from the 
macroscale due to the initial designed pore size to the micro- and nanoscale due to the addition of G5 
particles and to the pores left by solvent evaporation, was observed. Conversely, Ch scaffolds showed 
rather smooth surfaces. The theoretical volume porosity percentage was 85.7% for the PLA and PLA/G5 
scaffolds, and between 75.6% and 79.1% for the ChO and ChD scaffolds, respectively. The porosity 
percentages were calculated considering a distance between struts of 400 μm for orthogonal scaffolds, a 
distance between orthogonal struts of 1000 μm and a distance between diagonal struts of 700 μm for 
ChD. 
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Figure 4. 2. SEM images of the four polymeric platforms. Axial view of the (a) PLA orthogonal structure, (b) PLA/G5 
orthogonal structure, (c) ChD structure and (d) ChO structure, (e) pore geometry for orthogonal scaffolds, (f) pore geometry for 
diagonal scaffolds, (g) cross-section of a ChO scaffold and (h) cross-section of a PLA scaffold. 
 
4.3.2. Metabolic activity 
During inflammation, monocytes and not fully differentiated macrophages are recruited from the blood to 
the implant site, where they can differentiate into macrophages [29].  
Thus, studies addressing human macrophage–biomaterial interactions are commonly performed with 
peripheral blood monocytes that are allowed to differentiate into macrophages [6,7,16]. In this work, cell 
behavior was evaluated along monocyte to macrophage development by analyzing responses at early (day 
3) and late (days 7 and 10) stages of macrophage differentiation. 
The metabolic activity of cells incubated on all scaffolds remained on average at around 150% of that of 
cells cultured for 3 days in TCPS, indicating that the different materials were not cytotoxic (Fig. 4.3). No 
significant differences in time were found, except for cells incubated on ChO for 7 and 10 days, where 
there was an increase in relative metabolic activity to an average above 250% and 185%, respectively, 
and for cells incubated on TCPS, which showed decreased metabolic activity with time. 
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Figure 4. 3. Metabolic activity of monocytes/macrophages cultured on different 3-D scaffolds. Primary human monocytes 
were seeded on PLA, PLA/G5, ChO or ChD scaffolds or on TCPS and metabolic activity was measured by performing a 
resazurin assay after 3, 7 or 10 days of incubation and normalized relative to the metabolic activity in TCPS after 3 days of 
culture. Left, each symbol corresponds to the average of three replicas for different donors (A, B, C, D and E). The bar represents 
the average of the analyzed donors. Right, Mann–Whitney tests were performed for every pair of conditions (*p ≤ 0.05; **p ≤ 
0.01; ns, not significant). 
 
 
4.3.3. Morphological analysis (actin staining) 
Actin was stained to observe the morphology of macrophages after 10 days of differentiation in the 3-D 
scaffolds. Microscopy observation indicated a non-uniform distribution of cells, particularly in Ch 
scaffolds (data not shown). A more detailed visualization of cells revealed the presence of both round and 
elongated cells (Fig. 4a). Furthermore, cells exhibited filopodia-like and podosome-like structures, which 
are involved in cell motility and adhesion, respectively (Fig. 4a). Nanotubes, which may regulate long-
distance intercellular communication by allowing vesicle trafficking [30], were also observed (Fig. 4.4a). 
Crucially, MGCs were found, although no external cytokines were added (Fig. 4.4a). Visual inspection of 
the different scaffolds revealed very heterogeneous cell populations, but ChO scaffolds seemed to have 
more MGCs, PLA more cells with many filopodia and ChD showed more elongated cells (Fig. 4.4b). 
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Figure 4. 4. Morphology of cells in contact with the different scaffolds. Upon incubation for 10 days in the presence of the 
indicated scaffolds, cells were fixed and stained for actin (green) and the nuclei (blue) before being visualized by laser scanning 
confocal microscopy. The scaffolds can be observed in blue due to their autofluorescence. (a) Examples of macrophages and 
multinucleated giant cells (*) in the indicated scaffolds. Dashed lines indicate the limits of the scaffolds struts. Grey dashed 
arrow, nanotube. Big arrowhead, cell with filopodia-like structures. Small arrow, cell with podosome-like structures. (b) Table 
with the relative amounts of multinucleated giant cells, cells with filopodia and elongated cells for five independent cell donors 
(A–E). +, few cells; ++, some cells; +++, many cells; –, no cells. 
 
4.3.4. Cytokine secretion 
To analyze secretion of both pro- and anti-inflammatory cytokines by monocytes/macrophages in contact 
with scaffolds, supernatants were analyzed for TNF-α, IL-6, IL-12/23, IL-10 and TGF-β levels. 
Interestingly, despite donor differences, we found that, overall, TNF- α levels (Fig. 5a) were significantly 
higher for cells incubated on Ch than for cells incubated on PLA, PLA/G5 or TCPS, except for ChO 
scaffolds after 3 days. No differences were observed when comparing PLA with PLA/G5, which did not 
elicit any detectable amounts of this cytokine. However, differences were found when comparing Ch 
scaffolds with the different geometries, with ChO scaffolds leading to higher secretion of TNF- α than 
ChD for late time points. Also, there were no significant differences with the incubation time for each 
material, except with ChD, where a decrease could be observed from 7 to 10 days. 
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Figure 4. 5. TNF-α, IL-6 and IL-12/23 cytokine secretion pattern of monocytes/macrophages cultured on distinct 
scaffolds. Cells were cultured for 3, 7 or 10 days on PLA, PLA/G5, ChO or ChD scaffolds or on TCPS and the amounts of (a) 
TNF-a, (b) IL-6 and (c) IL-12/23 present in the pooled supernatants from three replicas were quantified by ELISA. Left, each 
symbol corresponds to one donor (from A to E) and the bar represents the average. Right, Mann–Whitney tests were performed 
for every pair of conditions (*p ≤ 0.05; **p ≤ 0.01; ns, not significant). 
 
 
Remarkably, the analysis of IL-6 secretion revealed a different outcome (Fig. 4.5b). The amount of IL-6 
was higher in PLA or PLA/G5 than in Ch scaffolds, where it remained mostly very low. However, for 10 
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days of incubation with ChO and 7 and 10 days with ChD, values were higher than when cells were 
incubated on TCPS for 3 and 7 days. No major differences were observed when comparing PLA with 
PLA/G5, or when comparing Ch scaffolds with different geometries. 
The amount of the subunit p40, shared by both IL-12 and IL-23, was in general higher in PLA and 
PLA/G5 than in Ch scaffolds (with significant differences more evident with diagonal scaffolds) and in 
TCPS (Fig. 4.5c). No statistically significant differences were found between PLA and PLA/G5, though 
we observed a tendency for an increase with PLA/G5. Also, there is a trend for an increase in the amount 
of IL-12/23 produced over time when cells are incubated with Ch scaffolds. Furthermore, a slight but 
statistically significant increase was found with ChO as opposed to ChD scaffolds. The amount of IL-
12/23 was higher on ChO scaffolds than with TCPS for 7 and 10 days, but no major differences were 




Figure 4. 6. IL-10 and TGF-b cytokine secretion pattern of monocytes/macrophages cultured on distinct scaffolds. Cells 
were cultured for 3, 7 or 10 days on PLA, PLA/G5, ChO or ChD scaffolds or on TCPS and the amounts of (a) IL-10 and (b) 
TGF-β present in the supernatant were quantified by ELISA. Left, each symbol corresponds to one donor (from A to E) and the 
bar represents the average. Right, Mann–Whitney tests were performed for every pair of conditions (*p ≤ 0.05; **p ≤ 0.01; ns, 
not significant). 
Interestingly, there was a tendency for IL-10 levels to be higher with PLA than with other scaffolds (Fig. 
6a). Significant differences were found when comparing cells cultured on PLA or PLA/G5 with cells 
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cultured on TCPS. Cells seeded on PLA (cultured for 7 and 10 days) or PLA/G5 (3 days) showed 
significantly higher values than cells seeded on ChO (3 days) and ChD (3 and 10 days) scaffolds and on 
TCPS (3, 7 and 10 days). Also, IL-10 levels were significantly higher on cells cultured on PLA for 7 days 
than on PLA/G5 (7 and 10 days). Though the amount of secreted IL-10 was slightly higher for cells 
cultured on Ch scaffolds than on TCPS, no significant differences were found. Finally, no significant 
differences were found for secretion of TGF-β in the presence of the different scaffolds (Fig. 4.6b).  
 
4.4. Discussion 
New approaches elucidating the role of inflammation and of macrophages in particular, in tissue 
repair/regeneration are attracting more and more attention within the field of regenerative medicine. 
Though the role of the inflammatory response to implantable biomaterials has long been recognized, the 
impact of 3-D scaffolds on human immune cells has not been properly examined and described. Many 
studies are currently done with murine models, and caution should be taken when extrapolating data to 
the human system, as a direct comparison between the human and murine immune responses remains 
controversial [31]. Here, striking differences in the cytokine secretion profile of human macrophages 
interacting with 3-D structures with different architectures and surface properties were revealed. To study 
the response of macrophages to differences in scaffold geometry and surface properties (mainly 
chemistry), we chose to study four platforms: two based on PLA (PLA and PLA/G5) and two based on 
Ch (ChO and ChD). PLA, PLA/G5 and ChO allowed us to study differences in surface chemistry and 
topography while keeping the same architecture, whereas ChD and ChO allowed us to evaluate 
differences due to architecture while keeping the same chemistry/topography. As far as we are aware, this 
is the first study where the specific impact of materials with precisely defined 3-D structures on 
macrophage responses was analyzed (as opposed to 2-D materials with different topographies or 
comparisons between 3-D materials with disorganized and random porous and non-porous structures). 
Rapid prototyping was used to fabricate structures with a well-defined and reproducible geometry. PLA 
(thermostable polymer) and Ch (hydrogel) require completely different fabrication approaches. Thus, the 
fabrication parameters were optimized and carefully tuned for the fabrication of both PLA- and Ch-based 
scaffolds. In the case of PLA-based scaffolds, the right interplay between temperature/plasticizer/printing 
parameters and the post-processing shrinkage of the struts was achieved to obtain scaffolds with struts 
with significantly smaller diameter than the nominal ones [18]. For Ch, the right concentration and 
dispensing rate of the NaOH solution to neutralize and cross-link Ch and keep the scaffolds’ integrity 
were optimized. 
Though PLA is a well-known polymer in the biomedical field, its use in the fabrication of rapid 
prototyping scaffolds, in particular by nozzle-based printing systems, has been limited. Currently, most of 
the work done with PLA and 3-D printing require the molecular modification of the PLA matrix, or the 
use of high temperatures to melt the polymer [32–34]. Thus, as reported in chapter 3 [18], fabrication of 
PLA-based scaffolds, like the ones reported in this work, with higher resolution than the ones obtained 
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with other currently used methods is a novelty. Also, in addition to the high resolution achieved, having 
the possibility of adding up to 50% (w/w) of glass particles (< 40 μm) distributed well within the scaffold, 
as well as tuning other properties, such as the mechanical properties or surface topography, by controlling 
the solvent and glass concentrations, are advantages over current PLA RP scaffolds. 
Chitosan scaffolds with orthogonal geometry have been previously developed by a rapid prototyping 
robotic system [26,35], by hybrid system coupling nozzle deposition and by freeze-drying processes [36]. 
However, the present study allowed the development of two different designs: a displaced double-layer 
design (ChO) and an orthogonal–diagonal one (ChD). Moreover, the scaffolds developed in this study 
have achieved a structural integrity that allows them to be used without being lyophilized. Most of the 
studies found in the literature performed biological assessment on freeze-dried scaffolds. 
Ch swells when in contact with aqueous media and thus structures with significantly larger struts 
diameter than the predefined one were obtained. Observation of hydrated Ch scaffolds by SEM has rarely 
been reported. Here, a low vacuum protocol was chosen to reduce the vacuum effect and analyze the Ch 
structures. According to SEM analysis, despite the struts’ thickness differences in comparison to 
predefined structures, the predetermined geometry and the distance between theoretical axes were 
successfully reproduced. The remarkable difference in diameter between PLA and Ch scaffolds was 
translated into a higher surface area of PLA and PLA/G5 structures in comparison to Ch ones. With 
respect to porosity, all structures presented pores between 150 and 600 μm, which are in the accepted 
range for cell growth, migration and vascularization [37,38]. With Ch, the sizes of struts and pores were 
highly dependent on the degree of hydration of the sample. Ch swelling also led to differences in the 
transverse porosity, pores in the Ch scaffolds being considerably smaller than those in the PLA and 
PLA/G5 counterparts. Relevant differences in the axial porosity of ChD and ChO were also observed. 
ChD displayed smaller pores and a different pore geometry due to the presence of diagonal struts, which 
led to the formation of triangular pores and decreased the pore size in comparison to the orthogonal 
design. 
These four scaffolds (PLA, PLA/G5, ChO and ChD) were then used to determine whether and how these 
properties might affect human monocytes/macrophages responses. 
Analysis of the cells metabolic activity revealed small differences between the different structures, while 
the values for metabolic activity in TCPS were found to be low. This implies that scaffolds supported 
adhesion and development of monocyte/macrophages. Visualization of cells upon actin staining showed 
that cells could indeed adhere to all of the scaffolds analyzed. Furthermore, observations of cellular 
morphology indicate that cells interacting with scaffolds adhere, communicate with each other and can 
adopt varied morphologies, showing a heterogeneous profile in all scaffolds. Cell morphology was 
analyzed by imaging up to 200 μm, as confocal imaging did not allow imaging deeper in the scaffold. In 
our previous studies with MSCs, scaffolds were cut into slices and cells were found to be distributed 
throughout the scaffold, with no significant differences between the surface and the inner scaffold (data 
not shown). Also, scaffolds used in this work had pore sizes that should allow cells to migrate easily. 
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Thus, it is reasonable to assume that no major differences will be found between different layers of these 
scaffolds. 
Interestingly, observation of MGCs was more evident in ChO. The presence of MGCs correlated with a 
higher secretion of TNFa, which is one of the main cytokines related to MGCs, being involved in 
granuloma formation [39]. Elongated cells were observed mainly in ChD scaffolds, whereas rounded 
cells with filopodia-like structures were mainly present in PLA scaffolds. The effect of both surface 
chemistry and topography on cell morphology has been widely documented [40–42]. The structures used 
in this study presented somewhat different surface properties. Previous surface characterization of these 
materials revealed contact angles of 76.6° for PLA (PLA/PEG), 60.3° for PLA/G5 (PLA/PEG/G5) and 
87.2° for Ch; and roughness values (Sa) of 147.12 nm for PLA, 1003.89 nm for PLA/G5 and 1.50 nm for 
Ch [18,43]. Though these values were obtained from polymer films, it is most likely that they are also 
valid for the studied 3-D structures since the fabrication process of both films and 3-D scaffolds is 
similar. Here, elongated cells were more evident in both Ch scaffolds, specifically in ChD. Given that 
almost no elongated cells were seen in PLA/G5, which are the rougher scaffolds, these results suggest 
that macrophages have a tendency to adopt an elongated configuration when in contact with 
flatter/smooth surfaces, in agreement with others, who showed an increase in cell elongation with 
decreasing roughness [41]. The more rounded cells with filopodia-like structures, found mainly on PLA 
and PLA/G5, seemed to prefer rougher surfaces. Similar macrophage morphology has been reported by 
other studies both in vitro and in vivo [1,40]. On the other hand, as experiments reported here were 
performed in the presence of serum, it is also possible that scaffolds with a different chemical 
composition affect macrophage behavior indirectly, due to differences in protein adsorption on their 
surface. Indeed, protein adsorption to surfaces with different chemistries has been shown to affect 
macrophage adhesion and morphology [42]. Paracrine effects between cells adhering to the scaffolds or 
to the plastic surface, which may regulate subsequent cell behavior, cannot be excluded. 
A major goal of this work was to determine a cytokine profile of monocyte/macrophages when in contact 
with different 3-D scaffolds. The impacts of the 3-D PLA and Ch scaffolds on the macrophage cytokine 
profile are substantially different (Fig. 4.7). Clearly, the PLA and PLA/G5 scaffolds lead to a secretion 
profile distinct from that of Ch, with the former eliciting higher secretion of IL-6, IL-12/23 and IL-10. 
Strikingly, Ch scaffolds stimulated production of large amounts of TNF-α, which remained high through 
the incubation time, and small amounts of IL-10 that did not increase with time, with no differences in the 
amount of TGF-β being secreted. The results presented here are thus somewhat different from what has 
been found with 2-D Ch films, where production of pro-inflammatory cytokines decreased with time and 
production of IL-10 and TGF-β increased [16]. Different outcomes on macrophage behavior in the 
presence of 2-D or 3-D substrates have also been reported by others [44] and attest to the importance of 
studying the impact of 3-D scaffolds on inflammatory responses for TE approaches. 
 
Chapter 4  
  97 
 
Figure 4. 7. Scheme summarizing the effect of each scaffold on macrophage cytokine profile. The overall tendency for 
cytokine secretion levels by macrophages cultured with the analyzed scaffolds is represented by arrows of different sizes. Red 
and green arrows represent anti- and pro-inflammatory cytokines, respectively. MGCs, elongated cells and cells with filopodia-
like structures are also represented. Not to scale. 
 
As for the impact of scaffold geometry, some differences were found when comparing ChO with ChD 
scaffolds, with the orthogonal scaffolds stimulating higher levels of TNF-α and IL-12/23, particularly for 
late time points, correlating with an increase in the metabolic activity. This correlation between the 
amounts of TNF-α and IL-12/23 with the cells’ metabolic activity is most likely not due to an increase in 
cell number, as otherwise the secreted amounts of IL-10 and TGF-β would also have increased with time 
and also macrophages are unlikely to proliferate. Here we used a resazurin assay to estimate the 
metabolic activity of macrophages, which more specifically measures the cells redox metabolism. 
Interestingly, it has been suggested that the cells redox metabolism may contribute to macrophage 
polarization, and that proinflammatory cells are associated with a ‘‘reductive state’’ [45,46]. This 
correlates well with the fact that scaffolds leading to increased metabolic activity (ChO) also lead to 
increase production of the pro-inflammatory cytokines TNF-α and IL-12/23. 
Interestingly, more MGCs existed in the presence of orthogonal scaffolds while diagonal scaffolds had 
more elongated cells. Taken together, these data seem to suggest that an orthogonal geometry is 
correlated with a stronger inflammatory reaction than a diagonal geometry, where cells may adopt more 
elongated morphologies upon adhesion to struts that form tighter angles and smaller pores. In line with 
this hypothesis, substrate shape can indeed affect cellular behavior, as seen, for example, with MSC 
differentiation [17] and proliferation of pre-osteoblastic cells [47]. 
Some studies have focused on analyzing whether macrophages polarize towards an M1 or an M2 
phenotype, which have been correlated with a pro-inflammatory and a pro-regenerative function, 
respectively, by analyzing the production of a number of soluble factors and the expression of cell surface 
markers [2,16,21]. Here, we focused on characterizing a cytokine secretion profile that is a crucial 
functional readout, rather than analyzing in detail the polarization of cells into M1 or M2. Thus, we 
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quantified the secretion of the cytokines TNF-α, IL-6, IL-12/23, IL-10 and TGF-β, which are commonly 
analyzed with biomaterials and have a role in regulating tissue repair/regeneration. Interestingly, for each 
scaffold we describe a profile that is not typical of either a classic M1 or M2 phenotype. The 
heterogeneity of monocyte/macrophage populations implicates difficulties in classify them within any of 
these two types. Macrophage plasticity implies that cells may shift from one profile to the other [5], and it 
has even been suggested that this plasticity allows cells to transdifferentiate [48]. Others have also found 
that culturing macrophages in 3-D nanofibers induced the expression of surface markers characteristic of 
M1 macrophages, accompanied by secretion of pro-angiogenic factors and decreased production of pro-
inflammatory cytokines, which usually characterizes M2 polarization [44]. Furthermore, it has been 
suggested that, at least in a pathogenic scenario, macrophages can exhibit a heterogeneous profile, 
expressing both M1 and M2 markers at the same time [49]. Therefore, more than classifying cells as 
being M1 or M2, it is important to understand which functional responses will be stimulated by different 
biomaterials, cytokines being crucial players in driving subsequent cellular responses. 
 
4.5. Conclusions 
Building the right 3-D platforms with parameters that are tunable on demand is of paramount importance 
to analyzing and deciphering the monocyte/macrophage response to different materials/structures. Rapid 
prototyping has been demonstrated to be a valuable tool for the fabrication of such platforms. This work 
shows that the impact of four different 3-D platforms on macrophage morphology and cytokine profile is 
distinct, with macrophages being mostly affected by material properties and slightly by scaffold features 
such as pore geometry. More specifically, PLA-based scaffolds induced higher production of IL-6, IL-
12/23 and IL-10, while Ch led to increased secretion of TNF-α, with the scaffold geometry impacting on 
the amounts of TNF-α and IL-12/23 secreted. Thus, we believe that it is important to select biomaterials 
based on the right chemistry, surface properties and geometry. However, the ideal response and cytokine 
environment still remain uncertain, and more complex studies (e.g. with co-cultures with other cell types, 
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Chapter 5 - PLA and PLA/CaP glass 3D scaffolds for Guided Bone 
Regeneration (GBR) devices: An in vivo study  
Chapter 4 showed how materials, geometries and morphological features affect the in vitro 
inflammatory response to different 3D-printed scaffolds. Moreover, the important role of biomaterials 
on monocytes/macrophages morphology and cytokines profile was observed. In addition to surface 
properties and geometrical features, scaffolds degradation rate also play an important role in the 
inflammatory response. 
Given the known relation between inflammation and regeneration, and the effect of scaffolds properties 
on inflammatory cells, the present chapter aims to develop and characterize a novel scaffold, a 3D 
biphasic PLA - PLA/G5 scaffold for Guided Bone Regeneration (GBR). The study involves an in vitro 
degradation evaluation of the scaffolds together with in vivo testing. 
Combining the previous in vitro analysis with the study of in vivo response will allow a better 
understanding of the role of scaffold design parameters with the final goal of modulating inflammation 
and improving tissue regeneration. 
 
5.1. Introduction 
The search of novel and suitable bone grafts for the treatment of osseous defects is strongly required. 
Bone defects may originate as a result of dental and periodontal infections, traumatic injuries, tumor 
surgery, congenital diseases or developmental disorders, among others. 
For instance, periodontal disease is due to chronic inflammation and bacterial infection of the gum that 
diffuse to the ligaments and alveolar bone that support the teeth. If it is not adequately threated can 
provoke the reduction of bone level at the zone surrounding the teeth with consequently loss.  
Among the strategies to increase the rate of bone formation and to expand the bone volume, guided 
bone regeneration (GBR) represents one of the most promising approaches. The main fundamentals of 
GBR have had origin during the eighties with the guided tissue regeneration strategies (GTR) developed 
by Nyman and Karring [1]. Since then, GBR methods have been used to enhance bone tissue in the site 
with lack of bone volume for the fixation of endosseous dental implants. GTR process is based on the 
principle of guiding the proliferation and regrowth of the different components of the periodontal tissue. 
GTR strategies have also been applied for the regeneration of other areas such as bone loss due to dental 
trauma or maxillofacial injuries that need plastic surgery procedures.  
Basically, the main concept of GBR is that the cells migrating in a defined zone establish the tissue 
regenerating in that zone. In order to guarantee the augmentation of bone volume, a mechanism to stop 
the fast moving epithelia tissue is required. Therefore, the development of barrier-systems enabling the 
exclusion of endothelial and gingival connective tissue cells from the resorbed bone area is a good 
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option. Such systems could allow the periodontal ligament cells and bone cells to repopulate the area 
and regenerate new bone. 
More specifically, it would be desirable to develop scaffolds/membranes that act as a) initial barrier that 
becomes integrated by the tissue afterwards, and b) stimulates transmembrane vascularization with the 
end of supplying oxygen and nutrient to the inner zone for promoting bone development. Indeed, 
vascularization of the implanted material is a fundamental aspect for its integration and degradation, and 
therefore the tissue growth [2]. 
Up to now, a number of membrane systems have been adopted both in experimental and clinical studies 
for GBR. Different no resorbable materials have been successfully used such as polytetrafluoroethylene 
(PTFE) [3], titanium [4]. In spite of their high performance in GBR, such materials have a clear 
limitation to be non resorbable and, therefore, have to be removed with a second surgical procedure. 
This procedure can also damage the tissue and affect patients’ morbidity. Thus, the aim of recent 
research in guided bone regeneration is the development of resorbable barriers for clinical application. 
A number of biodegradable materials have been used such as freeze-dried collagen [5], silk fibroin [6], 
polylactic-co-glycolic acid [7] among others. Moreover, novel studies have been conducted by using 
membrane guides in conjunction with preformed porous scaffolds or a particulate osteoconductive 
material in order to enhance bone regeneration [8]. Several approaches such as growth factors, or 
antibiotics have been used for the activation of vascularization through scaffolds and to avoid infections 
in the implanted site [9,10]. Among others, a more typical tissue engineering strategy has been adopted 
by Gomez and colleagues [11] applying a cell sheet technique for cementum-periodontal regeneration. 
However, the implantation of such fragile in vitro developed extracellular matrix sheet has been always 
coupled with a support of synthetic membranes that eventually need a second operation to be extracted. 
To increase implant stability and avoid the membrane extraction step, Vaquette and colleagues proposed 
a cell-engineering construct in which different cells where previously in vitro seeded on a biodegradable 
scaffold obtained coupling rapid prototyping with electrospum fibers to regenerate bone and periodontal 
ligament respectively [12]. Nevertheless, the advantages of using cell-free scaffolds have been already 
mentioned in the introduction of this thesis, and are strongly required for GBR applications. 
In this scenario, the development of biphasic cell-free scaffolds composed by PLA and PLA/G5 could 
be a good option to regenerate the soft tissue and the bone compartment respectively. The G5 
angiogenic effect [13,14] could contribute to the transmembrane vascularization that selectively will 
form new bone and soft tissue. Moreover, the use of 3D-printing technique allows the fabrication of 
biphasic scaffold in a controllable and reproducible way with a precise spatial deposition of materials. In 
addition, it permits evaluating the role of both PLA and PLA/G5 while keeping same 
structural/geometrical properties. 
Recent works indicate that macrophages and multinucleated giant cells (MGCs), both starring actors of 
the inflammatory response and foreign body reaction are not only involved in the degradation process of 
implanted biomaterial scaffolds but also on the production of angiogenic signaling molecules, such as 
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VEGF that could also contribute significantly to scaffold vascularization [6,15]. In particular, it has 
been shown that the penetration of host inflammatory cells, specifically macrophages, into a fibroin 
scaffold play a key role in the vascularization process by their production of pro-angiogenic growth 
factors [6]. 
Moreover, it has been reported that the host tissue reaction is in some way related to the material 
degradation rate, being macrophages and multinucleated giant cells involved in the degradation of 
scaffolds [6,16]. Thus, from this point of view, it is important to understand the degradation behavior of 
the material and its relation to MGCs formation in order to develop suitable scaffolds for guided tissue 
regeneration. In this chapter, various experiments have been performed to determine the impact of the 
developed scaffolds on monocytes and further MGCs fusion and stimulation due to materials 
degradation. Furthermore, the pro-angiogenic effect of G5 together with the presence of MGCs is also 
evaluated.  
The aims of this work are: a) the design, fabrication, and characterization of new biphasic scaffolds 
composed by PLA and PLA/G5 phases, b) evaluation of the in vitro degradation behavior of PLA and 
PLA/G5 scaffolds, and c) the assessment of the in vivo response of the studied scaffolds in terms of 
inflammation and vascularization in order to evaluate their potential for GBR applications. 
 
 
5.2. Materials and Methods 
5.2.1. Materials 
The materials used have been described in chapter 2 (2.2.1) and combined according to the 
compositions shown in Table 5.1.    
Scaffold Polymer matrix (w/w %) G5 particles (w/w%) 
 PLA PEG  
PLA 95 5 - 
PLA/ G5a 95 5 50 
Biphasicb 95 5 - 95 5 50 
 Table 5. 1. Composition of the studied materials. a The percentage shown for the polymer matrix of the PLA/G5 scaffolds 
correspond to 50% of the total weight of the scaffold. b Biphasic scaffolds are a combination of both PLA and PLA/G5 phases 
as shown in Figure 1. 
 
5.2.2. Scaffolds fabrication 
Scaffold fabrication has been conducted following the protocol described in chapter 2 (2.2.2). A 
displaced double layer design shown in Figure 5.1 was adopted to fabricate the polymeric (PLA), 
composite (PLA/G5) and biphasic (composed by PLA and PLA/G5 phases) three-dimensional 
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structures described in Figure 5.1. For this, polymer and composite blends (Table 5.1) were dispensed 
through a G27 (200µm) nozzle at a pressure ranging between 40-80 psi and a motor speed of 7 mm s-1. 
Polymer and composite inks were kept at 40 ± 5ºC during the printing process by using a heating jacket. 
Room temperature was kept at 25 ± 2 ºC. Finally, cylindrical scaffolds (4 mm diameter x 4 mm height) 
were cored from larger 3D printed pieces and used in the degradation studies and in vivo implantation.  
 
5.2.3. Degradation study in simulated body fluid (SBF) 
In vitro degradation studies were performed by immersing the scaffolds in simulated body fluid (SBF) 
as described in chapter 2 (2.2.4). Samples were immersed in SBF at 37ºC during 8 weeks. Materials 
degradation was evaluated in terms of weight loss, molecular weight and morphological variations along 
the immersion time. Aging studies were only conducted with PLA and PLA/G5 scaffolds. 
 
5.2.4. Morphological SEM study 
Morphological analysis of the 3D structures was carried out by scanning electron microscopy (as 
mentioned in 2.2.3.1) to visualize and evaluate: the architecture of the 3D scaffolds, surface morphology 
of the deposited struts, and the distribution and exposure of the glass particles. Moreover, SEM 
observation was used to visualize any degradation sign appearing at the material surface after 8 weeks 
of immersion in SBF.   
In order to check if the glass particles were exposed on the struts surface of the PLA/G5 scaffolds, an 
Alizarin Red S assay (ARS) (Millipore, Billerica, MA), which stains calcium into a red color, was 
performed. 
 
5.2.5. Weight loss 
Scaffolds' weight loss during immersion in SBF was measured by recording the weight changes of the 
dry specimen after the specified incubation time periods (4 and 8 weeks). The percentage of weight loss 
was computed using the same approach described in chapter 2 (2.2.4.1). 
 
5.2.6. GPC analysis 
Weight average molecular weight (Mw) of PLA/PEG 95/5 and PLA/PEG/G5 composite scaffolds along 
degradation was determined by gel permeation chromatography (GPC) using a modular system, 
composed of an isocratic pump, a vacuum degasser, and refractive index detector (Waters Alliance 
2414). Separations were performed in column PSS PFG Analytical 103 Å (Dimensions: 300 x 8.00 mm, 
particle size: 7 µm). Narrow poly(methyl methacrylate) standards (Fluka) were used for calibration. 
Analysis were performed at 30°C, using 50mM in hexafluoroisopropanol as solvent and filtered (0.22 
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µm) before injection with a flow-rate of 0.8 ml/min. Acquisition and treatment of chromatographic data 
was carried out by Empower GPC Software. 
 
5.2.7. Mechanical properties of scaffolds 
The evaluation of the mechanical properties of the scaffolds has been conducted using the procedure 
described in chapter 3 (3.2.3.5). Compressive modulus of PLA and PLA/G5 scaffolds has been 
measured before and after 8 weeks of incubation in SBF. 
 
5.2.8. Experimental study design and subcutaneous implantation 
For these experiments 60 female, 6-8 week-old CD-1 mice (Charles River Laboratories, Germany) were 
coincidentally divided into four study groups. Thereby each of the first three study groups contained 16 
animals, which obtained subcutaneous implantation of the three different scaffolds for four study time 
points, i.e. 3, 10, 15 and 30 days, with n = 4 animals per experimental group and time point. 
A fourth group (“control”) underwent the operation without biomaterial insertion to analyze 
comparatively the tissue reaction to the surgical procedure. Therefore 12 animals were used in this 
group for the above-mentioned study time points (n = 3 animals per time point). 
The subcutaneous implantation was conducted following the protocol described by Ghanaati and 
collegues [17,18]. In brief, the animals were anesthetized via an intraperitoneal injection (10 ml 
ketamine [50 mg/ml] with 1.6 ml Xylazine [2%]). After shaving and disinfection of the rostral 
subscapular region, a horizontal incision down to the subcutaneous tissue was made and a subcutaneous 
pocket was built, in which the biomaterials were inserted. Finally the wounds were sutured. 
Animal housing was conducted at the in vivo Laboratory Animal Unit of the Institute of Pathology. 
Thereby the animals were kept under standard conditions (water ad libitum, artificial light and regular 
rat pellet (Laboratory Rodent Chow, Altromin, Germany)) and a pre- and postoperative care was 
accomplished. The described in vivo experiments were previously authorized by the Committee on the 
Use of Live Animals in Teaching and Research of the State of Rhineland-Palatinate, Germany. 
 
5.2.9. Explantation and histological workup 
After the course of the experiments the animals were euthanized with an overdose of the above-
described anesthetics and a subsequent thorax opening. Immediately afterwards the implanted 
biomaterials and the surrounding tissue or the area of the control incision were explanted. The 
histological workup was conducted as previously described by Ghanaati and colleagues [18]. Thereby 
the explanted tissue was fixed using a 4% formalin solution for 24 hours and afterwards the explants 
were cut into in three segments of identical dimensions including the left margin, the centre and the 
right margin of the biomaterial. Subsequently a dehydratation via a series of increasing alcohol 
concentrations and a final xylol exposure was performed before paraffin embedding. After that 3-5 µm 
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thick slides were made using a rotation microtome (Leica, Wetzlar, Germany) and primarily stained 
with with haematoxylin and eosin (H&E) to choose the best of the three tissue blocks per animal. 
Following this, five further slides were cut from every tissue block.  
After these preparation steps the following stains were made for quantitative and qualitative analyses of 
the tissue reactions: Haematoxylin and eosin-staining (H&E) (nuclei and cytoplasm), Azan-staining 
(nuclei and collagen), Movat Pentachrome-staining (collagen), Tartrate-resistant acid phosphatase 
(TRAP) (osteoclast-like cells and multinucleated giant cells) staining as well as an 
immunohistochemical CD31-staining (endothelial cells, blood vessel, identification of angiogenesis), 
which included a respective control slide, according to methods described by Ghanaati et al. [18].  
 
5.2.10. Histological analyses 
The histological analyses, which involved the outcome of the tissue-biomaterial-interactions within the 
implantation beds of he scaffolds and their surrounding tissue, were conducted using an Eclipse 80i 
histological microscope (Nikon, Tokyo, Japan). Thereby special focus was on the evaluation of the 
following parameters within the framework of the early and the late tissue response related to the 
implants: Fibrosis, haemorrhage, necrosis, vascularization and the presence of neutrophils, lymphocytes, 
plasma cells, macrophages, multinucleated giant cells and TRAP-positive, osteoclast-like cells.  
Finally microphotographs were made via a Nikon DS-Fi1 digital camera and a DS-L2 digital sight 
control unit (both: Nikon, Tokyo, Japan) connected to the microscope. 
 
5.2.11. Histomorphometrical analyses 
The histomorphometrical analyses included the comparative measurements of the vascularization 
(vessel density and percent vascularization) as well as the measurement of the extent of material-related 
multinucleated giant cells as described in [18]. In brief, so-called “total scans” were generated with aid 
of an specialized scanning microscope, which consists of an Eclipse 80i histological microscope 
combined with a DS-Fi1 digital camera and an automatic scanning table (Prior Scientific, Rockland, 
MA) connected to an PC system running the NIS-Elements software (all: Nikon, Tokyo, Japan). The 
resulting images were composed of 100 to 120 single images with a 100x magnification in a resolution 
of 2500x1200 pixels and contain the complete biomaterial area as well as the peri-implant tissue. For 
conduction of this study the Azan slides as well as the CD-31 stains were digitized. These images 
allowed to analyze the tissue reactions to the biomaterials with the use of the NIS-Elements software.  
For measurement of the vascularization the complete area of the biomaterial was measured with the 
“area tool” within the digitized CD-31 stains at first. After that the vessels were manually marked also 
using this tool. For calculation of the vessel density (vessels/mm2) the number of counted vessels per 
slide was related to one millimeter of the implant area, while the measurements of the percent 
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vascularization were realized by calculating the percent amount of the vascularized implant area based 
on the summarized vessel areas and the total implant area. 
Additionally for measurement of the extents of the material-related multinucleated giant cells, the 
amounts of these cells were manually counted using the “count tool” of the NIS-Elements software and 
related to the total implant area (giant cells/mm2). 
 
5.2.12. Statistical analyses 
Quantitative data are shown as mean ± standard deviation after an analysis of variance (ANOVA) 
followed by LSD post hoc assessment, which enabled to compare the data from the study groups via the 
GraphPad Prism 6.0 software (GraphPad Software Inc., La Jolla, USA). Thereby statistical differences 
were marked as significant if p-values were less than 0.05 (*p ≤ 0.05), and highly significant if p-values 
were less than 0.01 (**p ≤ 0.01). 
 
5.3. Results 
5.3.1. SEM observation 
Figure 5.1 summarizes the structures of the studied scaffolds namely PLA, PLA/G5 and biphasic ones. 
As observed, the 3D printed scaffolds reproduced very well the predesigned structures (Figure 5.1a,e,i). 
Structures with struts diameters of approximately 75 ± 5 μm and pores of 165 ± 5 μm respectively were 
obtained, as the scaffolds described in chapters 3 and 4. In the case of biphasic scaffolds a clear 
transition from the polymer phase to the composite one was observed. Both SEM observation and 
alizarin red staining (Figure 5.1b-d, f-h, j-l) confirmed the presence and exposure of glass particles well 
distributed in the surface and inner part of the struts. 
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Figure 5. 1. Structures of the studied scaffolds. (a,e,i) Design of the scaffols, (b,f,j) axial and (c,g,k) cross-sectional SEM 
micrographs, and (d,h,l) alizarin red staining  images of the PLA, PLA/G5 and biphasic scaffold respectively. 
 
 
Figure 5.2 displays the surfaces of both PLA and PLA/G5 scaffolds before and after the degradation 
time.  Figures 5.2a,b show PLA scaffolds before immersion in SBF whereas Figures 5.2c and d show 
PLA/G5 ones. In the case of PLA scaffolds a rather smooth and continuous surface is observed. In the 
case of the PLA/G5 composite scaffolds a significantly rough surface with irregularities and 
protuberances due to the presence of the glass particles is seen. Figures 5.2e,f and 5.2 g-k reveal clearly 
eroded surfaces after 8 weeks of immersion in SBF. Degradation signs were more visible in the case of 
PLA/G5 scaffolds than in PLA ones. PLA/G5 scaffolds exhibited the formation of cracks as well as an 
increased exposure of the glass particles and a rougher PLA matrix. 
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Figure 5. 2. SEM micrographs indicating surface morphology of PLA and PLA/G5 scaffolds before and after the 
degradation. In particular: (a,e) PLA and (b,f) PLA/G5 scaffolds before degradation; (c,g) PLA and (d,h,) PLA/G5 after 




The evolution of the physical and chemical properties of the studied scaffolds over an 8-week aging 
period is shown in Figure 5.3. Figure 5.3a shows the weight variation of the PLA and PLA/G5 scaffolds 
during the aging period. According to the graph, both types of scaffolds underwent an increasing mass 
loss; however, each material showed a different behavior. PLA/G5 scaffolds displayed an increasing 
weight loss since the first weeks of immersion in SBF, whereas, in the case of PLA scaffolds mass loss 
started after the second week of aging. Though PLA/G5 revealed an initial faster weight loss in 
comparison to PLA, PLA scaffolds showed a steeper trend, loosing up to 8% of its mass after 8 weeks 
of degradation.   
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Figure 5. 3.  (a) Weight loss, (b) molecular weight evolution, and (c) mechanical test of PLA and PLA/G5 scaffolds over 
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5.3.3. Evolution of the molecular weight 
The molecular weight (Mw) of the polymer samples was analyzed by GPC, the obtained results are 
shown in Figure 5.3b. A significant reduction of around 50% of the initial weight average molecular 
weight was observed for both materials after 4 weeks of study. Moreover, PEG and PLA/G5 scaffolds 
showed a Mw decrease around 80% and 66% respectively after 8 weeks of immersion in the fluid. 
 
5.3.4. Mechanical test 
Figure 5.3c displays the variation of the compressive strength of PLA and PLA/G5 scaffolds after 8 
weeks of degradation. As expected, there was an initial increase of the compressive strength with the 
addition of glass particles. In fact, PLA scaffolds showed compressive modulus around 28 MPa while 
PLA/G5 showed values around 44 MPa.  As observed in the graph, immersion in SBF affected 
significantly the mechanical stability of the scaffolds. The compressive modulus decreased to 21 MPa in 
the case of the polymer scaffolds and to 31 MPa for the composite ones. 
 
5.3.5. Qualitative histological results 
The histological analyses revealed that the implantation of the scaffolds of each study group did not 
show any signs of necrosis, implant loss or exaggerated inflammatory reactions at any of the study time 
points (Fig. 5.4a, 5.5a and 5.6a).  
At day 3 after implantation a mixture of fibrin and connective tissue fibers combined with a low extent 
of mononuclear cells were observed within the implantation bed of all scaffolds, i.e. the PLA scaffolds 
(Fig. 5.4b), the PLA/G5 scaffolds (Fig. 5.5b) as well as the biphasic scaffolds (Fig. 5.6b). No signs of 
ingrowth of complex tissue, vessels or multinucleated giant cells were observable at this early time 
point. 
At day 10 after implantation the scaffolds of each study group were integrated within a connective / 
granulation tissue (Fig. 5.4c, 5.5c and 5.6c). Thereby the composition of the surrounding tissue as well 
as the occurrence and the amounts of the material-adherent cells differed between the three different 
scaffolds.  
The peri-implant tissue of the PLA scaffolds showed signs of a low-grade manifestation of a material-
induced inflammatory reaction as it showed a fibre-rich composition without a high amount of cells and 
blood vessels (Fig. 5.4c). A high amount of mononuclear cells were detectable at the surfaces of the 
PLA biomaterial, while only a few multinucleated giant cells were found (Fig. 5.4c).  
In contrast, the peri-implant tissue of the PLA/G5 scaffolds showed a high amount of cells and blood 
vessels at this study time point in combination with high extents of multinucleated giant cells and low 
numbers of mononuclear cells at their material-tissue-interfaces (Fig. 5.5c). 
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The histological observation of the mixture of both material classes, i.e. the biphasic scaffolds, showed 
that this material induced a high number of adherent multinucleated giant cells (Fig. 5.6c). The peri-
implant tissue of this group did also contain of a high number of cells and vessels (Fig. 5.6c). 
At day 15 and day 30 after implantation the histological analyses furthermore revealed comparable 
results as described for day 10. Altogether the PLA materials induced also at these study time points the 
lowest amount of material-adherent multinucleated giant cells combined with high amounts of 
mononuclear cells as well as the lowest amount of vascularization of the implantation bed (Fig. 5.4d and 
e). The observation revealed furthermore that the PLA/G5 materials evoke the highest extents of 
multinucleated giant cells and vessels, while mononuclear cells were only involved to a minor degree 
within the tissue reaction (Fig. 5.5d and e). At these study time points the biphasic materials showed an 
intermediate extent of both the amount of material-induced multinucleated giant cells as well as 
vascularization of the implantation bed (Fig. 5.6d and e). 
Additionally, the histological analysis of the TRAP expression also showed that the amount of TRAP-
positive multinucleated giant cells at all study time points was lowest in the PLA study group and 
highest in the PLA/G5 group, while the group of the biphasic scaffolds showed an middle-grade extent 
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Figure 5. 4. Histological images of PLA scaffold. (a) A total scan of the implant region did not show any signs of necrosis, 
implant loss or exaggerated inflammatory reactions. At (b) day 3, (c) day 10, (d) day 15 and (e) day 30 after implantation. 
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Figure 5. 5. Histological images of PLA/G5 scaffold. (a) A total scan of the implant region did not show any signs of 
necrosis, implant loss or exaggerated inflammatory reactions. At (b) day 3, (c) day 10, (d) day 15 and (e) day 30 after 
implantation. 
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Figure 5. 6. Histological images of Biphasic scaffold. (a) A total scan of the implant region did not show any signs of 
necrosis, implant loss or exaggerated inflammatory reactions. At (b) day 3, (c) day 10, (d) day 15 and (e) day 30 after 
implantation. 
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Figure 5. 7. In vivo data comparative TRAP activity after 30 days for (a) PLA, (b) PLA/G5, and (c) Biphasic scaffolds 
(TRAP staining, red triangles, 200× magnification). 
 
 
5.3.6. Quantitative histomorphometrical results 
5.3.6.1 Results of the vascularization measurements 
The comparative measurements of the vessel density showed that within none of the implantation bed of 
the three scaffold types any signs of vessel ingrowth were findable. In contrast, the control group 
showed a moderate amount of vessel ingrowth that has therefore high significant higher values 
compared to the three study groups (** p ≤ 0.01) (Fig. 5.8a). At day 10 after implantation the analyses 
revealed that the PLA/G5 group showed the highest vessel density that was significantly higher than 
PLA and the control group, but not in comparison to the biphasic scaffolds (** p ≤ 0.01) (Fig. 5.8a). 
Additionally, there were no significant differences between the PLA group, the biphasic group and the 
control group. 
The histomorphometrical results furthermore showed that the PLA/G5 group induced a significantly 
higher amount of vessels compared to the PLA group and the control group at day 15 after implantation 
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(** p ≤ 0.01), while no differences were measurable in comparison to the biphasic study group (Fig. 
5.8a). In addition, the biphasic study group showed significantly higher amounts of vessels compared to 
the PLA group and the control group (** p ≤ 0.01) (Fig. 5.8a). No significant differences were measured 
between the PLA group and the control group (Fig. 5.8a). 
At day 30 after implantation the measurements revealed that the PLA/G5 group again induced 
significantly higher amounts of vessel in comparison to the PLA group and the control group (** p ≤ 
0.01), while no differences were measurbable compared to the biphasic study group (Fig. 5.8a).  
Furthermore, the vessel density of the biphasic group showed significantly higher values in comparison 
to the PLA and the control group (* p ≤ 0.05), while no differences were identifiable between the PLA 
and the control group (Fig. 5.8a). 
The histomorphometrical analyses of the percent vascularization showed that at day 3 after implantation 
the control group has high significant higher values compared to the other three study groups (** p ≤ 
0.01), whose values did not differ (Fig. 5.8b). 
At day 10 after implantation the PLA/G5 group showed the highest values that were (high) significant 
greater compared to the biphasic group, the PLA group and the control group (* p ≤ 0.05 / ** p ≤ 0.01 / 
*** p ≤ 0.001) (Fig. 5.8b). The biphasic study group additionally showed (high) significant more 
vascularization percent compared to the PLA group and the control group (* p ≤ 0.05 / ** p ≤ 0.01) 
(Fig. 8b). The PLA group showed significantly higher vascularization percentage compared to the 
control group at this time point (* p ≤ 0.05) (Fig. 5.8b). 
At day 15 after implantation the PLA/G5 group furthermore showed significantly higher vascularization 
percentage compared to the PLA group and the control group (** p ≤ 0.01 / *** p ≤ 0.001), while no 
differences in comparison to the biphasic group were measurable (Fig. 5.8b). The biphasic group 
showed also significantly higher values in comparison to both groups (** p ≤ 0.01) (Fig. 5.8b). In 
addition, the PLA group showed a significantly higher vascularization percentage compared to the 
control group (* p ≤ 0.05) (Fig. 5.8b). 
The analyses revealed that at day 30 after implantation the PLA/G5 group again showed significantly 
higher values of vascularization in comparison to the PLA group and the control group (** p ≤ 0.01 / 
*** p ≤ 0.001), while no differences compared to the biphasic group were found (Fig. 8b). Additionally, 
the biphasic group had significantly higher percentage of vascularization compared to the control group 
(** p ≤ 0.01) and also no significant differences compared to the PLA group were measured (Fig. 5.8b). 
The PLA group had again significantly higher vascularization compared to the control group (* p ≤ 
0.05) (Fig. 5.8b). 
 
5.3.6.2. Results of the giant cell measurements 
The histomorphometrical analysis of the extent of material-induced multinucleated giant cells showed 
that the implantation beds of all study groups did not exhibit cells of this lineage at day 3 after 
implantation (Fig. 5.8c). Therefore, no significant differences were measured.  
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Figure 5. 8. Quantitative histomorphometrical in vivo data for PLA, PLA/G5, and Biphasic scaffolds. (a) vessel density, 
(b) vascularization percentage, and (c) amount of multinucleated giant cells. 
 
 
At day 10 after implantation the analyses revealed that the PLA/G5 group showed the highest amount of 
multinucleated giants cells, which significantly differed in comparison to the two other study groups (* 
p ≤ 0.05 / ** p ≤ 0.01) (Fig. 5.8c). The biphasic study group also induced significantly more giant cells 
compared to the PLA group at this time point (* p ≤ 0.05) (Fig. 5.8c). 
At day 15 and day 30 after implantation no significant differences of the amount of multinucleated giant 
cells were measurable between the PLA/G5 group and the biphasic study group as well as between the 
PLA group and the biphasic study group, while the PLA/G5 group induced a significant higher amount 
of giant cells compared to the PLA group at both time points (** p ≤ 0.01) (Fig. 5.8c). 
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5.4. Discussion 
This study has explored a novel therapeutic approach to guided bone regeneration by using a biphasic 
PLA-based scaffold developed via 3-D printing technique. The in vivo implantation of PLA-based 
devices has been largely reported and the degradation time is in the order of several years [19,20]. 
Moreover, it is generally noted that in vivo degradation is faster than the in vitro one [21,22], and many 
are the limitations to re-create the in vivo microenvironment in order to carry on these experiments. In 
addition, a main limitation in conducting in vivo degradation measurements of implanted 3D porous 
structures consists in the presence of the new tissue entrapped into the pores. This tissue is hardly 
removed from the pores and hinders the appropriate evaluation of scaffold degradation [22,23]. For this 
reason, only few studies have been done to assess the degradation of PLA-based scaffolds in vivo [22, 
24].  
In this work a dual approach, both in vitro / in vivo has been used to study the evolution of the scaffold 
properties. The use of an additive manufacturing technique, allowing the fabrication of precise and 
reproducible geometries, improved the assessment of the mechanical and morphological properties. 
Such approach could lead to less confused conclusions than the ones obtained by using random 
architectures with high variability among the samples [23]. 
The in vitro degradation study conducted up to 8 weeks, allowed the observation of the changes in 
morphology, weight loss, molecular weight, and mechanical properties. At this early stage of 
degradation, 3D structures maintain structural stability without completely losing the initial architecture 
and strength. It allows comparing morphological and mechanical properties with the ones of the initial 
scaffolds. 
Figure 5.1 shows the results of the scaffolds design and fabrication from a morphological point of view. 
The development of three different scaffolds: polymeric (Fig. 5.1a, b, c, d), composite (Fig. 5.1e, f, g, 
h), and biphasic (Fig. 5.1i, j, k, l) was achieved. Interestingly, the cross-section view (indicated in Fig. 
5.1c, g, k) evidenced the different morphologies of the structures. As explained in previous chapters, the 
PLA/PEG scaffolds (Fig 5.1c) presented struts with smoother surface than the composite ones (Fig. 
5.1g). A clear discontinuity in terms of morphology could be observed in the case of the biphasic 
structure in Figure 5.1k. Finally, alizarin red assay was an additional method to elucidate the presence of 
the two phases in biphasic scaffolds. Figure 5.1l highlights the different phases due to the polymeric and 
composite layers.  
The changes in morphology of the polymeric and composite scaffolds after 8 weeks of immersion in 
SBF solution are shown in Fig. 5.2. An increase of surface roughness was observed for both types of 
samples. In the case of the polymeric scaffolds, the increase of roughness was mostly attributed to an 
enlargment of the micro and nanopores already present in the surface of the strut due to the fabrication 
process as described in chapter 3 [25].  
In the case of the composite structures, higher surface erosion was noticed after 8 weeks. The struts 
containing G5 glass particles were slightly thinner than before degradation and showed superficial 
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cracks that were observed at higher magnifications (Figure 5.2i, j, k). This phenomenon could be 
attributed to an easier penetration of fluid at the interface between the polymeric matrix and the 
hydrophilic G5 particles. It led to an acceleration of the hydrolytic degradation of the polymer matrix, 
and the formation of cracks at the struts surface [26]. As a consequence, glass particles were more 
exposed to the surface. 
Interestingly, the weight loss studies showed significant differences between both types of scaffolds. 
PLA/G5 exhibited a higher and progressive weight loss during the first two weeks of degradation in 
SBF. However, between weeks 4 to 6 the degradation rate decreased significantly. Finally, after 8 
weeks, the composite scaffold showed a weight loss of about 4.5% (Figure 5.3a). On the contrary, PLA 
weight loss started only after two weeks of immersion overtaking the PLA/G5 at 4 weeks and reaching 
the 8% of weight loss after 8 weeks.  As mentioned before, the weak interface between polymer and 
glass particles could be the driving agent of the faster weight loss in composite scaffolds at the initial 
weeks. Since the fourth week to the end of the immersion period the weight loss evolution was 
influenced by other two events strictly related with the incorporation of G5 particles. The first one 
consisted in the possible formation of CaP precipitates on the surface of the composite (PLA/G5) 
scaffolds as observed by Navarro et al. in a previous study on similar materials [26]. To explain the 
second event it is important to remark that PLA generates acidic products (mostly lactic acid) that can 
lower down the pH of the surrounding solution accelerating the degradation in an autocatalytic way 
[27]. Thus, in the case of the composite (PLA/G5) scaffolds, G5 particles acted as a buffer agent for the 
surrounding solution mitigating the degradation process. Both phenomena acted synergistically to slow 
down the composite scaffolds weight loss, which became lower than the polymeric one after 8 weeks.   
However, it is interesting to observe that, excluding the brief sprint of the composite material at the 
early steps, weight loss curves for the 3D scaffolds were quite similar to the one shown by 2D PLA/G5 
films reported in chapter 2. Final weight loss percentages were between 4.5 and 8% for both materials in 
2D and 3D. As mentioned in chapter 2, the presence of PEG domains strongly influenced the 
degradation rate of the 2D materials. In this chapter, same amount of PEG (5%) was used for the 
development of both polymeric and composite scaffolds. The effect of hydrophilic PEG, enhancing the 
fluid erosion at the interface between polymer and G5 particles, led to a faster degradation of the 
PLA/G5 scaffolds during the first weeks of immersion. Furthermore, PEG showed a more determinant 
effect in the degradation process of the polymeric (PLA) scaffolds leading to higher weight loss after 8 
weeks.  
To confirm the degradation of the scaffolds, GPC analysis was carried out. Figure 5.3b shows the data 
obtained from GPC analysis. It displays a continuous decrease in molecular weight values due to the 
progressive cleavage of the polymeric chains. In particular, it seems that the PLA/PEG/G5 reduction of 
molecular weight was less than for the PLA/PEG one. This result was in good agreement with the 
weight loss analysis previously described. It could be explained by the higher concentration of PEG in 
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the PLA scaffold in comparison to the composiste one (PLA/G5) where 50% (w/w) is composed by 
glass particles.    
It is known that an ideal scaffold should gradually transfer the load to the new forming bone during 
degradation [23,28]. Thus, a suitable choice of materials and designs in order to tune both degradation 
rate and mechanical properties should be done. In this study, the values of compressive modulus 
diminished for both scaffolds after 8 weeks of immersion in SBF. Furthermore, diminutions of 25% and 
30% were observed for the PLA and the PLA/G5 scaffolds respectively. Thus, the composite scaffold 
became weaker than the polymeric one. A possible reason could be found observing the SEM 
micrographs (Fig. 5.2). As previously written, PLA/G5 surface was mainly subjected to liquid erosion 
because of the fluid penetration at the interface between polymer and glass particles. The formation of 
fractures together with the weakening of polymer-glass adhesion led to the reduction of its mechanical 
properties. Nevertheless, even after the studied degradation process, composite scaffolds presented 
higher modulus than the one shown by the polymeric scaffold before degradation.  
As already mentioned in the introduction, the general aim of this chapter was the assessment of novel 
biphasic PLA-PLA/G5 scaffolds as temporary supports for GTR and GBR in maxillofacial applications.  
In this in vivo evaluation, the tissue reaction to the biphasic, PLA and PLA/G5 scaffolds was examined. 
Special focus was placed on the integration and degradation of its two morphologically distinct surfaces.  
Results were compared to the ones obtained with pure PLA and PLA/G5 scaffolds to observe whether 
the biphasic material induced two well differentiated responses similar to the ones obtained with PLA 
and PLA/G5 scaffolds or a new combined reaction. 
According to the results, there was neither an acute inflammatory response nor signs of necrosis or 
capsule formation at any of the studied time points for any of the studied materials. After the first 3 days 
of implantation the biological response was similar for the three types of scaffolds, only a mix of fibrin 
and connective tissue with a low content of mononuclear cells was observed. However, after 10 days 
and up to 30 days of implantation the studied materials led different tissue reactions. Basically, PLA 
scaffolds induced mainly the formation of a fiber-rich tissue with numerous mononuclear cells; PLA/G5 
scaffolds showed the presence of a significant amount of blood vessels and multinucleated giant cells; 
and the biphasic scaffold presented both responses depending on the scaffold side.  Thus, it is clear that 
the presence of both the multinucleated giant cells and the formation of blood vessels is related to the 
presence of G5 glass particles. 
In fact, in previous studies it has been reported that G5 possesses pro-angiogenic potential both in vivo 
and in vitro [13,29]. It is believed that the angiogenic potential of this glass is due to the chemotactic 
effect of the Ca ions released by the glass together with the material stiffness [13]. 
Moreover, it has also been stated that there is a close relationship between inflammation and 
vascularization. In particular, a study carried out by Ghanaati et al [6] demonstrated that inflammatory 
cells specifically, multinucleated giant cells are known to promote angiogenesis through the production 
of vascular endothelial growth factor, which is a known promoter of angiogenesis [30]. In this context, 
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biodegradable biomaterials are of special interest since their degradation process may facilitate 
triggering angiogenesis by activating and recruiting inflammatory cells. These inflammatory cells are 
usually partially activated by the degradation products of these materials and participate in the 
degradation process of the material as well as in the secretion of certain cytokines and factors that 
promote vascularization. 
It is clear from the obtained results that scaffolds containing glass particles induced a significantly 
higher amount of multinucleated giant cells. In general, the presence of multinucleated giant cells on the 
surface of the material seems to be the result of cells trying to mediate the cellular and enzymatic 
degradation of the material [30]. According to Figure 5.2 PLA/G5 scaffolds showed a faster degradation 
than PLA structures during the first two weeks of immersion in SBF. Thus, this faster degradation could 
be related to the activation of the formation of a higher amount of multinucleated giant cells. Moreover, 
it is known that giant cell formation is dependent on biomaterial surface properties, requiring the 
adsorption of a specific spectrum of proteins in order to trigger fusion of adherent mononuclear cells 
into multinucleated giant cells [31]. In the present work, it is possible that besides the degradation 
process of the composite material, the glass particles themselves induced this fusion of mononuclear 
cells into multinucleated giant ones. In fact, in previous chapters it has been described how the presence 
of glass particles affects surface properties, and consequently cell response. 
It has been reported that the host multinucleated giant cells and tissue reaction is, in certain way, related 
to both the easiness with which the material is degraded and the generated degradation by-products. 
Indeed, it has been observed that the immune response and formation of multinucleated giant cells with 
further vascularization is highly dependent on the polymer origin (synthetic or natural) [31]. Also, it has 
been seen that variables such as scaffold thickness, porosity, chemical cross-linking, source, and 
purification method of a same polymer affect tissue reaction significantly.  Thus, in addition to G5 
angiogenic potential, differences in the degradation rate between PLA and PLA/G5 could also be 
responsible of the formation of multinucleated giant cells and vascularization in the case of the 
composite scaffolds. 
Differences in vascularization were clearly observed after vessels quantification. Again, materials with 
G5 glass displayed a significantly higher percentage of vessels (Figure 5.8). Furthermore, TRAP 
staining also showed a higher presence of TRAP positive cells when G5 glass particles were present. 
TRAP is recognized to be expressed by osteoclasts, macrophages, lymphocytes, granulocytes and 
multinucleated giant cells [32]. The data shown in this work demonstrated that the PLA-based scaffolds 
used here, in particular the ones containing G5 glass induced a higher amount of TRAP positive cells in 
comparison to PLA. It has been reported that materials that induce TRAP-positive macrophages and the 
fusion of these cells to multinucleated giant cells might undergo greater vascularization than materials 
that induce a TRAP-negative mononuclear cellular inflammatory response [30]. 
As already mentioned the ideal material for GBR/GTR should on one hand, act as a tissue barrier 
membrane for an extended period of time and then become integrated by the surrounding soft tissue, 
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and on the other hand, should trigger tissue vascularization and bone regeneration. In this context, the 
developed biphasic scaffolds combines both characteristics in a satisfactory way. The PLA side acts as a 
temporary barrier while the PLA/G5 side enhances vascularization and therefore contributes to 
regenerate bone tissue. 
This study not only sheds lights on the use of these biphasic scaffolds for GTR/GBR applications but 
also brings up a relevant question on the effect of G5 glass on osteoclast-like cells. Finally, this study 
together with the previous chapter reinforces the possibility to tune the immune cell response by 




In this study, a novel approach to guided bone regeneration has been explored. A biphasic scaffold 
composed by two different compartments: PLA and PLA/G5 has been fabricated and characterized. An 
8 weeks long in vitro degradation showed that scaffolds kept their structural stability while changes in 
morphology were observed, specifically for the PLA/G5 scaffold.  Weight loss was higher for the 
polymeric scaffold, confirming the important effect of PEG in the degradation process. Mechanical 
properties decreased along degradation; nevertheless the PLA/G5 scaffolds presented higher 
compressive modulus than PLA ones, confirming the reinforcing effect of G5 even after immersion 
time. Finally, in vivo evaluation showed prevalence of mononucleated cells in PLA scaffold that did not 
experience relevant vascularization. On the contrary, PLA/G5 showed an elevated number of 
multinucleated giant cells and higher vascularization. The use of such biphasic scaffold represents a 
suitable platform to study the influence of multinucleated giant cells and G5 particles in inducing 
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Chapter 6 - Conclusions   
This thesis is an extensive study on development and characterization of scaffolds for tissue engineering 
applications. An additive manufacturing technique has been used to fabricate 3D structures, specifically a 
low temperature nozzle-based 3-D printer. The starting materials were polylactic acid (PLA) and a 
soluble calcium phosphate glass.  
 
• A full-scale study on the effect of PEG in the PLA-blends has been carried out with the aim of 
developing a novel PLA-based blend, containing PEG as plasticizer, ensuring materials printability 
and thermal stability. Such optimization of the materials and printing condition allowed the 
fabrication of 3D-printed PLA-based scaffolds with various PEG concentrations (5, 10, 20%w/w). 
Structural, surface, and mechanical characterization has been conducted on both film (2D) and 
scaffolds (3D); in addition, an in vitro degradation study has been performed. It has been shown that 
the presence of PEG led to non-uniform geometries, decreased the glass transition temperature and 
the mechanical properties of the scaffolds. Moreover, PEG increased surface roughness, wettability 
and degradation rate of the PLA-blends. Finally, addition of 5% PEG to the PLA-blend, in 
combination with the chosen processing parameters, allowed the fabrication of PLA-based 3D 
scaffolds at low temperature without affecting the polymer blend properties. 
 
• PLA and PLA/G5 scaffolds were fabricated by using two different designs: orthogonal (Orth) and a 
Displaced double layer design (Displ). Displ design allowed decreasing the pore size in the axial 
direction and increase in the transversal direction. Indeed, Orth geometry showed pore size around 
375 μm while for Displ geometry was around 165 μm. 
The achieved 3D-printed scaffolds presented higher-resolution and thinner struts (Φ ≈ 75 μm) with 
respect to the other nozzle-based fabrication systems reported in litterature (250 μm < Φ < 1000 μm). 
Furthermore, this was a suitable direct-printing method in order to tune both surface and bulk 
properties of the scaffolds. Indeed, an interesting strut’s topography due to a) the pores left by the 
evaporation of the solvent during the process and b) the presence of G5 particles exposed on the 
surface was achieved. MicroCT reconstruction of the 3D scaffolds showed fully interconnected 
structures with porosity ranging between 75 and 70% for the polymeric and composite scaffold 
respectively. Moreover glass particles were homogeneously dispersed into the matrix with a 
percentage close to the theorical one that we chose.   
The mechanical properties were considerably higher than conventional fabrication methods such as 
solvent casting (300 kPa) and thermally induced phase separation (4.72 MPa). The compressive 
modulus of PLA scaffolds was found to be 92.32 ± 2.18 MPa for the ORTH design and 28.38 ± 3.99 
MPa for the DISPL one, whereas for PLA/G5 the value increased to 99.81 ± 3.55 MPa for the ORTH 
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and to 44.19 ± 2.67 MPa for the DISPL design. Moreover, addition of G5 particles enhanced the 
mechanical properties of the scaffolds. Such increase was dependent on the scaffolds’ design.  
In vitro biological evaluation demonstrated that the presence of G5, adding bio-chemical and bio-
physical cues, had a positive effect on cell adhesion.  
An optimal set of parameters for the pumping equipment was selected: printing pressure in a range 
between 40 and 80 psi, deposition speed of 3-7 mm/s, and needle diameter of 200 μm (G27). The 
syringe temperature was set at 40-45 ºC while ambient temperature was 25 ± 2ºC. 
The technique/materials combination used in this thesis led to the fabrication of promising fully 
degradable, mechanically stable, bioactive and biocompatible composite scaffolds with well-defined 
architectures valuable for Tissue Engineering applications.  
 
• 3D-printing technique has demonstrated to be a valuable tool to fabricate 3D platforms for in vitro 
study, specifically to analyze and unravel the monocyte/macrophage response to different 
materials/structures. A new setup for the fabrication of 3D-printed Chitosan scaffolds was done and 
two geometries were achieved: orthogonal displaced double layer (O) and orthogonal-diagonal (D) 
scaffolds.  
Metabolic activity of monocytes/macrophages incubated in all scaffolds remained high along time, 
contrarily to cells incubated in TCPS, indicating that the different materials were not cytotoxic. 
Analysis of the cytokines released by macrophages was carried out. PLA-based scaffolds induced 
higher production of IL-6, IL-12/23 (pro-inflammatory cytokines) and IL-10 (anti-inflammatory 
cytokine). Chitosan scaffolds elicited increased secretion of TNF-α (pro-inflammatory cytokine), with 
the geometry of scaffolds impacting on production of TNF-α.  However, cytokine profile was mostly 
affected by material properties and slightly by scaffold properties such as pore geometry. 
Morphological evaluation of the monocytes/macrophages showed: a) rounded cells with filopodia-
like structures, mainly found on PLA and PLA/G5 scaffolds, confirming that this kind of cells prefer 
rough surface; b) multinucleated giant cells (MGCs), more present on ChO, confirming that high 
TNF-α levels are strongly related to granuloma formation; c) elongated cells, more evident in 
chitosan scaffolds, specifically in ChD confirming that they prefer smooth surface. 
 
• A novel therapeutic approach to guided bone regeneration (GBR) by using novel biphasic 3-D printed 
scaffolds has been investigated. Firstly, the design, fabrication, and in vitro degradation of new 
biphasic scaffolds composed by two PLA and PLA/G5 phases were achieved. Structural and 
morphological evaluation showed that the scaffolds maintained structural integrity after 8 weeks of 
degradation. However, changes in morphology are observed at higher magnification due to the G5 
particles more exposed on the surface. Higher weight loss was detected for the polymeric scaffold, 
confirming the important effect of PEG in the degradation process. The mechanical properties of the 
scaffolds decreased along the degradation process. The compressive modulus decreased from 28 to 
21 MPa for PLA scaffolds, while from 44 to 31 MPa for PLA/G5 ones. Such decrease was higher for 
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PLA/G5 scaffolds (30%) than for PLA ones. Anyhow, the reinforcing effect of glass particles was 
observed after the degradation process, when PLA/G5 compressive modulus was still higher than the 
one of the polymeric scaffold.  
In vivo study showed that PLA scaffolds mainly induced mononuclear cells and does not undergo a 
high vascularization. However, the addition of G5 particles enhanced the MGCs formation and 
accordingly enhanced the vascularization of the scaffolds.  
The combination of the two materials (PLA and PLA/G5) by implanting biphasic scaffolds can 
contribute to generate the “ideal” material for GBR/GTR. Indeed, the PLA-side acts as barrier, while 
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Appendix A - Additive manufacturing technique  
Technical specifications 
The 3D-printing tool used in this study is developed and commercialized by “nScrypt, Inc”. This machine 
(Tissue Engineering 3D-300 series) is able to print 3D scaffolds from different materials (such as 
polymer, ceramic, composites and living cell solutions) with large range of viscosities from 1 to 
1,000,000 cps (centipoises). It is connected with a CAD (Computer Aided Design) tool, which allows the 








Air-syringe pump: Also known as Air pressure pump. The air pressure is injected in a syringe containing 
the depositing solution. The syringe is fixed to the motion system, and can be plugged to a wide range of 
needles. Then, due to the pressure, the depositing solution is flowing via the needles, and printed on the 
substrate.  
Displacement pump: Also known as positive displacement pump. In this case, a piston is plugged inside 
the syringe and presses the material solution out of the needle. 
Smart Pump: This is the most important and clever pump of the machine. It is capable of dispensing 
material with a wide range from 1 to 1,000,000 cps (centipoises) precisely with accurately controlled air 
pressure, timing, valve opening and dispensing height. The valve is moving in z direction. To understand 
the process of the smart pump, here is a sketch, which describes the mechanism of operation (Figure A.2): 
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Figure A. 2. Schematic representation of the smart pump. 
 
This valve technology creates a backpressure when the dispensing process finishes, causing the material 
to be pulled back into the print nozzle. This removes the material on the tip and creates a fresh start for 
the next print session. 
 
CAD tool 
The CAD tool is a software that helps the user to create the desired design. Once it has been created, the 
design is sent to the RP machine and creates the desired structure. This is a very useful tool that allows 
the printing of very complex 3D shapes. Three steps are involved in the process for producing a scaffold: 
(i) Draw the design; (ii) Configuration of the machine; (iii) Launch of the RP. 
 
i. This is the very first step of the process. We have to draw the desired design (Figure A.3) with a 
special software. It is like programming, a code is required to create the required 3D design. 
ii. The machine configuration is done by the “Resource Control panel” (Figure A.4). This panel is the 
interface between the machine, the design software and the user. 
iii. Once the machine is configured and the design ready. The “RunForm” panel is opened, and the 
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Figure A. 3. Draw the design 
 
 
Figure A. 4. Resource control panel. 
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Appendix B - Optimization of printing parameters 
Prior to fabrication, standard “calibration curves” for the polymer and composite solutions were generated 
by depositing material lines at various speeds and pressures to establish the range of line widths 
obtainable for a given tip diameter. Different PEG concentrations (5-10-20%W/W) were mixed with PLA 
and G5 in order to evaluate the effect of PEG in the material processing. Two sets of two-dimensional 
structures composed of parallel lines were created: one by fixing the deposition rate at 3 mm s-1 and 
varying the extrusion pressure between 10 and 100 psi, the second by keeping the pressure constant at 50 
psi and varying the deposition rate between 1 and 10 m s-1. For each value of pressure and deposition 
speed, three lines were deposited and their widths were measured using a profilometer (Dektak 6M, 
Veeco) (Figure B.1). The calibration lines of the system were obtained for all polymer solutions and were 
used to establish the optimal printing parameters. 
 
 




Optimization of deposition parameters (“calibration curves”) 
Figure B.2 shows the measured line widths of solutions of PLA/PEG blend at different concentrations 
(20%, 10% and 5% w/w of PEG) and PLA/PEG/G5, respectively, as a function of the applied pressure. It 
is observed that in general, the lines width increases linearly as the applied pressure increases. 
Furthermore, for the same value of pressure, the width increases slightly by decreasing PEG 
concentration (and increasing PLA concentration) while G5 introduction had a more significant effect. 
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Figure B. 2. Line widths of PLA/PEG blend at different concentrations and PLA/PEG/G5 as a function of applied 
pressure. Deposition speed: 3 mm s-1; needle diameter: 200 μm. 
 
Figure B.3 shows line widths as a function of the deposition rate for the same set of solutions. It is 
observed that the lines width decreases remarkably as deposition speed increases. The blends with 20 and 
10 % of PEG (PLA/PEG 80/20 and 90/10) showed similar behaviours. The blend with 5% PEG 
(PLA/PEG 95/5) displayed a remarkable increase in line width in comparison to the other compositions. 




Figure B. 3. Line width of PLA/PEG blend at different concentrations as a function of the deposition speed. The points 
refer to experimental data Driving pressures: 50 psi; needle diameters: 200 μm 
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Dispensing pressure 40 - 80 psi 
Temperature 40 - 45 ºC 
Printing rate 3 mm/s 
Nozzle size 200 μm 
 
Table B. 1. Detailed processing parameters for the fabrication of scaffolds 
 
 
An optimal set of parameters for the pumping equipment was selected from the obtained results, i.e. a 
printing pressure in a range between 40 and 80 psi and a deposition speed of 3 mm/s. Such combination 
of parameters was used with a G27 (200μm) nozzle (Table B.1). The syringe temperature was set at 40-
45 ºC while ambient temperature was 25 ± 2ºC. 
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Appendix C - 3D printed PLA-based scaffolds: a versatile tool in 
regenerative medicine 
 
Rapid prototyping (RP), also known as additive manufacturing (AM), has been well received and adopted 
in the biomedical field. The capacity of this family of techniques to fabricate customized 3D structures 
with complex geometries and excellent reproducibility has revolutionized implantology and regenerative 
medicine. In particular, nozzle-based systems allow the fabrication of high-resolution polylactic acid 
(PLA) structures that are of interest in regenerative medicine. These 3D structures find interesting 
applications in the regenerative medicine field where promising applications including biodegradable 
templates for tissue regeneration purposes, 3D in vitro platforms for studying cell response to different 
scaffolds conditions and for drug screening are considered among others. Scaffolds functionality depends 
not only on the fabrication technique, but also on the material used to build the 3D structure, the geometry 
and inner architecture of the structure, and the final surface properties. All being crucial parameters 
affecting scaffolds success. This Commentary emphasizes the importance of these parameters in 
scaffolds’ fabrication and also draws the attention toward the versatility of these PLA scaffolds as a 
potential tool in regenerative medicine and other medical fields. 
 
1. Introduction 
Additive manufacturing techniques have been welcome in the biomaterials field. This family of 
techniques also known as Rapid prototyping (RP) has become part of the set of techniques currently used 
in the development of new implants and 3D scaffolds for tissue engineering [1-4]. Owing to their capacity 
to build custom-made 3D structures, RP techniques have arisen special interest within the regenerative 
medicine community. In addition to revolutionize implantology and regenerative therapies by introducing 
new possibilities to reconstruct and regenerate tissues in a patient-specific manner, RP also provides a 
tremendous tool to fabricate scaffolds on demand to obtain in vitro platforms for studying the effect of 
various parameters such as scaffolds architecture, pore size, geometry, topography, wettability, and 
mechanical properties among others, on cells behavior including inflammatory response. 
Within the additive manufacturing techniques family, nozzle-depositionbased ones have shown great 
versatility. The approach consisting in a controlled dispensing system integrated with pumping 
technology and a CAD/CAM system allows the precise and reproducible fabrication of 3D structures with 
well-defined predetermined geometries. In particular, the use of this technique to fabricate “high-
resolution” polylactic acid (PLA) 3D structures has been recently reported by us [5].  In that work we 
describe the fabrication of PLA based scaffolds with different geometries and provide valuable 
information on the importance of the different fabrication parameters on both bulk and surface properties, 
and their impact on cell adhesion. In brief, both PLA and PLA/glass scaffolds were 3D-printed using the 
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nozzle-deposition based system (Tissue Engineering 3-Dn-300, Sciperio/nScrypt Inc., available in the 
Rapid Prototyping service of the Biomedical Networking Center, CIBERBBN, and IBEC 
www.ibecbarcelona.eu/biomaterials). Homogeneous polymer and polymer/glass solutions in chloroform 
(5% w/v) were prepared and printed at 3mm/s and a pressure between 40–80 psi, through a G27 (200 μm) 
nozzle. Structures with two different architectures were fabricated: a) orthogonal structures (Fig. C.1a) 
with distance between struts axes (~500μ m) and struts diameter around ~70 μm, and b) displaced double-
layer structures (Fig. C.1d ) with a distance between struts axes of ~250 μm and two layers dispensed in 
each direction [5].  Structural, mechanical and surface properties of the developed scaffolds were studied 
as well as in vitro cell adhesion. Results shown in that work illustrate and highlight the significance of 
factors such as: (1) the material used to fabricate the 3D structure, (2) the geometry and architecture of 




Figure C. 1. SEM images of biodegradable 3D structures with various materials, geometries and architectures, (a) PLA/CaP glass 
composite orthogonal structure; (b) PLA tubular hexagonal mesh; (c,f) Chitosan orthogonal-diagonal structure; (d) PLA 
orthogonal-displaced structure, (e) PLA hexagonal mesh. 
 
 
2. Importance of materials in 3-d printing 
Choosing the right material is crucial to achieve functional 3D structures. Materials’ intrinsic properties 
may affect both surface and bulk properties of the final structure. Moreover, materials’ properties have a 
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direct effect on the attainment of certain predetermined geometries. All these aspects affect the 
mechanical properties and the overall performance of the 3D scaffold. 
In the case of PLA, processing with the already mentioned 3D printing tool allows obtaining highly 
precise structures with better resolution than the ones obtained with other currently used methods [6,7]. 
This improvement in resolution is due to a particular interplay between a set of 
temperature/plasticizer/printing parameters and the post-processing shrinkage of the struts due to solvent 
evaporation that must be carefully tuned in order to obtain such structures [5].  However, if a completely 
different material such as a hydrogel or a PLA/glass composite material is used, results are completely 
different. This is the case of chitosan scaffolds; chitosan is a natural hydrogel that requires in situ cross-
linking to keep the scaffold structural integrity. Moreover, chitosan swells when in contact with aqueous 
media. Thus, structures with significantly larger struts diameter than the pre-defined ones are obtained. 
In the case of composite materials such as PLA/glass particles, though the overall structural results are the 
same as with PLA, the increase of viscosity due to the addition of glass particles in the printing solution 
implies some changes in the printing parameters and the morphology of the final structures. Furthermore, 
from the morphological point of view, incorporation of glass particles in the polymer matrix has a 
significant effect on surface topography. In addition, the presence of glass particles in the scaffold affects 
the mechanical behavior of the structure and its degradation rate [8,9].  In fact, when 50% of glass 
particles (< 40 μ m) are blended in the polymer solution, the elastic modulus of the structures increases 
substantially (PLA = 28.38 ± 3.99 MPa, PLA/glass = 44.19 ± 2.67 MPa; n = 3) [5].  Therefore, it is clear 
that materials’ properties have to be carefully considered since each material requires different and 
specific processing conditions, and each material leads to different structures. 
 
3. Design and architecture of 3D scaffolds 
Design and inner architecture of the 3D structure strongly depends on its final application; in this sense, a 
wide variety of geometries can be developed as the ones depicted in Figure C.1. An important parameter 
affecting cell response is the scaffold geometry including pores size, shape, and struts size and orientation 
among others. Scaffolds architecture not only affects their mechanical performance but also affects their 
permeability, nutrients diffusion and cell response [10]. Indeed, it has been reported that mesenchymal 
stem cells (MSCs) differentiation and proliferation of pre-osteoblastic cells is highly affected by the 
geometry of individual pores within the scaffold [11,12]. 
Also, it has been published that the separation between struts as well as the morphology of pores and the 
angle formed between struts affect macrophages reponse [13].  In fact, we have recently confirmed that 
the variation of scaffold geometry from an orthogonal configuration (squared pores) to a diagonal 
configuration (triangular pores) (see Fig. C.1) affects both macrophages morphology and cytokine 
expression. Furthermore, orthogonal scaffolds promoted the presence of rounded multinucleated giant 
cells, whereas diagonal ones lead to elongated macrophages. 
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Moreover, the distribution of struts and their thickness may also affect significantly on the mechanical 
properties of the final scaffolds. As a matter of fact, it has been shown that by modifying scaffolds 
geometry from an orthogonal design to a displaced or shifted one (Fig. C.1a and d), there is a substantial 
variation on the compressive modulus of both scaffolds (Eorthogonal  = 93.32 ± 2.18; Edisplaced  = 28.38 ± 
3.99MPa; n = 3) as described by us [5].  Thus, depending on the mechanical requirements of the final 
application, the right material/design combination has to be chosen in order to get the most adequate 
structures. 
Additionally to struts’ orientation and conformation, struts’ thickness plays an important role. Thinner 
rods contribute to increasing the specific area of the scaffolds considerably and therefore the contact area 
between material and cells increases. However, diminishing struts diameter implies that the number of 
rods required to build a specific volume increases and therefore longer fabrication times are required. 
Nonetheless, higher scaffolds resolution is a valuable asset as pointed by Hollister et al. [14] who stated 
that one of the technical constraints of currently used solid free form techniques in order to fulfill 
scaffolds translation to clinic is their limitation in terms of feature size resolution to the hundreds of 
micron scale. Albeit this is the case in most of the work published in this area, the work reported by us 
reveals that high resolution structures with features below the hundreds of microns are possible with 
nozzle-based printing technology [5]. 
 
4. Enhancing cell response by controlling surface properties 
Overall, the success of a biomaterial strongly depends on its interaction with the biological environment. 
There are applications where a direct and tight contact between the tissue and the material is required 
while there are other applications where a rather antifouling behavior 
is needed. Hence, it is clear that biomaterials surfaces are crucial to enhance and control the biological 
response of scaffolds and implantable devices. Both surface chemistry and surface topography are the 
most important features affecting biomaterials biological response. 
Modification of surface chemistry is the most direct way to influence protein adsorption and therefore cell 
behavior. By tailoring functional groups available at the material surface it is possible to modify its 
surface properties, and consequently its wettability, surface electrical charges, and free energy are also 
changed. As a result, the affinity of some proteins and cellular response for a particular substrate is 
altered. Nowadays, different techniques aimed to modify scaffolds’ surface have been developed [15–18], 
among them surface functionalization with proteins or peptide sequences as well as the incorporation of 
an inorganic bioactive phase that triggers specific cell events have been successfully achieved. 
 
4.1. Surface functionalization with bioactive molecules 
Coupling functional groups, or specific biomolecules such as functional peptides to the surface by means 
of chemical treatments is one the most currently studied methods for improving biomaterials bioactivity. 
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In this context, surface functionalization of the already mentioned PLA 3D printed scaffolds with 
collagen has been investigated. Both, physisorbed and covalently bonded collagen surface coatings have 
been achieved. In the case of physical absorption, the scaffolds were directly immersed in a solution 
containing collagen, whereas to achieve covalent bonding the surface was previously treated with NaOH 
+ EDC/NHS in order to activate the accessible functional groups and subsequently immersed in the 
collagen solution (100 μg/ml in PBS, 24h at room temperature). Both types of samples were evaluated 
and characterized by CBQCA and Micro BCA assays to evaluate the amount and distribution 
of the biomolecule on the surface of the scaffolds. The experiment was performed in triplicate. As 
observed in Figure C.2, fully and homogeneously collagen covered scaffolds were obtained (Fig. C.2a). 
In addition, a higher protein density was quantified on the covalently functionalized scaffolds (Fig. C.2c). 
Also, a cell viability assay was performed to measure cell adhesion on both non-functionalized and 
functionalized (covalently attached collagen) scaffolds. Mesenchymal stem cells (3 × 105 cells/scaffold) 
were seeded in the scaffolds, polystyrene microplate wells were used as control. Cell adhesion was 
studied at 4 and 24 h using a LDH assay kit. Results shown in Figure C.2d are expressed as the average 
absorbance levels of three samples (Fig. C.2d). An ANOVA analysis was performed to establish possible 
statistical significant differences (p ≤ 0.05) in the absorbance values. Cell studies  showed a positive cell 
response in the functionalized scaffolds. In fact, after 72 h of culture, mesenchymal stem cells were very 
well spread and completely covering the scaffold surface (Fig. C.2b). 
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Figure C. 2. Surface functionalization of PLA 3D scaffolds: (a) Fully and homogeneously collagen covered scaffold; (b) rMSCs 
cultured on the functionalized scaffolds after 72 h; (c) Quantification of the amount of collagen on the scaffolds surface. 
Covalently functionalized scaffolds showed a significantly higher protein density than physisorbed ones; (d) LDH assay of 
adhered rMS Cs after 4 and 24h of culture on both covalently- and non-functionalized PLA scaffolds. Functionalized scaffolds 
showed a higher number of viable cells after 24h. The values marked with asterisk (*) showed statistical significant differences 
(p ≤ 0.05). 
 
 
4.2. Improving surface bioactivity by adding inorganic particles 
As previously mentioned, other method for modifying surface chemistry is by adding bioactive inorganic 
particles to the PLA matrix. In this line, addition of a soluble, bioactive CaP glass, known as G5 [19,20], 
in particles shape to reinforce and improve bioactivity of PLA scaffolds has been explored [9]. It is 
known that G5 glass is highly hydrophilic (contact angle = 29.8°) [21]. Thus, addition of G5 particles 
contributes to decrease PLA contact angle. Previous studies have demonstrated a preferential attachment 
and spreading of cells on G5 glass particles than in the polymer matrix [10,21]. This soluble glass 
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degrades along time while releasing different ions to the surrounding media [19]. It has been 
demonstrated that the presence of G5 glass particles not only increases cell attachment and spreading but 
also triggers angiogenesis and bone formation owing the Ca2+ release and stiffness of the glass [22,23].  
Indeed, several studies have demonstrated the relevant role of ions on tissue regeneration [24,25].  Given 
that the glass particles incorporated into the polymer scaffold are partially exposed in the surface, as 
demonstrated by an alizarin red assay (where only the calcified inorganic phase is stained in red color, 
Fig. 3b), their presence contribute both to modify surface chemistry and surface topography.  
Addition of G5 particles into the polymer matrix introduced an interesting topography to the scaffold 
surface as observed in Figure 3a and c. In addition, the surface of the polymer struts showed micro and 
nanopores left by the evaporation of the solvent (see Fig. 3d). Thus, the final structures presented a 
combination of porosities and other topography features ranging from the macroscale due to the pores 
initially designed to the micro and nanoscale due to solvent evaporation and the presence of glass 
particles. According to the interferometry results, the addition of glass particles significantly increased the 
average roughness (Sa) of the surface in comparison to PLA (PLA = 117.72 ± 60.50 nm, PLA/glass = 
1003.89 ± 228.45 nm; n = 9) [5].  It is known that both surface micro and nanoporosity play important 
roles in protein adhesion and therefore on cell response [26]. Surface nanoporosity not only increases the 
contact surface area between the material and biological entities but also generates nanoscale 
topographical cues affecting cell behavior. In fact, enhancement of cell interaction due to nanotopography 
has been reported [27,28]. Cells do not interact directly with biomaterials, but with an absorbed protein 
layer that provides anchoring sequences to cells. Protein adsorption is highly dependent on surface 
properties; in particular, it is believed that since the dimensions of surface nanofeatures are closer to 
proteins, their interaction is stronger. Thus, controlled nanoporosity might play an important role in 
biological interactions. 
We reported on the results of rMSCs response to PLA and PLA/CaP glass scaffolds with similar 
architecture at short periods of time. Cell viability (WST assay, n = 3) and morphology (confocal 
microscopy observation upon nuclei and cytoskeleton staining) were evaluated after 4 and 24 h of 
adhesion in contact with the materials. Results revealed that although both materials displayed similar cell 
viability results, noteworthy differences were observed in cells’ morphology when comparing both types 
of scaffolds. After 4 h, immunofluorescence images showed well spread cells with extended cytoskeleton 
on the scaffolds with CaP glass particles and relatively rounded cells on the PLA scaffolds. Thus, the 
obtained results suggested clear early cell morphological differences due to topographical and chemical 
changes [5]. 
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Figure C. 3. SEM images of (a and c) PLA/CaP glass composite scaffolds showing glass distribution and glass/polymer interface, 
white arrows indicate glass particles; (d) Struts of a PLA scaffold showing the micro and nanoporosity left after solvent 
evaporation; (b) PLA/CaP glass scaffold after Alizarin red staining. Red colored areas denote the CaP inorganic phase indicating 
the glass particles exposed on the scaffold surface. 
 
5. Conclusions 
Data reported by us is a glimpse that opens new possibilities to produce novel PLA-based scaffolds with 
finely tuned architectures at a higher resolution than currently used methods. As described in the previous 
sections, the success of 3D scaffolds depends on the combination of the appropriate materials with the 
right design and the right fabrication technique and fabrication conditions that lead to the attainment of 
tailored 3D structures adapted to specific needs. Current fabrication tools allow obtaining tridimensional 
structures with complex architectures and surface properties on demand. In this sense, the possibility to 
build customized scaffolds combining various bulk and surface properties is of main interest not only in 
the tissue/organs engineering field, where the aim is to obtain temporal templates with properties adapted 
to the tissue to be regenerated; but also, in drug screening and in certain malignancies therapeutics such as 
in cancer [29]. Three-dimensional scaffolds provide an environment able to recapitulate in vivo conditions 
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in a more resembling way than traditional 2D in vitro cell culture systems. In particular, in the case of 
cancer, it has been reported that tumor phenotype is governed by the 3D tumor microenvironment. Thus, 
3D scaffolds seem to be a good option to mimic tumor architecture and the in vivo scenario. 
In the same direction, it could be expected that in a near future advances in the fabrication techniques and 
development of 3D structures will provide scaffolds that allow a better replica of the in vivo milieu. 
Having templates that better mimic the in vivo microenvironment could lead to both, better scaffolds for 
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